"ID"	"Pathway"	"zscore"	"obs"	"mean"	"std"
"R-HSA-163200"	"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins."	"185.999"	"2267"	"156.28"	"11.348"
"R-HSA-611105"	"Respiratory electron transport"	"180.129"	"2245"	"154.32"	"11.607"
"R-HSA-6799198"	"Complex I biogenesis"	"177.77"	"1635"	"94"	"8.668"
"R-HSA-1428517"	"The citric acid (TCA) cycle and respiratory electron transport"	"142.888"	"2784"	"328.92"	"17.182"
"R-HSA-1430728"	"Metabolism"	"62.272"	"6999"	"3648"	"53.812"
"R-HSA-5368287"	"Mitochondrial translation"	"39.135"	"873"	"245.48"	"16.035"
"R-HSA-5368286"	"Mitochondrial translation initiation"	"39.112"	"809"	"226.74"	"14.887"
"R-HSA-5389840"	"Mitochondrial translation elongation"	"38.929"	"824"	"233.4"	"15.171"
"R-HSA-5419276"	"Mitochondrial translation termination"	"36.725"	"818"	"230.1"	"16.008"
"R-HSA-1268020"	"Mitochondrial protein import"	"34.121"	"667"	"180.22"	"14.266"
"R-HSA-917977"	"Transferrin endocytosis and recycling"	"31.718"	"474"	"134.8"	"10.694"
"R-HSA-71406"	"Pyruvate metabolism and Citric Acid (TCA) cycle"	"29.423"	"555"	"177.44"	"12.832"
"R-HSA-77387"	"Insulin receptor recycling"	"28.352"	"473"	"130.5"	"12.08"
"R-HSA-1222556"	"ROS, RNS production in phagocytes"	"27.857"	"464"	"133.64"	"11.859"
"R-HSA-389661"	"Glyoxylate metabolism and glycine degradation"	"25.241"	"274"	"73.48"	"7.944"
"R-HSA-2142789"	"Ubiquinol biosynthesis"	"24.998"	"70"	"8.3"	"2.468"
"R-HSA-71403"	"Citric acid cycle (TCA cycle)"	"24.44"	"357"	"110.56"	"10.084"
"WP3349"	"TP53 Regulates Metabolic Genes"	"23.577"	"795"	"364.38"	"18.264"
"hsa00620"	"Pyruvate metabolism"	"19.338"	"235"	"76.26"	"8.209"
"SMP00128"	"Gluconeogenesis"	"19.2"	"499"	"185.28"	"16.34"
"R-HSA-204174"	"Regulation of pyruvate dehydrogenase (PDH) complex"	"18.878"	"181"	"55.38"	"6.654"
"R-HSA-70895"	"Branched-chain amino acid catabolism"	"18.611"	"158"	"45.14"	"6.064"
"R-HSA-389960"	"Formation of tubulin folding intermediates by CCT/TriC"	"17.861"	"768"	"404.4"	"20.357"
"R-HSA-77289"	"Mitochondrial Fatty Acid Beta-Oxidation"	"17.552"	"98"	"21.44"	"4.362"
"R-HSA-70350"	"Fructose catabolism"	"17.526"	"86"	"17.64"	"3.901"
"R-HSA-6798695"	"Neutrophil degranulation"	"17.146"	"1981"	"1370.84"	"35.585"
"R-HSA-111458"	"Formation of apoptosome"	"16.904"	"33"	"3.94"	"1.719"
"R-HSA-71387"	"Metabolism of carbohydrates"	"16.758"	"1199"	"752.44"	"26.647"
"R-HSA-74752"	"Signaling by Insulin receptor"	"16.659"	"566"	"305.98"	"15.608"
"R-HSA-70326"	"Glucose metabolism"	"16.437"	"907"	"529.74"	"22.952"
"R-HSA-5362517"	"Signaling by Retinoic Acid"	"16.436"	"260"	"107.72"	"9.265"
"R-HSA-389958"	"Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding"	"16.166"	"838"	"458.24"	"23.492"
"R-HSA-5652084"	"Fructose metabolism"	"16.067"	"90"	"21.14"	"4.286"
"R-HSA-8949613"	"Cristae formation"	"15.924"	"22"	"1.4"	"1.294"
"R-HSA-163210"	"Formation of ATP by chemiosmotic coupling"	"15.924"	"22"	"1.4"	"1.294"
"R-HSA-180897"	"Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization"	"15.506"	"140"	"41.58"	"6.347"
"SMP00040"	"Glycolysis"	"14.869"	"794"	"488.64"	"20.536"
"R-HSA-389957"	"Prefoldin mediated transfer of substrate  to CCT/TriC"	"14.592"	"677"	"383.8"	"20.094"
"R-HSA-917937"	"Iron uptake and transport"	"14.541"	"829"	"456.14"	"25.641"
"R-HSA-983712"	"Ion channel transport"	"14.4"	"863"	"496.28"	"25.466"
"R-HSA-71064"	"Lysine catabolism"	"14.133"	"107"	"32.18"	"5.294"
"R-HSA-389977"	"Post-chaperonin tubulin folding pathway"	"14.103"	"568"	"287.68"	"19.877"
"R-HSA-382551"	"Transport of small molecules"	"14.044"	"1571"	"1094.16"	"33.953"
"R-HSA-3299685"	"Detoxification of Reactive Oxygen Species"	"14.02"	"192"	"77.46"	"8.17"
"R-HSA-6787450"	"tRNA modification in the mitochondrion"	"13.827"	"47"	"8.8"	"2.763"
"R-HSA-8949215"	"Mitochondrial calcium ion transport"	"13.579"	"150"	"55.18"	"6.983"
"WP3331"	"Mitochondrial biogenesis"	"13.445"	"225"	"107.24"	"8.759"
"R-HSA-379724"	"tRNA Aminoacylation"	"13.426"	"266"	"129.38"	"10.176"
"R-HSA-8955332"	"Carboxyterminal post-translational modifications of tubulin"	"13.318"	"486"	"247.16"	"17.933"
"R-HSA-15869"	"Metabolism of nucleotides"	"13.249"	"363"	"185.78"	"13.376"
"R-HSA-499943"	"Interconversion of nucleotide di- and triphosphates"	"13.181"	"222"	"100.54"	"9.214"
"R-HSA-446219"	"Synthesis of substrates in N-glycan biosythesis"	"12.926"	"158"	"72.14"	"6.643"
"R-HSA-2151201"	"Transcriptional activation of mitochondrial biogenesis"	"12.721"	"153"	"63.56"	"7.031"
"R-HSA-446193"	"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein"	"12.466"	"162"	"78.28"	"6.716"
"R-HSA-6788656"	"Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism"	"12.127"	"123"	"46.84"	"6.28"
"R-HSA-111457"	"Release of apoptotic factors from the mitochondria"	"12.005"	"40"	"6.9"	"2.757"
"R-HSA-77305"	"Beta oxidation of palmitoyl-CoA to myristoyl-CoA"	"11.995"	"34"	"5.88"	"2.344"
"R-HSA-1614635"	"Sulfur amino acid metabolism"	"11.981"	"138"	"60.62"	"6.458"
"R-HSA-1362409"	"Mitochondrial iron-sulfur cluster biogenesis"	"11.872"	"49"	"10.4"	"3.251"
"R-HSA-351202"	"Metabolism of polyamines"	"11.596"	"93"	"38.9"	"4.665"
"R-HSA-71384"	"Ethanol oxidation"	"11.504"	"119"	"53.8"	"5.668"
"R-HSA-77286"	"mitochondrial fatty acid beta-oxidation of saturated fatty acids"	"11.436"	"54"	"11.94"	"3.678"
"R-HSA-392499"	"Metabolism of proteins"	"11.304"	"7638"	"6550.78"	"96.183"
"R-HSA-379716"	"Cytosolic tRNA aminoacylation"	"11.192"	"198"	"102.32"	"8.549"
"R-HSA-156580"	"Phase II - Conjugation of compounds"	"11.057"	"220"	"107.46"	"10.178"
"R-HSA-6783984"	"Glycine degradation"	"10.874"	"54"	"13.38"	"3.736"
"WP698"	"Glucuronidation"	"10.248"	"48"	"17.56"	"2.97"
"R-HSA-168249"	"Innate Immune System"	"10.215"	"3602"	"3012.2"	"57.737"
"R-HSA-5365859"	"RA biosynthesis pathway"	"10.07"	"97"	"42.12"	"5.45"
"R-HSA-111459"	"Activation of caspases through apoptosome-mediated cleavage"	"10.008"	"38"	"8.92"	"2.906"
"R-HSA-111461"	"Cytochrome c-mediated apoptotic response"	"10.008"	"38"	"8.92"	"2.906"
"R-HSA-2408508"	"Metabolism of ingested SeMet, Sec, MeSec into H2Se"	"9.914"	"101"	"44.82"	"5.667"
"R-HSA-72766"	"Translation"	"9.871"	"1931"	"1521"	"41.534"
"R-HSA-390450"	"Folding of actin by CCT/TriC"	"9.642"	"245"	"149.52"	"9.902"
"R-HSA-446205"	"Synthesis of GDP-mannose"	"9.324"	"81"	"30.14"	"5.455"
"R-HSA-70635"	"Urea cycle"	"9.245"	"57"	"20.44"	"3.955"
"R-HSA-111471"	"Apoptotic factor-mediated response"	"9.219"	"48"	"14.34"	"3.651"
"R-HSA-8978868"	"Fatty acid metabolism"	"9.203"	"275"	"163.16"	"12.153"
"R-HSA-8873719"	"RAB geranylgeranylation"	"9.124"	"210"	"116.76"	"10.219"
"R-HSA-3371497"	"HSP90 chaperone cycle for steroid hormone receptors (SHR)"	"9.035"	"588"	"407.26"	"20.005"
"R-HSA-70614"	"Amino acid synthesis and interconversion (transamination)"	"8.748"	"106"	"46.04"	"6.854"
"R-HSA-211859"	"Biological oxidations"	"8.725"	"445"	"297.74"	"16.879"
"R-HSA-156581"	"Methylation"	"8.62"	"111"	"51.92"	"6.854"
"R-HSA-8854214"	"TBC/RABGAPs"	"8.568"	"213"	"127.84"	"9.939"
"R-HSA-390466"	"Chaperonin-mediated protein folding"	"8.508"	"992"	"736.4"	"30.043"
"R-HSA-5689880"	"Ub-specific processing proteases"	"8.442"	"1715"	"1357.22"	"42.379"
"R-HSA-391251"	"Protein folding"	"8.27"	"993"	"740.18"	"30.573"
"R-HSA-8982491"	"Glycogen metabolism"	"8.26"	"145"	"77.42"	"8.182"
"R-HSA-379726"	"Mitochondrial tRNA aminoacylation"	"8.255"	"87"	"40.64"	"5.616"
"R-HSA-189451"	"Heme biosynthesis"	"8.16"	"40"	"12.9"	"3.321"
"R-HSA-446210"	"Synthesis of UDP-N-acetyl-glucosamine"	"7.955"	"62"	"26.18"	"4.503"
"R-HSA-189445"	"Metabolism of porphyrins"	"7.934"	"48"	"16.98"	"3.91"
"R-HSA-75108"	"Activation, myristolyation of BID and translocation to mitochondria"	"7.838"	"30"	"8.32"	"2.766"
"R-HSA-8849175"	"Threonine catabolism"	"7.746"	"41"	"14.18"	"3.462"
"R-HSA-8978934"	"Metabolism of cofactors"	"7.656"	"156"	"84.2"	"9.379"
"R-HSA-1483166"	"Synthesis of PA"	"7.644"	"64"	"22.98"	"5.366"
"R-HSA-189200"	"Cellular hexose transport"	"7.329"	"54"	"20.4"	"4.585"
"R-HSA-196854"	"Metabolism of vitamins and cofactors"	"7.304"	"349"	"239.44"	"15.001"
"R-HSA-70370"	"Galactose catabolism"	"7.267"	"49"	"15.76"	"4.574"
"R-HSA-168277"	"Influenza Virus Induced Apoptosis"	"7.213"	"46"	"16.36"	"4.11"
"R-HSA-173599"	"Formation of the active cofactor, UDP-glucuronate"	"7.148"	"28"	"9.94"	"2.527"
"R-HSA-196780"	"Biotin transport and metabolism"	"7.086"	"51"	"21.12"	"4.217"
"R-HSA-70221"	"Glycogen breakdown (glycogenolysis)"	"6.93"	"109"	"56.7"	"7.546"
"R-HSA-204626"	"Hypusine synthesis from eIF5A-lysine"	"6.926"	"56"	"24.88"	"4.493"
"R-HSA-196849"	"Metabolism of water-soluble vitamins and cofactors"	"6.75"	"165"	"98.34"	"9.876"
"R-HSA-75876"	"Synthesis of very long-chain fatty acyl-CoAs"	"6.651"	"77"	"38.98"	"5.716"
"R-HSA-3371568"	"Attenuation phase"	"6.369"	"586"	"451.72"	"21.083"
"R-HSA-71737"	"Pyrophosphate hydrolysis"	"6.311"	"44"	"18.46"	"4.047"
"R-HSA-162699"	"Synthesis of dolichyl-phosphate mannose"	"6.21"	"14"	"3.24"	"1.733"
"R-HSA-3371571"	"HSF1-dependent transactivation"	"6.166"	"609"	"479"	"21.085"
"R-HSA-156590"	"Glutathione conjugation"	"6.14"	"58"	"26.4"	"5.147"
"R-HSA-5689603"	"UCH proteinases"	"6.127"	"1044"	"827.52"	"35.329"
"R-HSA-71336"	"Pentose phosphate pathway (hexose monophosphate shunt)"	"6.065"	"70"	"33.04"	"6.094"
"R-HSA-75105"	"Fatty acyl-CoA biosynthesis"	"6.012"	"107"	"60.72"	"7.699"
"R-HSA-1614603"	"Cysteine formation from homocysteine"	"5.915"	"36"	"15.62"	"3.446"
"R-HSA-164516"	"Minus-strand DNA synthesis"	"5.912"	"24"	"10.08"	"2.355"
"R-HSA-164525"	"Plus-strand DNA synthesis"	"5.912"	"24"	"10.08"	"2.355"
"R-HSA-162589"	"Reverse Transcription of HIV RNA"	"5.912"	"24"	"10.08"	"2.355"
"R-HSA-162585"	"Uncoating of the HIV Virion"	"5.912"	"24"	"10.08"	"2.355"
"R-HSA-3322077"	"Glycogen synthesis"	"5.875"	"58"	"29.78"	"4.803"
"R-HSA-8956320"	"Nucleobase biosynthesis"	"5.833"	"103"	"58.78"	"7.582"
"R-HSA-1483206"	"Glycerophospholipid biosynthesis"	"5.765"	"172"	"111.56"	"10.485"
"R-HSA-3371511"	"HSF1 activation"	"5.752"	"563"	"438.68"	"21.613"
"R-HSA-8949664"	"Processing of SMDT1"	"5.752"	"49"	"21.52"	"4.778"
"R-HSA-5688426"	"Deubiquitination"	"5.729"	"1937"	"1660.88"	"48.201"
"R-HSA-196108"	"Pregnenolone biosynthesis"	"5.727"	"21"	"6.66"	"2.504"
"R-HSA-74182"	"Ketone body metabolism"	"5.63"	"29"	"10.68"	"3.254"
"R-HSA-73728"	"RNA Polymerase I Promoter Opening"	"5.592"	"541"	"412.2"	"23.033"
"R-HSA-1296346"	"Tandem pore domain potassium channels"	"5.587"	"10"	"1.98"	"1.436"
"R-HSA-9007101"	"Rab regulation of trafficking"	"5.499"	"325"	"248.02"	"13.998"
"R-HSA-171306"	"Packaging Of Telomere Ends"	"5.418"	"496"	"380.9"	"21.242"
"R-HSA-912446"	"Meiotic recombination"	"5.342"	"511"	"390.7"	"22.518"
"R-HSA-1483148"	"Synthesis of PG"	"5.328"	"19"	"4.8"	"2.665"
"R-HSA-77288"	"mitochondrial fatty acid beta-oxidation of unsaturated fatty acids"	"5.239"	"15"	"4"	"2.1"
"R-HSA-180024"	"DARPP-32 events"	"5.23"	"251"	"184.16"	"12.78"
"R-HSA-380612"	"Metabolism of serotonin"	"5.157"	"33"	"15.24"	"3.444"
"R-HSA-1296052"	"Ca2+ activated K+ channels"	"5.15"	"23"	"7.7"	"2.971"
"R-HSA-380615"	"Serotonin clearance from the synaptic cleft"	"5.136"	"33"	"15.42"	"3.423"
"R-HSA-202670"	"ERKs are inactivated"	"5.066"	"147"	"99.22"	"9.431"
"R-HSA-1299308"	"Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)"	"4.953"	"7"	"1.42"	"1.126"
"R-HSA-156587"	"Amino Acid conjugation"	"4.94"	"5"	"0.06"	"0.24"
"R-HSA-159424"	"Conjugation of carboxylic acids"	"4.94"	"5"	"0.06"	"0.24"
"R-HSA-5334118"	"DNA methylation"	"4.92"	"512"	"402.1"	"22.339"
"R-HSA-163841"	"Gamma carboxylation, hypusine formation and arylsulfatase activation"	"4.879"	"88"	"53"	"7.174"
"R-HSA-73817"	"Purine ribonucleoside monophosphate biosynthesis"	"4.868"	"68"	"38.88"	"5.982"
"R-HSA-8876198"	"RAB GEFs exchange GTP for GDP on RABs"	"4.86"	"239"	"178.26"	"12.498"
"R-HSA-556833"	"Metabolism of lipids"	"4.765"	"948"	"820.46"	"26.764"
"R-HSA-77111"	"Synthesis of Ketone Bodies"	"4.729"	"25"	"10.2"	"3.13"
"WP3397"	"Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3"	"4.725"	"520"	"414.86"	"22.253"
"R-HSA-450282"	"MAPK targets/ Nuclear events mediated by MAP kinases"	"4.719"	"260"	"197.48"	"13.25"
"R-HSA-111447"	"Activation of BAD and translocation to mitochondria "	"4.698"	"197"	"148.84"	"10.251"
"R-HSA-163754"	"Insulin effects increased synthesis of Xylulose-5-Phosphate"	"4.689"	"27"	"10.4"	"3.54"
"R-HSA-112311"	"Neurotransmitter clearance"	"4.641"	"33"	"16.32"	"3.594"
"R-HSA-2978092"	"Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate"	"4.602"	"15"	"4.02"	"2.386"
"R-HSA-5668914"	"Diseases of metabolism"	"4.602"	"15"	"4.02"	"2.386"
"R-HSA-389542"	"NADPH regeneration"	"4.602"	"15"	"4.02"	"2.386"
"R-HSA-194840"	"Rho GTPase cycle"	"4.598"	"296"	"226.56"	"15.101"
"R-HSA-72731"	"Recycling of eIF2:GDP"	"4.577"	"76"	"48.3"	"6.052"
"R-HSA-427359"	"SIRT1 negatively regulates rRNA expression"	"4.378"	"522"	"418.46"	"23.649"
"WP1841"	"Intrinsic Pathway for Apoptosis"	"4.303"	"322"	"260.28"	"14.343"
"R-HSA-74217"	"Purine salvage"	"4.294"	"28"	"13.96"	"3.27"
"R-HSA-1614558"	"Degradation of cysteine and homocysteine"	"4.292"	"30"	"13.14"	"3.928"
"R-HSA-1614517"	"Sulfide oxidation to sulfate"	"4.257"	"8"	"2.42"	"1.311"
"R-HSA-6782315"	"tRNA modification in the nucleus and cytosol"	"4.025"	"58"	"35.24"	"5.655"
"R-HSA-212300"	"PRC2 methylates histones and DNA"	"4.01"	"574"	"475.02"	"24.682"
"R-HSA-177128"	"Conjugation of salicylate with glycine"	"3.94"	"4"	"0.06"	"0.24"
"R-HSA-168256"	"Immune System"	"3.938"	"4718"	"4463.22"	"64.701"
"R-HSA-187042"	"TRKA activation by NGF"	"3.903"	"65"	"43.98"	"5.385"
"R-HSA-5205685"	"Pink/Parkin Mediated Mitophagy"	"3.884"	"369"	"294.36"	"19.217"
"R-HSA-164378"	"PKA activation in glucagon signalling"	"3.853"	"103"	"74.58"	"7.376"
"R-HSA-5620922"	"BBSome-mediated cargo-targeting to cilium"	"3.841"	"139"	"106.22"	"8.534"
"R-HSA-198753"	"ERK/MAPK targets"	"3.815"	"169"	"128.48"	"10.62"
"R-HSA-5576886"	"Phase 4 - resting membrane potential"	"3.799"	"11"	"3.8"	"1.895"
"R-HSA-168330"	"Viral RNP Complexes in the Host Cell Nucleus"	"3.795"	"62"	"39.74"	"5.865"
"R-HSA-450341"	"Activation of the AP-1 family of transcription factors"	"3.783"	"156"	"113.14"	"11.33"
"R-HSA-198725"	"Nuclear Events (kinase and transcription factor activation)"	"3.749"	"173"	"134.96"	"10.146"
"R-HSA-418457"	"cGMP effects"	"3.704"	"26"	"11.96"	"3.79"
"R-HSA-77346"	"Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA"	"3.698"	"23"	"10.26"	"3.445"
"R-HSA-187706"	"Signalling to p38 via RIT and RIN"	"3.681"	"67"	"46.44"	"5.585"
"R-HSA-1483257"	"Phospholipid metabolism"	"3.68"	"282"	"223.44"	"15.913"
"R-HSA-2395516"	"Electron transport from NADPH to Ferredoxin"	"3.64"	"4"	"0.36"	"0.485"
"R-HSA-936837"	"Ion transport by P-type ATPases"	"3.638"	"112"	"78.3"	"9.263"
"R-HSA-8876725"	"Protein methylation"	"3.63"	"203"	"158.78"	"12.181"
"R-HSA-163685"	"Integration of energy metabolism"	"3.575"	"436"	"369.32"	"18.652"
"R-HSA-170984"	"ARMS-mediated activation"	"3.553"	"103"	"77.82"	"7.087"
"R-HSA-77348"	"Beta oxidation of octanoyl-CoA to hexanoyl-CoA"	"3.512"	"21"	"9.58"	"3.252"
"R-HSA-500753"	"Pyrimidine biosynthesis"	"3.495"	"35"	"19.9"	"4.32"
"R-HSA-196757"	"Metabolism of folate and pterines"	"3.492"	"48"	"32.76"	"4.364"
"R-HSA-2408517"	"SeMet incorporation into proteins"	"3.434"	"60"	"40.68"	"5.626"
"R-HSA-8953897"	"Cellular responses to external stimuli"	"3.426"	"2779"	"2532.32"	"72.009"
"R-HSA-210455"	"Astrocytic Glutamate-Glutamine Uptake And Metabolism"	"3.42"	"11"	"3.94"	"2.064"
"R-HSA-112313"	"Neurotransmitter uptake and metabolism In glial cells"	"3.42"	"11"	"3.94"	"2.064"
"R-HSA-163767"	"PP2A-mediated dephosphorylation of key metabolic factors"	"3.419"	"85"	"59.78"	"7.377"
"R-HSA-1475029"	"Reversible hydration of carbon dioxide"	"3.398"	"9"	"2.86"	"1.807"
"R-HSA-5578775"	"Ion homeostasis"	"3.336"	"121"	"88.88"	"9.629"
"R-HSA-381070"	"IRE1alpha activates chaperones"	"3.281"	"65"	"44.66"	"6.199"
"R-HSA-73843"	"5-Phosphoribose 1-diphosphate biosynthesis"	"3.27"	"14"	"6.36"	"2.337"
"R-HSA-211945"	"Phase I - Functionalization of compounds"	"3.265"	"225"	"188.02"	"11.327"
"R-HSA-450513"	"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA"	"3.256"	"97"	"68.3"	"8.814"
"R-HSA-114608"	"Platelet degranulation "	"3.243"	"384"	"325.98"	"17.891"
"R-HSA-3065676"	"SUMO is conjugated to E1 (UBA2:SAE1)"	"3.213"	"146"	"117.72"	"8.802"
"R-HSA-190840"	"Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane"	"3.212"	"11"	"4.7"	"1.961"
"R-HSA-75035"	"Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex"	"3.198"	"191"	"162.32"	"8.968"
"R-HSA-3065679"	"SUMO is proteolytically processed"	"3.192"	"146"	"116.46"	"9.254"
"R-HSA-2262752"	"Cellular responses to stress"	"3.191"	"2594"	"2356.24"	"74.517"
"R-HSA-5620920"	"Cargo trafficking to the periciliary membrane"	"3.141"	"190"	"156.2"	"10.761"
"R-HSA-8956321"	"Nucleotide salvage"	"3.119"	"32"	"19.64"	"3.963"
"R-HSA-157579"	"Telomere Maintenance"	"3.082"	"638"	"559.9"	"25.34"
"R-HSA-977225"	"Amyloid fiber formation"	"3.062"	"811"	"691.36"	"39.078"
"R-HSA-77108"	"Utilization of Ketone Bodies"	"3.039"	"12"	"5.44"	"2.159"
"R-HSA-450408"	"AUF1 (hnRNP D0) binds and destabilizes mRNA"	"3.031"	"172"	"139.5"	"10.723"
"R-HSA-5674499"	"Negative feedback regulation of MAPK pathway"	"3.027"	"68"	"46.3"	"7.169"
"R-HSA-170968"	"Frs2-mediated activation"	"2.992"	"101"	"79.86"	"7.065"
"R-HSA-190872"	"Transport of connexons to the plasma membrane"	"2.976"	"11"	"5.12"	"1.976"
"R-HSA-73777"	"RNA Polymerase I Chain Elongation"	"2.966"	"652"	"568.36"	"28.2"
"R-HSA-392154"	"Nitric oxide stimulates guanylate cyclase"	"2.965"	"32"	"18.38"	"4.593"
"R-HSA-947581"	"Molybdenum cofactor biosynthesis"	"2.945"	"14"	"6.78"	"2.452"
"R-HSA-381033"	"ATF6 (ATF6-alpha) activates chaperones"	"2.939"	"37"	"24.12"	"4.383"
"R-HSA-71291"	"Metabolism of amino acids and derivatives"	"2.932"	"1116"	"1026.96"	"30.365"
"R-HSA-1660514"	"Synthesis of PIPs at the Golgi membrane"	"2.931"	"61"	"40.96"	"6.836"
"R-HSA-196025"	"Formation of annular gap junctions"	"2.895"	"100"	"76.94"	"7.965"
"R-HSA-5358493"	"Synthesis of diphthamide-EEF2"	"2.868"	"31"	"19.02"	"4.177"
"R-HSA-2299718"	"Condensation of Prophase Chromosomes"	"2.865"	"546"	"474.98"	"24.791"
"R-HSA-163615"	"PKA activation"	"2.862"	"114"	"89.7"	"8.491"
"R-HSA-190861"	"Gap junction assembly"	"2.801"	"11"	"5.22"	"2.063"
"R-HSA-190704"	"Oligomerization of connexins into connexons"	"2.801"	"11"	"5.22"	"2.063"
"R-HSA-190827"	"Transport of connexins along the secretory pathway"	"2.801"	"11"	"5.22"	"2.063"
"R-HSA-5625740"	"RHO GTPases activate PKNs"	"2.799"	"730"	"647.94"	"29.316"
"R-HSA-196783"	"Coenzyme A biosynthesis"	"2.781"	"6"	"2.44"	"1.28"
"R-HSA-392517"	"Rap1 signalling"	"2.725"	"116"	"89.84"	"9.601"
"R-HSA-1500620"	"Meiosis"	"2.719"	"534"	"465.58"	"25.166"
"R-HSA-111996"	"Ca-dependent events"	"2.708"	"157"	"129.64"	"10.103"
"R-HSA-198745"	"Signalling to STAT3"	"2.699"	"68"	"52.34"	"5.802"
"R-HSA-111931"	"PKA-mediated phosphorylation of CREB"	"2.692"	"117"	"94.06"	"8.522"
"R-HSA-1221632"	"Meiotic synapsis"	"2.68"	"346"	"291.8"	"20.222"
"R-HSA-71262"	"Carnitine synthesis"	"2.665"	"14"	"7.16"	"2.566"
"R-HSA-168253"	"Host Interactions with Influenza Factors"	"2.665"	"103"	"80.2"	"8.555"
"R-HSA-381042"	"PERK regulates gene expression"	"2.656"	"42"	"29.24"	"4.805"
"WP3404"	"Oxidative Stress Induced Senescence"	"2.637"	"1108"	"996.82"	"42.167"
"R-HSA-418359"	"Reduction of cytosolic Ca++ levels"	"2.635"	"53"	"35.6"	"6.602"
"R-HSA-190873"	"Gap junction degradation"	"2.632"	"100"	"79.18"	"7.909"
"WP3391"	"Senescence-Associated Secretory Phenotype (SASP)"	"2.601"	"963"	"858.44"	"40.198"
"R-HSA-71288"	"Creatine metabolism"	"2.595"	"10"	"5.28"	"1.819"
"R-HSA-1660661"	"Sphingolipid de novo biosynthesis"	"2.585"	"54"	"37.02"	"6.57"
"R-HSA-196836"	"Vitamin C (ascorbate) metabolism"	"2.554"	"21"	"11.76"	"3.617"
"R-HSA-9006931"	"Signaling by Nuclear Receptors"	"2.545"	"1267"	"1165.68"	"39.817"
"R-HSA-1474165"	"Reproduction"	"2.54"	"534"	"469.48"	"25.405"
"R-HSA-190828"	"Gap junction trafficking"	"2.538"	"100"	"79.7"	"7.998"
"R-HSA-2022377"	"Metabolism of Angiotensinogen to Angiotensins"	"2.527"	"31"	"18.62"	"4.899"
"R-HSA-5673000"	"RAF activation"	"2.511"	"187"	"159.84"	"10.818"
"R-HSA-76005"	"Response to elevated platelet cytosolic Ca2+"	"2.495"	"387"	"340.24"	"18.744"
"R-HSA-1445148"	"Translocation of GLUT4 to the plasma membrane"	"2.483"	"237"	"206.22"	"12.399"
"R-HSA-3214847"	"HATs acetylate histones"	"2.479"	"745"	"676.04"	"27.817"
"R-HSA-8951664"	"Neddylation"	"2.421"	"1171"	"1080.5"	"37.377"
"R-HSA-1855183"	"Synthesis of IP2, IP, and Ins in the cytosol"	"2.394"	"24"	"14.3"	"4.052"
"R-HSA-5250924"	"B-WICH complex positively regulates rRNA expression"	"2.381"	"694"	"621.92"	"30.268"
"R-HSA-425374"	"Amino acid and oligopeptide SLC transporters"	"2.376"	"21"	"13.04"	"3.35"
"R-HSA-352230"	"Amino acid transport across the plasma membrane"	"2.371"	"16"	"9.18"	"2.876"
"R-HSA-427389"	"ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression"	"2.357"	"534"	"477.72"	"23.882"
"R-HSA-167021"	"PLC-gamma1 signalling"	"2.356"	"65"	"51.34"	"5.798"
"R-HSA-8866911"	"TFAP2 (AP-2) family regulates transcription of cell cycle factors"	"2.351"	"68"	"53.1"	"6.338"
"R-HSA-168275"	"Entry of Influenza Virion into Host Cell via Endocytosis"	"2.33"	"41"	"27.6"	"5.75"
"R-HSA-111995"	"phospho-PLA2 pathway"	"2.328"	"28"	"17.22"	"4.63"
"R-HSA-187024"	"NGF-independant TRKA activation"	"2.327"	"65"	"50.5"	"6.231"
"R-HSA-422356"	"Regulation of insulin secretion"	"2.272"	"310"	"272.18"	"16.648"
"R-HSA-5205647"	"Mitophagy"	"2.26"	"414"	"362.98"	"22.575"
"R-HSA-1980150"	"Signaling by NOTCH4"	"2.238"	"23"	"14.86"	"3.637"
"R-HSA-1237112"	"Methionine salvage pathway"	"2.235"	"13"	"6.3"	"2.998"
"R-HSA-381119"	"Unfolded Protein Response (UPR)"	"2.223"	"75"	"58.78"	"7.296"
"R-HSA-211728"	"Regulation of PAK-2p34 activity by PS-GAP/RHG10"	"2.212"	"11"	"6.4"	"2.08"
"WP3395"	"Cellular response to heat stress"	"2.21"	"1028"	"945.66"	"37.259"
"R-HSA-6814848"	"Glycerophospholipid catabolism"	"2.173"	"8"	"3.9"	"1.887"
"R-HSA-3371453"	"Regulation of HSF1-mediated heat shock response"	"2.157"	"812"	"745.6"	"30.79"
"R-HSA-193692"	"Regulated proteolysis of p75NTR"	"2.153"	"63"	"48.46"	"6.753"
"R-HSA-418360"	"Platelet calcium homeostasis"	"2.143"	"57"	"41.06"	"7.438"
"R-HSA-5223345"	"Miscellaneous transport and binding events"	"2.121"	"13"	"8.04"	"2.338"
"R-HSA-447038"	"NrCAM interactions"	"2.116"	"36"	"25.76"	"4.838"
"R-HSA-8939236"	"RUNX1 regulates transcription of genes involved in differentiation of HSCs"	"2.094"	"772"	"692.48"	"37.967"
"R-HSA-187015"	"Activation of TRKA receptors"	"2.089"	"65"	"51.52"	"6.453"
"R-HSA-447041"	"CHL1 interactions"	"2.086"	"75"	"61.7"	"6.377"
"WP4115"	"Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models"	"2.063"	"133"	"111.74"	"10.305"
"R-HSA-8863678"	"Neurodegenerative Diseases"	"2.063"	"133"	"111.74"	"10.305"
"R-HSA-9010642"	"ROBO receptors bind AKAP5"	"2.058"	"69"	"55.94"	"6.345"
"R-HSA-157212"	"A third proteolytic cleavage releases NICD"	"2.047"	"35"	"25.02"	"4.876"
"R-HSA-180689"	"APOBEC3G mediated resistance to HIV-1 infection"	"1.997"	"25"	"18"	"3.505"
"R-HSA-201722"	"Formation of the beta-catenin:TCF transactivating complex"	"1.983"	"649"	"593.32"	"28.079"
"R-HSA-177162"	"Conjugation of phenylacetate with glutamine"	"1.98"	"2"	"0.02"	"0.141"
"R-HSA-111452"	"Activation and oligomerization of BAK protein"	"1.955"	"5"	"1.92"	"1.576"
"R-HSA-196071"	"Metabolism of steroid hormones"	"1.95"	"45"	"34.42"	"5.425"
"R-HSA-177135"	"Conjugation of benzoate with glycine"	"1.94"	"2"	"0.06"	"0.24"
"R-HSA-111463"	"SMAC binds to IAPs "	"1.919"	"17"	"11.22"	"3.012"
"R-HSA-111469"	"SMAC-mediated apoptotic response"	"1.919"	"17"	"11.22"	"3.012"
"R-HSA-111464"	"SMAC-mediated dissociation of IAP:caspase complexes "	"1.919"	"17"	"11.22"	"3.012"
"R-HSA-71182"	"Phenylalanine and tyrosine catabolism"	"1.904"	"8"	"4.24"	"1.975"
"R-HSA-171319"	"Telomere Extension By Telomerase"	"1.901"	"64"	"52.1"	"6.261"
"R-HSA-169911"	"Regulation of Apoptosis"	"1.9"	"12"	"7.38"	"2.432"
"R-HSA-189483"	"Heme degradation"	"1.886"	"8"	"4.08"	"2.078"
"WP4132"	"RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function"	"1.886"	"560"	"512.86"	"24.997"
"R-HSA-1299316"	"TWIK-releated acid-sensitive K+ channel (TASK)"	"1.88"	"2"	"0.12"	"0.48"
"R-HSA-5675221"	"Negative regulation of MAPK pathway"	"1.843"	"462"	"418.68"	"23.504"
"R-HSA-193775"	"Synthesis of bile acids and bile salts via 24-hydroxycholesterol"	"1.828"	"24"	"17.56"	"3.523"
"R-HSA-8949275"	"RUNX3 Regulates Immune Response and Cell Migration"	"1.804"	"21"	"14.06"	"3.846"
"R-HSA-8948700"	"Competing endogenous RNAs (ceRNAs) regulate PTEN translation"	"1.794"	"57"	"44.96"	"6.713"
"R-HSA-8943723"	"Regulation of PTEN mRNA translation"	"1.794"	"57"	"44.96"	"6.713"
"R-HSA-880009"	"Interconversion of 2-oxoglutarate and 2-hydroxyglutarate"	"1.782"	"5"	"2.3"	"1.515"
"R-HSA-191273"	"Cholesterol biosynthesis"	"1.773"	"52"	"40"	"6.767"
"R-HSA-111933"	"Calmodulin induced events"	"1.741"	"129"	"112.42"	"9.524"
"R-HSA-111997"	"CaM pathway"	"1.741"	"129"	"112.42"	"9.524"
"R-HSA-2161522"	"Abacavir transport and metabolism"	"1.715"	"8"	"4.34"	"2.134"
"R-HSA-390471"	"Association of TriC/CCT with target proteins during biosynthesis"	"1.715"	"278"	"249.46"	"16.643"
"R-HSA-68911"	"G2 Phase"	"1.678"	"60"	"48.34"	"6.948"
"R-HSA-5693571"	"Nonhomologous End-Joining (NHEJ)"	"1.666"	"441"	"407.84"	"19.902"
"R-HSA-8937144"	"Aryl hydrocarbon receptor signalling"	"1.665"	"57"	"47.24"	"5.861"
"R-HSA-5624958"	"ARL13B-mediated ciliary trafficking of INPP5E"	"1.653"	"4"	"1.74"	"1.367"
"R-HSA-983170"	"Antigen Presentation: Folding, assembly and peptide loading of class I MHC"	"1.652"	"131"	"115.44"	"9.42"
"R-HSA-71240"	"Tryptophan catabolism"	"1.641"	"17"	"11.26"	"3.498"
"R-HSA-169893"	"Prolonged ERK activation events"	"1.616"	"103"	"91.18"	"7.314"
"R-HSA-196299"	"Beta-catenin phosphorylation cascade"	"1.604"	"134"	"118.76"	"9.499"
"R-HSA-1296025"	"ATP sensitive Potassium channels"	"1.6"	"2"	"0.4"	"0.639"
"R-HSA-5336415"	"Uptake and function of diphtheria toxin"	"1.593"	"23"	"16.8"	"3.891"
"R-HSA-3065678"	"SUMO is transferred from E1 to E2 (UBE2I, UBC9)"	"1.592"	"151"	"134.88"	"10.127"
"R-HSA-597592"	"Post-translational protein modification"	"1.565"	"4460"	"4326.02"	"85.59"
"WP3810"	"Cardiac conduction"	"1.562"	"136"	"117.14"	"12.073"
"WP3472"	"XBP1(S) activates chaperone genes"	"1.557"	"26"	"19.9"	"3.919"
"R-HSA-1489509"	"DAG and IP3 signaling"	"1.555"	"147"	"130.16"	"10.828"
"R-HSA-1483248"	"Synthesis of PIPs at the ER membrane"	"1.49"	"9"	"5.7"	"2.215"
"R-HSA-1483115"	"Hydrolysis of LPC"	"1.482"	"3"	"1.3"	"1.147"
"R-HSA-5682910"	"LGI-ADAM interactions"	"1.472"	"35"	"27.36"	"5.189"
"R-HSA-3214815"	"HDACs deacetylate histones"	"1.453"	"564"	"528.66"	"24.321"
"R-HSA-448424"	"Interleukin-17 signaling"	"1.446"	"616"	"580.96"	"24.224"
"R-HSA-450294"	"MAP kinase activation"	"1.446"	"616"	"580.96"	"24.224"
"R-HSA-204998"	"Cell death signalling via NRAGE, NRIF and NADE"	"1.38"	"431"	"402.34"	"20.762"
"R-HSA-2161541"	"Abacavir metabolism"	"1.378"	"5"	"2.72"	"1.654"
"R-HSA-977347"	"Serine biosynthesis"	"1.375"	"13"	"8.98"	"2.924"
"R-HSA-399721"	"Glutamate binding, activation of AMPA receptors and synaptic plasticity"	"1.369"	"140"	"125.72"	"10.428"
"R-HSA-399719"	"Trafficking of AMPA receptors"	"1.369"	"140"	"125.72"	"10.428"
"R-HSA-427601"	"Multifunctional anion exchangers"	"1.36"	"2"	"0.64"	"0.749"
"R-HSA-3215018"	"Processing and activation of SUMO"	"1.357"	"151"	"136.72"	"10.527"
"hsa00600"	"Sphingolipid metabolism"	"1.344"	"59"	"48.44"	"7.856"
"R-HSA-9033241"	"Peroxisomal protein import"	"1.333"	"332"	"306.68"	"18.998"
"R-HSA-211736"	"Stimulation of the cell death response by PAK-2p34"	"1.332"	"13"	"9.5"	"2.628"
"R-HSA-8857538"	"PTK6 promotes HIF1A stabilization"	"1.326"	"51"	"43.16"	"5.912"
"R-HSA-2197563"	"NOTCH2 intracellular domain regulates transcription"	"1.314"	"42"	"33.8"	"6.24"
"R-HSA-8866654"	"E3 ubiquitin ligases ubiquitinate target proteins"	"1.272"	"565"	"527.24"	"29.682"
"R-HSA-446388"	"Regulation of cytoskeletal remodeling and cell spreading by IPP complex components"	"1.22"	"23"	"17.96"	"4.13"
"R-HSA-176033"	"Interactions of Vpr with host cellular proteins"	"1.216"	"213"	"198.02"	"12.32"
"R-HSA-2151209"	"Activation of PPARGC1A (PGC-1alpha) by phosphorylation"	"1.207"	"53"	"45.44"	"6.263"
"R-HSA-9026395"	"Biosynthesis of DHA-derived sulfido conjugates"	"1.2"	"2"	"0.8"	"0.926"
"R-HSA-9026762"	"Biosynthesis of maresin conjugates in tissue regeneration (MCTR)"	"1.2"	"2"	"0.8"	"0.926"
"R-HSA-110331"	"Cleavage of the damaged purine"	"1.198"	"5"	"2.94"	"1.719"
"R-HSA-73927"	"Depurination"	"1.198"	"5"	"2.94"	"1.719"
"R-HSA-110330"	"Recognition and association of DNA glycosylase with site containing an affected purine"	"1.198"	"5"	"2.94"	"1.719"
"R-HSA-427413"	"NoRC negatively regulates rRNA expression"	"1.183"	"670"	"635.86"	"28.851"
"R-HSA-168316"	"Assembly of Viral Components at the Budding Site"	"1.174"	"14"	"10.14"	"3.289"
"R-HSA-168268"	"Virus Assembly and Release"	"1.174"	"14"	"10.14"	"3.289"
"R-HSA-2161517"	"Abacavir transmembrane transport"	"1.173"	"3"	"1.62"	"1.176"
"R-HSA-199220"	"Vitamin B5 (pantothenate) metabolism"	"1.173"	"10"	"6.98"	"2.575"
"R-HSA-450385"	"Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA"	"1.158"	"79"	"68.46"	"9.101"
"R-HSA-432142"	"Platelet sensitization by LDL"	"1.156"	"119"	"109"	"8.647"
"R-HSA-77285"	"Beta oxidation of myristoyl-CoA to lauroyl-CoA"	"1.151"	"7"	"4.4"	"2.259"
"R-HSA-8869496"	"TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation"	"1.091"	"69"	"59.56"	"8.652"
"R-HSA-727802"	"Transport of nucleotide sugars"	"1.08"	"2"	"0.92"	"0.853"
"R-HSA-975138"	"TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation"	"1.06"	"718"	"686.36"	"29.849"
"R-HSA-6793080"	"rRNA modification in the mitochondrion"	"1.055"	"7"	"4.66"	"2.219"
"R-HSA-8868766"	"rRNA processing in the mitochondrion"	"1.055"	"7"	"4.66"	"2.219"
"R-HSA-211957"	"Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"	"1.04"	"2"	"0.96"	"0.989"
"R-HSA-2142712"	"Synthesis of 12-eicosatetraenoic acid derivatives"	"1.031"	"3"	"1.78"	"1.183"
"R-HSA-8852135"	"Protein ubiquitination"	"1.013"	"620"	"589.32"	"30.277"
"R-HSA-5669034"	"TNFs bind their physiological receptors"	"1.012"	"21"	"16.58"	"4.366"
"R-HSA-9013973"	"TICAM1-dependent activation of IRF3/IRF7"	"1.009"	"28"	"23.56"	"4.399"
"R-HSA-9027307"	"Biosynthesis of maresin-like SPMs"	"1.003"	"11"	"7.86"	"3.13"
"R-HSA-4411364"	"Binding of TCF/LEF:CTNNB1 to target gene promoters"	"1.002"	"66"	"59"	"6.984"
"R-HSA-975871"	"MyD88 cascade initiated on plasma membrane"	"0.997"	"715"	"684.76"	"30.326"
"R-HSA-168142"	"Toll Like Receptor 10 (TLR10) Cascade"	"0.997"	"715"	"684.76"	"30.326"
"R-HSA-168176"	"Toll Like Receptor 5 (TLR5) Cascade"	"0.997"	"715"	"684.76"	"30.326"
"R-HSA-432722"	"Golgi Associated Vesicle Biogenesis"	"0.995"	"231"	"218.02"	"13.042"
"R-HSA-163358"	"PKA-mediated phosphorylation of key metabolic factors"	"0.995"	"39"	"33.64"	"5.386"
"R-HSA-5661270"	"Catabolism of glucuronate to xylulose-5-phosphate"	"0.975"	"6"	"4.04"	"2.01"
"R-HSA-168138"	"Toll Like Receptor 9 (TLR9) Cascade"	"0.965"	"726"	"697.56"	"29.463"
"R-HSA-210991"	"Basigin interactions"	"0.961"	"41"	"36.24"	"4.951"
"R-HSA-975155"	"MyD88 dependent cascade initiated on endosome"	"0.951"	"718"	"689.52"	"29.939"
"R-HSA-168181"	"Toll Like Receptor 7/8 (TLR7/8) Cascade"	"0.951"	"718"	"689.52"	"29.939"
"R-HSA-1483213"	"Synthesis of PE"	"0.94"	"11"	"8.48"	"2.682"
"R-HSA-844456"	"The NLRP3 inflammasome"	"0.931"	"60"	"54.04"	"6.405"
"R-HSA-438066"	"Unblocking of NMDA receptor, glutamate binding and activation"	"0.931"	"67"	"60.36"	"7.131"
"R-HSA-174403"	"Glutathione synthesis and recycling"	"0.93"	"8"	"5.82"	"2.345"
"R-HSA-2408552"	"Methylation of MeSeH for excretion"	"0.92"	"1"	"0.08"	"0.274"
"R-HSA-173107"	"Binding and entry of HIV virion"	"0.91"	"29"	"25.6"	"3.736"
"R-HSA-162592"	"Integration of provirus"	"0.909"	"55"	"50.28"	"5.19"
"R-HSA-112043"	"PLC beta mediated events"	"0.906"	"191"	"179.16"	"13.062"
"R-HSA-157858"	"Gap junction trafficking and regulation"	"0.901"	"103"	"94.98"	"8.897"
"R-HSA-196819"	"Vitamin B1 (thiamin) metabolism"	"0.897"	"2"	"0.96"	"1.16"
"R-HSA-8866423"	"VLDL assembly"	"0.896"	"19"	"15.76"	"3.617"
"R-HSA-9018682"	"Biosynthesis of maresins"	"0.884"	"11"	"8.28"	"3.078"
"R-HSA-5250941"	"Negative epigenetic regulation of rRNA expression"	"0.878"	"673"	"647.44"	"29.123"
"R-HSA-73854"	"RNA Polymerase I Promoter Clearance"	"0.863"	"714"	"687.26"	"30.973"
"R-HSA-1237044"	"Erythrocytes take up carbon dioxide and release oxygen"	"0.862"	"9"	"6.6"	"2.785"
"R-HSA-1480926"	"O2/CO2 exchange in erythrocytes"	"0.862"	"9"	"6.6"	"2.785"
"R-HSA-8847453"	"Synthesis of PIPs in the nucleus"	"0.847"	"3"	"1.96"	"1.228"
"R-HSA-2408550"	"Metabolism of ingested H2SeO4 and H2SeO3 into H2Se"	"0.846"	"3"	"1.82"	"1.395"
"R-HSA-2142770"	"Synthesis of 15-eicosatetraenoic acid derivatives"	"0.825"	"3"	"1.94"	"1.284"
"R-HSA-203927"	"MicroRNA (miRNA) biogenesis"	"0.816"	"43"	"37.96"	"6.174"
"R-HSA-3232118"	"SUMOylation of transcription factors"	"0.809"	"218"	"207.56"	"12.908"
"WP3308"	"Oncogene Induced Senescence"	"0.788"	"423"	"404.92"	"22.941"
"R-HSA-2046105"	"Linoleic acid (LA) metabolism"	"0.763"	"5"	"3.52"	"1.94"
"R-HSA-2046104"	"alpha-linolenic (omega3) and linoleic (omega6) acid metabolism"	"0.756"	"12"	"9.74"	"2.988"
"R-HSA-2046106"	"alpha-linolenic acid (ALA) metabolism"	"0.756"	"12"	"9.74"	"2.988"
"R-HSA-193648"	"NRAGE signals death through JNK"	"0.756"	"101"	"93.88"	"9.419"
"R-HSA-73864"	"RNA Polymerase I Transcription"	"0.756"	"714"	"690.5"	"31.068"
"R-HSA-8951430"	"RUNX3 regulates WNT signaling"	"0.745"	"67"	"61.5"	"7.385"
"R-HSA-428643"	"Organic anion transporters"	"0.742"	"4"	"2.78"	"1.645"
"R-HSA-451308"	"Activation of Ca-permeable Kainate Receptor"	"0.741"	"48"	"43.38"	"6.236"
"R-HSA-451306"	"Ionotropic activity of kainate receptors"	"0.741"	"48"	"43.38"	"6.236"
"R-HSA-198323"	"AKT phosphorylates targets in the cytosol"	"0.728"	"74"	"68.78"	"7.169"
"R-HSA-166058"	"MyD88:Mal cascade initiated on plasma membrane"	"0.726"	"720"	"698.44"	"29.695"
"R-HSA-181438"	"Toll Like Receptor 2 (TLR2) Cascade"	"0.726"	"720"	"698.44"	"29.695"
"R-HSA-168179"	"Toll Like Receptor TLR1:TLR2 Cascade"	"0.726"	"720"	"698.44"	"29.695"
"R-HSA-168188"	"Toll Like Receptor TLR6:TLR2 Cascade"	"0.726"	"720"	"698.44"	"29.695"
"R-HSA-428559"	"Proton-coupled neutral amino acid transporters"	"0.725"	"3"	"2.04"	"1.324"
"R-HSA-77352"	"Beta oxidation of butanoyl-CoA to acetyl-CoA"	"0.72"	"4"	"2.78"	"1.694"
"R-HSA-1299361"	"TWIK-related alkaline pH activated K+ channel (TALK)"	"0.72"	"1"	"0.28"	"0.497"
"R-HSA-114294"	"Activation, translocation and oligomerization of BAX"	"0.716"	"5"	"3.56"	"2.012"
"R-HSA-442720"	"CREB phosphorylation through the activation of Adenylate Cyclase"	"0.715"	"42"	"38.26"	"5.229"
"R-HSA-8963898"	"Plasma lipoprotein assembly"	"0.704"	"71"	"65.72"	"7.5"
"R-HSA-444257"	"RSK activation"	"0.701"	"29"	"25.26"	"5.337"
"R-HSA-1632852"	"Macroautophagy"	"0.695"	"200"	"190.6"	"13.535"
"R-HSA-2465910"	"MASTL Facilitates Mitotic Progression"	"0.686"	"91"	"84.74"	"9.127"
"R-HSA-193144"	"Estrogen biosynthesis"	"0.684"	"6"	"4.46"	"2.252"
"R-HSA-879415"	"Advanced glycosylation endproduct receptor signaling"	"0.668"	"124"	"115.88"	"12.151"
"R-HSA-77350"	"Beta oxidation of hexanoyl-CoA to butanoyl-CoA"	"0.656"	"9"	"7.1"	"2.894"
"R-HSA-77310"	"Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA"	"0.646"	"9"	"7.1"	"2.943"
"R-HSA-217271"	"FMO oxidises nucleophiles"	"0.64"	"1"	"0.36"	"0.631"
"R-HSA-5687128"	"MAPK6/MAPK4 signaling"	"0.632"	"472"	"454.98"	"26.949"
"R-HSA-5676934"	"Protein repair"	"0.626"	"10"	"8.28"	"2.748"
"R-HSA-209943"	"Steroid hormones"	"0.622"	"115"	"109.22"	"9.292"
"R-HSA-73886"	"Chromosome Maintenance"	"0.614"	"661"	"645.2"	"25.723"
"R-HSA-8963896"	"HDL assembly"	"0.608"	"43"	"39.9"	"5.1"
"R-HSA-425407"	"SLC-mediated transmembrane transport"	"0.604"	"104"	"96.92"	"11.712"
"R-HSA-6814122"	"Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"	"0.595"	"278"	"269.7"	"13.958"
"R-HSA-8939245"	"RUNX1 regulates transcription of genes involved in BCR signaling"	"0.59"	"7"	"5.68"	"2.236"
"R-HSA-1483191"	"Synthesis of PC"	"0.572"	"68"	"63.2"	"8.386"
"R-HSA-3700989"	"Transcriptional Regulation by TP53"	"0.571"	"1925"	"1900.38"	"43.153"
"R-HSA-114508"	"Effects of PIP2 hydrolysis"	"0.543"	"21"	"18.8"	"4.051"
"R-HSA-5638303"	"Inhibition of Signaling by Overexpressed EGFR"	"0.539"	"29"	"26.34"	"4.939"
"R-HSA-5638302"	"Signaling by Overexpressed Wild-Type EGFR in Cancer"	"0.539"	"29"	"26.34"	"4.939"
"R-HSA-2564830"	"Cytosolic iron-sulfur cluster assembly"	"0.52"	"1"	"0.48"	"0.646"
"R-HSA-1855191"	"Synthesis of IPs in the nucleus"	"0.52"	"1"	"0.48"	"0.707"
"R-HSA-205043"	"NRIF signals cell death from the nucleus"	"0.509"	"295"	"285.42"	"18.827"
"R-HSA-622312"	"Inflammasomes"	"0.485"	"66"	"62.66"	"6.889"
"R-HSA-112303"	"Electric Transmission Across Gap Junctions"	"0.48"	"1"	"0.52"	"0.707"
"R-HSA-8964572"	"Lipid particle organization"	"0.48"	"1"	"0.52"	"0.707"
"R-HSA-112307"	"Transmission across Electrical Synapses "	"0.48"	"1"	"0.52"	"0.707"
"R-HSA-209543"	"p75NTR recruits signalling complexes"	"0.463"	"50"	"47.1"	"6.257"
"R-HSA-111453"	"BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members"	"0.45"	"13"	"11.58"	"3.156"
"R-HSA-532668"	"N-glycan trimming in the ER and Calnexin/Calreticulin cycle"	"0.449"	"344"	"334.18"	"21.86"
"R-HSA-888590"	"GABA synthesis, release, reuptake and degradation"	"0.439"	"80"	"76.44"	"8.104"
"R-HSA-5689901"	"Metalloprotease DUBs"	"0.417"	"479"	"469.52"	"22.745"
"WP2718"	"Signaling by NOTCH2"	"0.4"	"300"	"292.12"	"19.703"
"R-HSA-5358346"	"Hedgehog ligand biogenesis"	"0.393"	"295"	"287.14"	"20.018"
"R-HSA-112040"	"G-protein mediated events"	"0.372"	"193"	"188.3"	"12.63"
"R-HSA-196807"	"Nicotinate metabolism"	"0.366"	"14"	"12.5"	"4.097"
"R-HSA-426486"	"Small interfering RNA (siRNA) biogenesis"	"0.356"	"29"	"27.24"	"4.947"
"R-HSA-174362"	"Transport and synthesis of PAPS"	"0.356"	"2"	"1.5"	"1.403"
"R-HSA-426496"	"Post-transcriptional silencing by small RNAs"	"0.351"	"24"	"22.32"	"4.791"
"R-HSA-5657655"	"MGMT-mediated DNA damage reversal"	"0.35"	"2"	"1.54"	"1.313"
"WP3339"	"TCF dependent signaling in response to WNT"	"0.347"	"1205"	"1188.7"	"47.031"
"WP3807"	"Regulation of TP53 Expression and Degradation"	"0.336"	"473"	"464.98"	"23.849"
"R-HSA-192905"	"vRNP Assembly"	"0.332"	"45"	"43.04"	"5.907"
"R-HSA-2033515"	"t(4;14) translocations of FGFR3"	"0.323"	"2"	"1.62"	"1.176"
"R-HSA-3000484"	"Scavenging by Class F Receptors"	"0.32"	"74"	"71.58"	"7.568"
"R-HSA-69541"	"Stabilization of p53"	"0.319"	"308"	"302.26"	"18.005"
"R-HSA-937042"	"IRAK2 mediated activation of TAK1 complex"	"0.318"	"31"	"29.62"	"4.342"
"R-HSA-975163"	"IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation"	"0.318"	"31"	"29.62"	"4.342"
"R-HSA-198765"	"Signalling to ERK5"	"0.318"	"7"	"6.22"	"2.452"
"R-HSA-5218859"	"Regulated Necrosis"	"0.315"	"51"	"48.9"	"6.659"
"R-HSA-5213460"	"RIPK1-mediated regulated necrosis"	"0.315"	"51"	"48.9"	"6.659"
"R-HSA-6804757"	"Regulation of TP53 Degradation"	"0.314"	"472"	"464.54"	"23.765"
"R-HSA-2025928"	"Calcineurin activates NFAT"	"0.272"	"38"	"36.22"	"6.554"
"R-HSA-5652227"	"Fructose biosynthesis"	"0.268"	"4"	"3.5"	"1.865"
"R-HSA-6811434"	"COPI-dependent Golgi-to-ER retrograde traffic"	"0.266"	"270"	"265.68"	"16.239"
"R-HSA-1236977"	"Endosomal/Vacuolar pathway"	"0.262"	"26"	"24.84"	"4.423"
"R-HSA-1679131"	"Trafficking and processing of endosomal TLR"	"0.26"	"16"	"14.92"	"4.159"
"R-HSA-438064"	"Post NMDA receptor activation events"	"0.249"	"162"	"159.18"	"11.337"
"R-HSA-9014325"	"TICAM1,TRAF6-dependent induction of TAK1 complex"	"0.242"	"32"	"30.86"	"4.708"
"R-HSA-69563"	"p53-Dependent G1 DNA Damage Response"	"0.238"	"354"	"349.62"	"18.397"
"R-HSA-69580"	"p53-Dependent G1/S DNA damage checkpoint"	"0.238"	"354"	"349.62"	"18.397"
"R-HSA-5607763"	"CLEC7A (Dectin-1) induces NFAT activation"	"0.217"	"42"	"40.44"	"7.2"
"R-HSA-69473"	"G2/M DNA damage checkpoint"	"0.216"	"662"	"655.74"	"28.92"
"R-HSA-1306955"	"GRB7 events in ERBB2 signaling"	"0.215"	"16"	"15.4"	"2.785"
"R-HSA-442729"	"CREB phosphorylation through the activation of CaMKII"	"0.212"	"79"	"77.34"	"7.824"
"R-HSA-1855167"	"Synthesis of pyrophosphates in the cytosol"	"0.209"	"2"	"1.74"	"1.242"
"R-HSA-205025"	"NADE modulates death signalling"	"0.208"	"35"	"33.84"	"5.582"
"R-HSA-73621"	"Pyrimidine catabolism"	"0.207"	"2"	"1.64"	"1.735"
"R-HSA-69202"	"Cyclin E associated events during G1/S transition "	"0.165"	"448"	"443.74"	"25.765"
"R-HSA-5423646"	"Aflatoxin activation and detoxification"	"0.148"	"11"	"10.56"	"2.97"
"R-HSA-446203"	"Asparagine N-linked glycosylation"	"0.147"	"955"	"949.9"	"34.689"
"R-HSA-5674400"	"Constitutive Signaling by AKT1 E17K in Cancer"	"0.144"	"105"	"103.86"	"7.9"
"R-HSA-71032"	"Propionyl-CoA catabolism"	"0.14"	"1"	"0.86"	"0.969"
"R-HSA-373756"	"SDK interactions"	"0.14"	"1"	"0.86"	"0.969"
"R-HSA-429947"	"Deadenylation of mRNA"	"0.128"	"132"	"130.48"	"11.831"
"R-HSA-5250913"	"Positive epigenetic regulation of rRNA expression"	"0.11"	"707"	"703.54"	"31.358"
"R-HSA-166208"	"mTORC1-mediated signalling"	"0.094"	"88"	"87.22"	"8.313"
"R-HSA-209560"	"NF-kB is activated and signals survival"	"0.088"	"302"	"300.34"	"18.857"
"R-HSA-5387390"	"Hh mutants abrogate ligand secretion"	"0.081"	"274"	"272.42"	"19.533"
"R-HSA-5362768"	"Hh mutants that don,t undergo autocatalytic processing are degraded by ERAD"	"0.081"	"274"	"272.42"	"19.533"
"R-HSA-9018677"	"Biosynthesis of DHA-derived SPMs"	"0.075"	"15"	"14.7"	"3.991"
"R-HSA-2559583"	"Cellular Senescence"	"0.067"	"1243"	"1239.96"	"45.186"
"R-HSA-114452"	"Activation of BH3-only proteins"	"0.066"	"234"	"233.16"	"12.645"
"R-HSA-6798163"	"Choline catabolism"	"0.058"	"1"	"0.94"	"1.038"
"R-HSA-166016"	"Toll Like Receptor 4 (TLR4) Cascade"	"0.058"	"794"	"792.26"	"30.005"
"R-HSA-8849932"	"Synaptic adhesion-like molecules"	"0.056"	"52"	"51.6"	"7.108"
"WP3316"	"Hedgehog ,off, state"	"0.054"	"410"	"408.84"	"21.672"
"R-HSA-2979096"	"NOTCH2 Activation and Transmission of Signal to the Nucleus"	"0.05"	"264"	"263.06"	"18.749"
"R-HSA-448706"	"Interleukin-1 processing"	"0.047"	"26"	"25.76"	"5.105"
"R-HSA-390918"	"Peroxisomal lipid metabolism"	"0.045"	"17"	"16.82"	"4.019"
"R-HSA-175474"	"Assembly Of The HIV Virion"	"0.044"	"260"	"259.14"	"19.379"
"R-HSA-9033500"	"TYSND1 cleaves peroxisomal proteins"	"0.043"	"7"	"6.9"	"2.323"
"R-HSA-629597"	"Highly calcium permeable nicotinic acetylcholine receptors"	"0.04"	"1"	"0.96"	"0.903"
"R-HSA-901042"	"Calnexin/calreticulin cycle"	"0.02"	"280"	"279.58"	"20.913"
"R-HSA-3249367"	"STAT6-mediated induction of chemokines"	"0.016"	"9"	"8.96"	"2.539"
"R-HSA-389887"	"Beta-oxidation of pristanoyl-CoA"	"0.013"	"6"	"5.96"	"3.057"
"R-HSA-382556"	"ABC-family proteins mediated transport"	"0.009"	"331"	"330.82"	"20.464"
"R-HSA-1482798"	"Acyl chain remodeling of CL"	"0"	"8"	"8"	"3.017"
"R-HSA-2466712"	"Biosynthesis of A2E, implicated in retinal degradation"	"0"	"0"	"0"	"0"
"R-HSA-9018678"	"Biosynthesis of specialized proresolving mediators (SPMs)"	"0"	"15"	"15"	"4.03"
"R-HSA-2474795"	"Diseases associated with visual transduction"	"0"	"0"	"0"	"0"
"R-HSA-2534343"	"Interaction With Cumulus Cells"	"0"	"0"	"0"	"0"
"R-HSA-975574"	"Reactions specific to the hybrid N-glycan synthesis pathway"	"0"	"0"	"0"	"0"
"R-HSA-2453864"	"Retinoid cycle disease events"	"0"	"0"	"0"	"0"
"R-HSA-1299287"	"Tandem pore domain halothane-inhibited K+ channel (THIK)"	"0"	"0"	"0"	"0"
"R-HSA-167590"	"Nef Mediated CD4 Down-regulation"	"-0.012"	"58"	"58.1"	"8.457"
"R-HSA-5668541"	"TNFR2 non-canonical NF-kB pathway"	"-0.017"	"118"	"118.18"	"10.378"
"R-HSA-168164"	"Toll Like Receptor 3 (TLR3) Cascade"	"-0.017"	"740"	"740.54"	"31.32"
"R-HSA-351143"	"Agmatine biosynthesis"	"-0.02"	"0"	"0.02"	"0.141"
"R-HSA-5683177"	"Defective ABCC8 can cause hypoglycemias and hyperglycemias"	"-0.02"	"0"	"0.02"	"0.141"
"R-HSA-561048"	"Organic anion transport"	"-0.02"	"0"	"0.02"	"0.141"
"R-HSA-141334"	"PAOs oxidise polyamines to amines"	"-0.02"	"0"	"0.02"	"0.141"
"R-HSA-444411"	"Rhesus glycoproteins mediate ammonium transport."	"-0.02"	"0"	"0.02"	"0.141"
"R-HSA-6785470"	"tRNA processing in the mitochondrion"	"-0.02"	"0"	"0.02"	"0.141"
"R-HSA-1483226"	"Synthesis of PI"	"-0.033"	"3"	"3.06"	"1.845"
"R-HSA-1300645"	"Acrosome Reaction"	"-0.04"	"0"	"0.04"	"0.198"
"R-HSA-9026766"	"Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR)"	"-0.04"	"0"	"0.04"	"0.198"
"R-HSA-140180"	"COX reactions"	"-0.04"	"0"	"0.04"	"0.198"
"R-HSA-350864"	"Regulation of thyroid hormone activity"	"-0.04"	"0"	"0.04"	"0.198"
"R-HSA-2142696"	"Synthesis of Hepoxilins (HX) and Trioxilins (TrX)"	"-0.04"	"0"	"0.04"	"0.198"
"R-HSA-432030"	"Transport of glycerol from adipocytes to the liver by Aquaporins"	"-0.04"	"0"	"0.04"	"0.198"
"R-HSA-1299344"	"TWIK-related spinal cord K+ channel (TRESK)"	"-0.04"	"0"	"0.04"	"0.198"
"R-HSA-8877627"	"Vitamin E"	"-0.04"	"0"	"0.04"	"0.198"
"R-HSA-5340573"	"WNT ligand secretion is abrogated by the PORCN inhibitor LGK974"	"-0.04"	"0"	"0.04"	"0.198"
"R-HSA-844455"	"The NLRP1 inflammasome"	"-0.051"	"6"	"6.12"	"2.37"
"R-HSA-8853383"	"Lysosomal oligosaccharide catabolism"	"-0.058"	"2"	"2.08"	"1.383"
"R-HSA-9007892"	"Interleukin-38 signaling"	"-0.06"	"0"	"0.06"	"0.24"
"R-HSA-622323"	"Presynaptic nicotinic acetylcholine receptors"	"-0.06"	"1"	"1.06"	"0.935"
"R-HSA-163125"	"Post-translational modification: synthesis of GPI-anchored proteins"	"-0.063"	"22"	"22.28"	"4.422"
"R-HSA-1566977"	"Fibronectin matrix formation"	"-0.067"	"25"	"25.3"	"4.469"
"R-HSA-193639"	"p75NTR signals via NF-kB"	"-0.067"	"307"	"308.26"	"18.834"
"WP2773"	"Degradation of beta-catenin by the destruction complex"	"-0.077"	"490"	"492"	"25.88"
"R-HSA-8963888"	"Chylomicron assembly"	"-0.078"	"28"	"28.44"	"5.661"
"R-HSA-177504"	"Retrograde neurotrophin signalling"	"-0.079"	"126"	"126.8"	"10.122"
"R-HSA-9025106"	"Biosynthesis of DPAn-6 SPMs"	"-0.08"	"0"	"0.08"	"0.274"
"R-HSA-140834"	"Extrinsic Pathway of Fibrin Clot Formation"	"-0.08"	"1"	"1.08"	"0.986"
"R-HSA-8981373"	"Intestinal hexose absorption"	"-0.08"	"0"	"0.08"	"0.274"
"R-HSA-8942233"	"Intestinal infectious diseases"	"-0.08"	"0"	"0.08"	"0.274"
"R-HSA-433137"	"Sodium-coupled sulphate, di- and tri-carboxylate transporters"	"-0.08"	"0"	"0.08"	"0.274"
"R-HSA-1855231"	"Synthesis of IPs in the ER lumen"	"-0.08"	"0"	"0.08"	"0.274"
"R-HSA-69615"	"G1/S DNA Damage Checkpoints"	"-0.091"	"355"	"356.64"	"18.033"
"R-HSA-1474151"	"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation"	"-0.095"	"71"	"71.88"	"9.271"
"R-HSA-5610785"	"GLI3 is processed to GLI3R by the proteasome"	"-0.1"	"343"	"345.24"	"22.298"
"R-HSA-1483152"	"Hydrolysis of LPE"	"-0.1"	"0"	"0.1"	"0.303"
"R-HSA-83936"	"Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane"	"-0.1"	"0"	"0.1"	"0.303"
"R-HSA-164938"	"Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters"	"-0.101"	"82"	"82.92"	"9.091"
"R-HSA-5610783"	"Degradation of GLI2 by the proteasome"	"-0.108"	"343"	"345.42"	"22.423"
"R-HSA-1369062"	"ABC transporters in lipid homeostasis"	"-0.113"	"12"	"12.38"	"3.368"
"R-HSA-73929"	"Base-Excision Repair, AP Site Formation"	"-0.116"	"8"	"8.32"	"2.766"
"R-HSA-112122"	"ALKBH2 mediated reversal of alkylation damage"	"-0.12"	"0"	"0.12"	"0.328"
"R-HSA-141333"	"Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB"	"-0.12"	"0"	"0.12"	"0.328"
"R-HSA-5662702"	"Melanin biosynthesis"	"-0.12"	"0"	"0.12"	"0.385"
"R-HSA-1299503"	"TWIK related potassium channel (TREK)"	"-0.12"	"0"	"0.12"	"0.328"
"R-HSA-70921"	"Histidine catabolism"	"-0.126"	"2"	"2.16"	"1.267"
"R-HSA-74259"	"Purine catabolism"	"-0.135"	"5"	"5.28"	"2.08"
"R-HSA-200425"	"Import of palmitoyl-CoA into the mitochondrial matrix"	"-0.136"	"23"	"23.7"	"5.148"
"R-HSA-5693565"	"Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"	"-0.137"	"688"	"692.64"	"33.827"
"R-HSA-140179"	"Amine Oxidase reactions"	"-0.14"	"0"	"0.14"	"0.405"
"R-HSA-8963678"	"Intestinal lipid absorption"	"-0.14"	"0"	"0.14"	"0.405"
"R-HSA-1483196"	"PI and PC transport between ER and Golgi membranes"	"-0.14"	"0"	"0.14"	"0.351"
"R-HSA-164940"	"Nef mediated downregulation of MHC class I complex cell surface expression"	"-0.151"	"23"	"23.6"	"3.969"
"R-HSA-442755"	"Activation of NMDA receptor and postsynaptic events"	"-0.164"	"164"	"165.88"	"11.476"
"R-HSA-977442"	"GABA A (rho) receptor activation"	"-0.18"	"0"	"0.18"	"0.388"
"R-HSA-8981607"	"Intracellular oxygen transport"	"-0.18"	"0"	"0.18"	"0.388"
"R-HSA-1912399"	"Pre-NOTCH Processing in the Endoplasmic Reticulum"	"-0.182"	"18"	"18.72"	"3.949"
"R-HSA-6782861"	"Synthesis of wybutosine at G37 of tRNA(Phe)"	"-0.182"	"2"	"2.28"	"1.539"
"R-HSA-1483255"	"PI Metabolism"	"-0.186"	"110"	"112.02"	"10.884"
"R-HSA-196741"	"Cobalamin (Cbl, vitamin B12) transport and metabolism"	"-0.194"	"2"	"2.26"	"1.337"
"R-HSA-450531"	"Regulation of mRNA stability by proteins that bind AU-rich elements"	"-0.198"	"334"	"338.1"	"20.682"
"R-HSA-964827"	"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2"	"-0.2"	"0"	"0.2"	"0.495"
"R-HSA-937072"	"TRAF6-mediated induction of TAK1 complex within TLR4 complex"	"-0.204"	"35"	"36.06"	"5.208"
"R-HSA-1169410"	"Antiviral mechanism by IFN-stimulated genes"	"-0.205"	"164"	"166.62"	"12.777"
"R-HSA-1169408"	"ISG15 antiviral mechanism"	"-0.205"	"164"	"166.62"	"12.777"
"R-HSA-1247673"	"Erythrocytes take up oxygen and release carbon dioxide"	"-0.206"	"4"	"4.46"	"2.233"
"R-HSA-5689877"	"Josephin domain DUBs"	"-0.208"	"281"	"284.94"	"18.971"
"R-HSA-2162123"	"Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"	"-0.219"	"7"	"7.62"	"2.835"
"R-HSA-8963676"	"Intestinal absorption"	"-0.22"	"0"	"0.22"	"0.465"
"R-HSA-427975"	"Proton/oligopeptide cotransporters"	"-0.22"	"0"	"0.22"	"0.465"
"R-HSA-3248023"	"Regulation by TREX1"	"-0.22"	"0"	"0.22"	"0.465"
"R-HSA-888593"	"Reuptake of GABA"	"-0.22"	"0"	"0.22"	"0.418"
"R-HSA-5357801"	"Programmed Cell Death"	"-0.224"	"476"	"480.26"	"19.034"
"R-HSA-168898"	"Toll-Like Receptors Cascades"	"-0.233"	"820"	"826.76"	"29.07"
"R-HSA-8934903"	"Receptor Mediated Mitophagy"	"-0.234"	"91"	"93.26"	"9.655"
"R-HSA-445144"	"Signal transduction by L1"	"-0.235"	"150"	"152.7"	"11.5"
"Vitamin B2 (riboflavin) metabolism"	"Vitamin B2 (riboflavin) metabolism"	"-0.235"	"1"	"1.24"	"1.021"
"R-HSA-180534"	"Vpu mediated degradation of CD4"	"-0.24"	"260"	"264.74"	"19.762"
"R-HSA-5693606"	"DNA Double Strand Break Response"	"-0.247"	"690"	"698.34"	"33.779"
"R-HSA-5610780"	"Degradation of GLI1 by the proteasome"	"-0.269"	"329"	"334.92"	"22.025"
"R-HSA-964975"	"Vitamins B6 activation to pyridoxal phosphate"	"-0.269"	"2"	"2.4"	"1.485"
"R-HSA-379397"	"Enzymatic degradation of dopamine by COMT"	"-0.28"	"0"	"0.28"	"0.497"
"R-HSA-379398"	"Enzymatic degradation of Dopamine by monoamine oxidase"	"-0.28"	"0"	"0.28"	"0.497"
"R-HSA-1483101"	"Synthesis of PS"	"-0.28"	"0"	"0.28"	"0.573"
"R-HSA-8941858"	"Regulation of RUNX3 expression and activity"	"-0.287"	"302"	"307.74"	"19.984"
"R-HSA-209931"	"Serotonin and melatonin biosynthesis"	"-0.3"	"0"	"0.3"	"0.463"
"R-HSA-1462054"	"Alpha-defensins"	"-0.307"	"5"	"5.68"	"2.217"
"R-HSA-8941237"	"Invadopodia formation"	"-0.308"	"3"	"3.58"	"1.885"
"R-HSA-399954"	"Sema3A PAK dependent Axon repulsion"	"-0.315"	"131"	"134.26"	"10.343"
"R-HSA-9026403"	"Biosynthesis of DPAn-3-derived 13-series resolvins"	"-0.32"	"0"	"0.32"	"0.587"
"R-HSA-9012546"	"Interleukin-18 signaling"	"-0.32"	"0"	"0.32"	"0.471"
"R-HSA-442982"	"Ras activation upon Ca2+ influx through NMDA receptor"	"-0.32"	"78"	"80.64"	"8.241"
"R-HSA-427589"	"Type II Na+/Pi cotransporters"	"-0.32"	"0"	"0.32"	"0.621"
"R-HSA-390247"	"Beta-oxidation of very long chain fatty acids"	"-0.331"	"7"	"7.86"	"2.595"
"R-HSA-432720"	"Lysosome Vesicle Biogenesis"	"-0.331"	"211"	"215.92"	"14.88"
"R-HSA-174113"	"SCF-beta-TrCP mediated degradation of Emi1"	"-0.338"	"285"	"291.76"	"20.008"
"R-HSA-426048"	"Arachidonate production from DAG"	"-0.34"	"0"	"0.34"	"0.593"
"R-HSA-68875"	"Mitotic Prophase"	"-0.342"	"789"	"800.44"	"33.416"
"R-HSA-9013507"	"NOTCH3 Activation and Transmission of Signal to the Nucleus"	"-0.342"	"298"	"305.08"	"20.685"
"R-HSA-8851680"	"Butyrophilin (BTN) family interactions"	"-0.353"	"2"	"2.5"	"1.418"
"R-HSA-9026290"	"Biosynthesis of DPAn-3-derived maresins"	"-0.36"	"0"	"0.36"	"0.598"
"R-HSA-9026286"	"Biosynthesis of DPAn-3-derived protectins and resolvins"	"-0.36"	"0"	"0.36"	"0.598"
"R-HSA-5576894"	"Phase 1 - inactivation of fast Na+ channels"	"-0.366"	"2"	"2.6"	"1.641"
"R-HSA-1369007"	"Mitochondrial ABC transporters"	"-0.368"	"1"	"1.46"	"1.249"
"R-HSA-425471"	"Bile salt and organic anion SLC transporters"	"-0.369"	"5"	"6.08"	"2.927"
"R-HSA-446343"	"Localization of the PINCH-ILK-PARVIN complex to focal adhesions"	"-0.373"	"17"	"18.62"	"4.347"
"R-HSA-351200"	"Interconversion of polyamines"	"-0.379"	"1"	"1.42"	"1.108"
"R-HSA-163316"	"Mitochondrial transcription termination"	"-0.38"	"0"	"0.38"	"0.53"
"R-HSA-166166"	"MyD88-independent TLR4 cascade "	"-0.391"	"740"	"752"	"30.719"
"R-HSA-937061"	"TRIF(TICAM1)-mediated TLR4 signaling "	"-0.391"	"740"	"752"	"30.719"
"R-HSA-203754"	"NOSIP mediated eNOS trafficking"	"-0.392"	"1"	"1.42"	"1.071"
"R-HSA-8847993"	"ERBB2 Activates PTK6 Signaling"	"-0.399"	"43"	"45.48"	"6.211"
"R-HSA-916853"	"Degradation of GABA"	"-0.4"	"0"	"0.4"	"0.7"
"R-HSA-2142850"	"Hyaluronan biosynthesis and export"	"-0.4"	"0"	"0.4"	"0.7"
"R-HSA-2187335"	"The retinoid cycle in cones (daylight vision)"	"-0.4"	"0"	"0.4"	"0.67"
"R-HSA-5678895"	"Defective CFTR causes cystic fibrosis"	"-0.407"	"280"	"287.92"	"19.456"
"R-HSA-5619084"	"ABC transporter disorders"	"-0.408"	"280"	"287.94"	"19.44"
"R-HSA-5619115"	"Disorders of transmembrane transporters"	"-0.408"	"280"	"287.94"	"19.44"
"R-HSA-1482788"	"Acyl chain remodelling of PC"	"-0.413"	"2"	"2.68"	"1.647"
"R-HSA-165159"	"mTOR signalling"	"-0.424"	"132"	"136.54"	"10.708"
"R-HSA-187577"	"SCF(Skp2)-mediated degradation of p27/p21"	"-0.425"	"326"	"334.5"	"19.993"
"R-HSA-5607761"	"Dectin-1 mediated noncanonical NF-kB signaling"	"-0.427"	"65"	"68.28"	"7.683"
"R-HSA-5676590"	"NIK-->noncanonical NF-kB signaling"	"-0.427"	"65"	"68.28"	"7.683"
"R-HSA-2142688"	"Synthesis of 5-eicosatetraenoic acids"	"-0.431"	"3"	"3.82"	"1.903"
"R-HSA-5693607"	"Processing of DNA double-strand break ends"	"-0.438"	"801"	"817.92"	"38.631"
"R-HSA-5676594"	"TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"	"-0.44"	"31"	"33.66"	"6.039"
"R-HSA-6807047"	"Cholesterol biosynthesis via desmosterol"	"-0.442"	"2"	"2.66"	"1.493"
"R-HSA-6807062"	"Cholesterol biosynthesis via lathosterol"	"-0.442"	"2"	"2.66"	"1.493"
"R-HSA-8957322"	"Metabolism of steroids"	"-0.452"	"239"	"245.5"	"14.393"
"R-HSA-446353"	"Cell-extracellular matrix interactions"	"-0.459"	"40"	"43.18"	"6.921"
"R-HSA-8854050"	"FBXL7 down-regulates AURKA during mitotic entry and in early mitosis"	"-0.459"	"287"	"296.12"	"19.89"
"R-HSA-442742"	"CREB phosphorylation through the activation of Ras"	"-0.466"	"115"	"119.72"	"10.136"
"R-HSA-156988"	"Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor"	"-0.469"	"244"	"252.82"	"18.816"
"R-HSA-429593"	"Inositol transporters"	"-0.48"	"0"	"0.48"	"0.735"
"R-HSA-5263617"	"Metabolism of ingested MeSeO2H into MeSeH"	"-0.48"	"0"	"0.48"	"0.614"
"R-HSA-5358351"	"Signaling by Hedgehog"	"-0.485"	"526"	"538.16"	"25.084"
"R-HSA-1170546"	"Prolactin receptor signaling"	"-0.491"	"74"	"78.3"	"8.753"
"R-HSA-193704"	"p75 NTR receptor-mediated signalling"	"-0.497"	"489"	"500.44"	"23.038"
"R-HSA-156582"	"Acetylation"	"-0.5"	"0"	"0.5"	"0.707"
"R-HSA-209905"	"Catecholamine biosynthesis"	"-0.5"	"0"	"0.5"	"0.58"
"R-HSA-964739"	"N-glycan trimming and elongation in the cis-Golgi"	"-0.5"	"0"	"0.5"	"0.839"
"R-HSA-180585"	"Vif-mediated degradation of APOBEC3G"	"-0.506"	"247"	"256.6"	"18.979"
"R-HSA-9018681"	"Biosynthesis of protectins"	"-0.512"	"4"	"5.1"	"2.15"
"R-HSA-6787639"	"GDP-fucose biosynthesis"	"-0.52"	"0"	"0.52"	"0.707"
"R-HSA-1222352"	"Latent infection of Homo sapiens with Mycobacterium tuberculosis"	"-0.52"	"0"	"0.52"	"0.646"
"R-HSA-1222449"	"Mtb iron assimilation by chelation"	"-0.52"	"0"	"0.52"	"0.646"
"R-HSA-1222499"	"Response of Mtb to phagocytosis"	"-0.52"	"0"	"0.52"	"0.646"
"R-HSA-1660517"	"Synthesis of PIPs at the late endosome membrane"	"-0.523"	"15"	"17.5"	"4.782"
"R-HSA-162588"	"Budding and maturation of HIV virion"	"-0.535"	"295"	"305.7"	"20.002"
"R-HSA-2028269"	"Signaling by Hippo"	"-0.539"	"98"	"103.56"	"10.306"
"R-HSA-162710"	"Synthesis of glycosylphosphatidylinositol (GPI)"	"-0.559"	"3"	"4.36"	"2.431"
"R-HSA-451307"	"Activation of Na-permeable kainate receptors"	"-0.56"	"0"	"0.56"	"0.812"
"R-HSA-192456"	"Digestion of dietary lipid"	"-0.56"	"0"	"0.56"	"0.733"
"R-HSA-166187"	"Mitochondrial Uncoupling Proteins"	"-0.56"	"0"	"0.56"	"0.705"
"R-HSA-167826"	"The fatty acid cycling model"	"-0.56"	"0"	"0.56"	"0.705"
"R-HSA-167827"	"The proton buffering model"	"-0.56"	"0"	"0.56"	"0.705"
"R-HSA-8948747"	"Regulation of PTEN localization"	"-0.568"	"267"	"277.64"	"18.718"
"R-HSA-73780"	"RNA Polymerase III Chain Elongation"	"-0.568"	"100"	"105.48"	"9.645"
"R-HSA-1482839"	"Acyl chain remodelling of PE"	"-0.575"	"2"	"3"	"1.738"
"R-HSA-112411"	"MAPK1 (ERK2) activation"	"-0.577"	"35"	"38.4"	"5.894"
"R-HSA-5620916"	"VxPx cargo-targeting to cilium"	"-0.578"	"45"	"48.82"	"6.611"
"R-HSA-901032"	"ER Quality Control Compartment (ERQC)"	"-0.581"	"243"	"254.24"	"19.347"
"R-HSA-5624138"	"Trafficking of myristoylated proteins to the cilium"	"-0.582"	"2"	"2.98"	"1.684"
"R-HSA-111885"	"Opioid Signalling"	"-0.584"	"353"	"364.6"	"19.846"
"R-HSA-163560"	"Triglyceride catabolism"	"-0.592"	"83"	"88.96"	"10.067"
"R-HSA-1852241"	"Organelle biogenesis and maintenance"	"-0.599"	"1024"	"1040.48"	"27.501"
"R-HSA-418346"	"Platelet homeostasis"	"-0.609"	"226"	"235.16"	"15.03"
"R-HSA-442660"	"Na+/Cl- dependent neurotransmitter transporters"	"-0.61"	"1"	"1.9"	"1.474"
"R-HSA-9010553"	"Regulation of expression of SLITs and ROBOs"	"-0.613"	"233"	"244.32"	"18.469"
"R-HSA-112409"	"RAF-independent MAPK1/3 activation"	"-0.618"	"69"	"74.1"	"8.257"
"R-HSA-435368"	"Zinc efflux and compartmentalization by the SLC30 family"	"-0.618"	"1"	"1.8"	"1.294"
"R-HSA-196791"	"Vitamin D (calciferol) metabolism"	"-0.624"	"70"	"74.8"	"7.693"
"R-HSA-9013957"	"TLR3-mediated TICAM1-dependent programmed cell death"	"-0.627"	"12"	"14.26"	"3.607"
"hsa00562"	"Inositol phosphate metabolism"	"-0.632"	"62"	"67.52"	"8.728"
"R-HSA-4641257"	"Degradation of AXIN"	"-0.633"	"238"	"249.1"	"17.541"
"R-HSA-1660516"	"Synthesis of PIPs at the early endosome membrane"	"-0.634"	"15"	"18.02"	"4.766"
"R-HSA-193048"	"Androgen biosynthesis"	"-0.635"	"17"	"19.76"	"4.35"
"R-HSA-1482925"	"Acyl chain remodelling of PG"	"-0.636"	"2"	"3.32"	"2.075"
"R-HSA-1296061"	"HCN channels"	"-0.64"	"0"	"0.64"	"0.875"
"R-HSA-193807"	"Synthesis of bile acids and bile salts via 27-hydroxycholesterol"	"-0.647"	"25"	"27.86"	"4.422"
"R-HSA-5649702"	"APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway"	"-0.648"	"7"	"8.96"	"3.023"
"R-HSA-174490"	"Membrane binding and targetting of GAG proteins"	"-0.649"	"236"	"248.2"	"18.794"
"R-HSA-174495"	"Synthesis And Processing Of GAG, GAGPOL Polyproteins"	"-0.649"	"236"	"248.2"	"18.794"
"R-HSA-3656534"	"Loss of Function of TGFBR1 in Cancer"	"-0.654"	"17"	"19.88"	"4.406"
"R-HSA-3642278"	"Loss of Function of TGFBR2 in Cancer"	"-0.654"	"17"	"19.88"	"4.406"
"R-HSA-3656532"	"TGFBR1 KD Mutants in Cancer"	"-0.654"	"17"	"19.88"	"4.406"
"R-HSA-3645790"	"TGFBR2 Kinase Domain Mutants in Cancer"	"-0.654"	"17"	"19.88"	"4.406"
"R-HSA-2473224"	"Antagonism of Activin by Follistatin"	"-0.66"	"0"	"0.66"	"0.772"
"R-HSA-4641263"	"Regulation of FZD by ubiquitination"	"-0.667"	"242"	"254.66"	"18.97"
"R-HSA-8956319"	"Nucleobase catabolism"	"-0.677"	"6"	"7.9"	"2.809"
"R-HSA-75094"	"Formation of the Editosome"	"-0.68"	"0"	"0.68"	"0.935"
"R-HSA-629587"	"Highly sodium permeable acetylcholine nicotinic receptors"	"-0.68"	"0"	"0.68"	"0.844"
"R-HSA-72200"	"mRNA Editing: C to U Conversion"	"-0.68"	"0"	"0.68"	"0.935"
"R-HSA-6803544"	"Ion influx/efflux at host-pathogen interface"	"-0.69"	"1"	"1.78"	"1.13"
"R-HSA-8963889"	"Assembly of active LPL and LIPC lipase complexes"	"-0.691"	"3"	"4.32"	"1.911"
"R-HSA-9014826"	"Interleukin-36 pathway"	"-0.7"	"0"	"0.7"	"0.839"
"R-HSA-2142700"	"Synthesis of Lipoxins (LX)"	"-0.7"	"0"	"0.7"	"0.909"
"R-HSA-6804760"	"Regulation of TP53 Activity through Methylation"	"-0.704"	"320"	"332.32"	"17.507"
"R-HSA-380972"	"Energy dependent regulation of mTOR by LKB1-AMPK"	"-0.708"	"63"	"69.32"	"8.922"
"R-HSA-139853"	"Elevation of cytosolic Ca2+ levels"	"-0.711"	"4"	"5.46"	"2.052"
"R-HSA-69610"	"p53-Independent DNA Damage Response"	"-0.715"	"248"	"260.28"	"17.166"
"R-HSA-69613"	"p53-Independent G1/S DNA damage checkpoint"	"-0.715"	"248"	"260.28"	"17.166"
"R-HSA-69601"	"Ubiquitin Mediated Degradation of Phosphorylated Cdc25A"	"-0.715"	"248"	"260.28"	"17.166"
"R-HSA-5578768"	"Physiological factors"	"-0.72"	"0"	"0.72"	"0.904"
"R-HSA-73614"	"Pyrimidine salvage"	"-0.723"	"4"	"5.8"	"2.491"
"R-HSA-2691232"	"Constitutive Signaling by NOTCH1 HD Domain Mutants"	"-0.73"	"241"	"254.94"	"19.096"
"R-HSA-2691230"	"Signaling by NOTCH1 HD Domain Mutants in Cancer"	"-0.73"	"241"	"254.94"	"19.096"
"R-HSA-163765"	"ChREBP activates metabolic gene expression"	"-0.74"	"0"	"0.74"	"0.853"
"R-HSA-9014843"	"Interleukin-33 signaling"	"-0.74"	"0"	"0.74"	"0.986"
"R-HSA-480985"	"Synthesis of dolichyl-phosphate-glucose"	"-0.74"	"0"	"0.74"	"0.777"
"R-HSA-425428"	"Amine compound SLC transporters"	"-0.747"	"1"	"2.22"	"1.632"
"hsa04210"	"Apoptosis"	"-0.748"	"458"	"471.58"	"18.166"
"R-HSA-162909"	"Host Interactions of HIV factors"	"-0.751"	"712"	"736.5"	"32.616"
"R-HSA-1655829"	"Regulation of cholesterol biosynthesis by SREBP (SREBF)"	"-0.758"	"68"	"75.78"	"10.262"
"R-HSA-1912420"	"Pre-NOTCH Processing in Golgi"	"-0.759"	"18"	"21.66"	"4.822"
"R-HSA-4641262"	"Disassembly of the destruction complex and recruitment of AXIN to the membrane"	"-0.76"	"134"	"142.44"	"11.101"
"R-HSA-379401"	"Dopamine clearance from the synaptic cleft"	"-0.76"	"0"	"0.76"	"0.771"
"R-HSA-888568"	"GABA synthesis"	"-0.76"	"0"	"0.76"	"0.847"
"R-HSA-5358508"	"Mismatch Repair"	"-0.767"	"83"	"90.28"	"9.491"
"R-HSA-1358803"	"Downregulation of ERBB2:ERBB3 signaling"	"-0.774"	"254"	"269.12"	"19.523"
"R-HSA-162594"	"Early Phase of HIV Life Cycle"	"-0.781"	"66"	"70.96"	"6.347"
"R-HSA-1482922"	"Acyl chain remodelling of PI"	"-0.785"	"1"	"2.3"	"1.657"
"R-HSA-433692"	"Proton-coupled monocarboxylate transport"	"-0.785"	"3"	"4.88"	"2.396"
"R-HSA-75896"	"Plasmalogen biosynthesis"	"-0.8"	"0"	"0.8"	"0.881"
"WP2706"	"Activation of gene expression by SREBF (SREBP)"	"-0.803"	"46"	"52.7"	"8.34"
"R-HSA-8874211"	"CREB3 factors activate genes"	"-0.806"	"5"	"7.04"	"2.531"
"R-HSA-5684264"	"MAP3K8 (TPL2)-dependent MAPK1/3 activation"	"-0.822"	"312"	"328"	"19.459"
"R-HSA-211999"	"CYP2E1 reactions"	"-0.823"	"9"	"11.5"	"3.039"
"R-HSA-193634"	"Axonal growth inhibition (RHOA activation)"	"-0.838"	"15"	"17.94"	"3.507"
"WP4036"	"MTF1 activates gene expression"	"-0.84"	"0"	"0.84"	"0.912"
"R-HSA-193368"	"Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"	"-0.843"	"30"	"34.26"	"5.054"
"R-HSA-212718"	"EGFR interacts with phospholipase C-gamma"	"-0.853"	"29"	"33.7"	"5.512"
"R-HSA-8876493"	"InlA-mediated entry of Listeria monocytogenes into host cells"	"-0.854"	"242"	"257.74"	"18.439"
"R-HSA-9020591"	"Interleukin-12 signaling"	"-0.854"	"23"	"26.3"	"3.866"
"R-HSA-629594"	"Highly calcium permeable postsynaptic nicotinic acetylcholine receptors"	"-0.857"	"1"	"2.36"	"1.588"
"R-HSA-8850843"	"Phosphate bond hydrolysis by NTPDase proteins"	"-0.86"	"0"	"0.86"	"0.969"
"R-HSA-171286"	"Synthesis and processing of ENV and VPU"	"-0.86"	"0"	"0.86"	"0.948"
"R-HSA-3134975"	"Regulation of innate immune responses to cytosolic DNA"	"-0.864"	"242"	"258.6"	"19.221"
"R-HSA-420597"	"Nectin/Necl  trans heterodimerization"	"-0.869"	"1"	"2.08"	"1.243"
"R-HSA-2142816"	"Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)"	"-0.879"	"8"	"10.52"	"2.866"
"R-HSA-427652"	"Sodium-coupled phosphate cotransporters"	"-0.88"	"0"	"0.88"	"0.94"
"R-HSA-9027604"	"Biosynthesis of electrophilic ?-3 PUFA oxo-derivatives"	"-0.889"	"0"	"0.94"	"1.058"
"R-HSA-6802949"	"Signaling by RAS mutants"	"-0.889"	"179"	"189.64"	"11.964"
"R-HSA-110329"	"Cleavage of the damaged pyrimidine "	"-0.893"	"4"	"6.04"	"2.285"
"R-HSA-73928"	"Depyrimidination"	"-0.893"	"4"	"6.04"	"2.285"
"R-HSA-110328"	"Recognition and association of DNA glycosylase with site containing an affected pyrimidine"	"-0.893"	"4"	"6.04"	"2.285"
"R-HSA-1253288"	"Downregulation of ERBB4 signaling"	"-0.896"	"243"	"259.74"	"18.688"
"R-HSA-163282"	"Mitochondrial transcription initiation"	"-0.903"	"1"	"2.56"	"1.728"
"R-HSA-428542"	"Regulation of commissural axon pathfinding by SLIT and ROBO"	"-0.906"	"11"	"14.06"	"3.377"
"R-HSA-936964"	"Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon"	"-0.908"	"31"	"35.82"	"5.306"
"R-HSA-181431"	"Acetylcholine binding and downstream events"	"-0.909"	"1"	"2.46"	"1.606"
"R-HSA-629602"	"Activation of Nicotinic Acetylcholine Receptors"	"-0.909"	"1"	"2.46"	"1.606"
"R-HSA-622327"	"Postsynaptic nicotinic acetylcholine receptors"	"-0.909"	"1"	"2.46"	"1.606"
"R-HSA-1660499"	"Synthesis of PIPs at the plasma membrane"	"-0.91"	"76"	"84.78"	"9.652"
"R-HSA-1483076"	"Synthesis of CL"	"-0.914"	"0"	"1.02"	"1.116"
"R-HSA-110357"	"Displacement of DNA glycosylase by APEX1"	"-0.919"	"8"	"11.06"	"3.328"
"R-HSA-1296067"	"Potassium transport channels"	"-0.92"	"0"	"0.92"	"0.9"
"R-HSA-1300652"	"Sperm:Oocyte Membrane Binding"	"-0.92"	"0"	"0.92"	"0.922"
"R-HSA-113501"	"Inhibition of replication initiation of damaged DNA by RB1/E2F1"	"-0.922"	"89"	"97.48"	"9.195"
"R-HSA-73980"	"RNA Polymerase III Transcription Termination"	"-0.927"	"101"	"110.08"	"9.793"
"R-HSA-9020933"	"Interleukin-23 signaling"	"-0.932"	"23"	"27.62"	"4.957"
"R-HSA-112310"	"Neurotransmitter release cycle"	"-0.932"	"91"	"99.48"	"9.096"
"R-HSA-1300642"	"Sperm Motility And Taxes"	"-0.935"	"0"	"1"	"1.069"
"R-HSA-73942"	"DNA Damage Reversal"	"-0.936"	"4"	"6.64"	"2.819"
"R-HSA-8849469"	"PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1"	"-0.953"	"241"	"258.7"	"18.577"
"R-HSA-70688"	"Proline catabolism"	"-0.957"	"0"	"1.04"	"1.087"
"R-HSA-162658"	"Golgi Cisternae Pericentriolar Stack Reorganization"	"-0.958"	"107"	"117.78"	"11.258"
"R-HSA-350562"	"Regulation of ornithine decarboxylase (ODC)"	"-0.961"	"1"	"2.34"	"1.394"
"R-HSA-425393"	"Transport of inorganic cations/anions and amino acids/oligopeptides"	"-0.971"	"35"	"40.82"	"5.996"
"R-HSA-9018683"	"Biosynthesis of DPA-derived SPMs"	"-0.981"	"0"	"1.02"	"1.04"
"R-HSA-9025094"	"Biosynthesis of DPAn-3 SPMs"	"-0.981"	"0"	"1.02"	"1.04"
"R-HSA-211981"	"Xenobiotics"	"-0.981"	"22"	"27.96"	"6.074"
"R-HSA-1236978"	"Cross-presentation of soluble exogenous antigens (endosomes)"	"-0.99"	"0"	"1.1"	"1.111"
"R-HSA-75815"	"Ubiquitin-dependent degradation of Cyclin D"	"-0.993"	"236"	"254.88"	"19.013"
"R-HSA-69229"	"Ubiquitin-dependent degradation of Cyclin D1"	"-0.993"	"236"	"254.88"	"19.013"
"R-HSA-168927"	"TICAM1, RIP1-mediated IKK complex recruitment "	"-1.002"	"305"	"323.54"	"18.506"
"R-HSA-1482883"	"Acyl chain remodeling of DAG and TAG"	"-1.02"	"0"	"1.02"	"0.915"
"R-HSA-211994"	"Sterols are 12-hydroxylated by CYP8B1"	"-1.02"	"0"	"1.02"	"0.869"
"R-HSA-421837"	"Clathrin derived vesicle budding"	"-1.025"	"279"	"294.76"	"15.376"
"R-HSA-199992"	"trans-Golgi Network Vesicle Budding"	"-1.025"	"279"	"294.76"	"15.376"
"R-HSA-844623"	"The IPAF inflammasome"	"-1.027"	"0"	"1.28"	"1.246"
"R-HSA-1606341"	"IRF3 mediated activation of type 1 IFN"	"-1.029"	"5"	"7.58"	"2.508"
"R-HSA-5250955"	"Toxicity of botulinum toxin type D (BoNT/D)"	"-1.031"	"4"	"6.78"	"2.698"
"R-HSA-5250981"	"Toxicity of botulinum toxin type F (BoNT/F)"	"-1.031"	"4"	"6.78"	"2.698"
"R-HSA-68827"	"CDT1 association with the CDC6:ORC:origin complex"	"-1.041"	"237"	"256.78"	"19.007"
"R-HSA-2173791"	"TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)"	"-1.048"	"265"	"285.36"	"19.423"
"R-HSA-168276"	"NS1 Mediated Effects on Host Pathways"	"-1.049"	"57"	"63.84"	"6.523"
"R-HSA-1300644"	"Interaction With The Zona Pellucida"	"-1.051"	"0"	"1.94"	"1.845"
"R-HSA-8848584"	"Wax biosynthesis"	"-1.052"	"0"	"1.08"	"1.027"
"R-HSA-6811438"	"Intra-Golgi traffic"	"-1.057"	"77"	"87.7"	"10.122"
"R-HSA-8852405"	"Signaling by MST1"	"-1.059"	"1"	"3.04"	"1.927"
"R-HSA-425381"	"Bicarbonate transporters"	"-1.073"	"1"	"2.44"	"1.343"
"R-HSA-426117"	"Cation-coupled Chloride cotransporters"	"-1.077"	"0"	"1.48"	"1.374"
"R-HSA-432047"	"Passive transport by Aquaporins"	"-1.082"	"0"	"1.4"	"1.294"
"R-HSA-2660826"	"Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant"	"-1.088"	"6"	"9.8"	"3.493"
"R-HSA-1251932"	"PLCG1 events in ERBB2 signaling"	"-1.088"	"35"	"41.42"	"5.901"
"R-HSA-2660825"	"Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant"	"-1.088"	"6"	"9.8"	"3.493"
"R-HSA-140837"	"Intrinsic Pathway of Fibrin Clot Formation"	"-1.093"	"22"	"28.08"	"5.562"
"R-HSA-6802955"	"Paradoxical activation of RAF signaling by kinase inactive BRAF"	"-1.094"	"179"	"192.42"	"12.269"
"R-HSA-6802946"	"Signaling by moderate kinase activity BRAF mutants"	"-1.094"	"179"	"192.42"	"12.269"
"R-HSA-5362798"	"Release of Hh-Np from the secreting cell"	"-1.099"	"2"	"4.3"	"2.092"
"R-HSA-9026357"	"NTF4 activates NTRK2 (TRKB) signaling"	"-1.103"	"0"	"1.2"	"1.088"
"R-HSA-110320"	"Translesion Synthesis by POLH"	"-1.112"	"335"	"360.18"	"22.642"
"R-HSA-2672351"	"Stimuli-sensing channels"	"-1.121"	"289"	"311.66"	"20.217"
"R-HSA-1839128"	"FGFR4 mutant receptor activation"	"-1.124"	"0"	"1.26"	"1.121"
"R-HSA-937041"	"IKK complex recruitment mediated by RIP1"	"-1.128"	"308"	"328.74"	"18.38"
"R-HSA-75944"	"Transcription from mitochondrial promoters"	"-1.128"	"1"	"2.94"	"1.719"
"R-HSA-442745"	"Activation of CaMK IV"	"-1.134"	"19"	"24.36"	"4.728"
"R-HSA-8979227"	"Triglyceride metabolism"	"-1.141"	"84"	"95.96"	"10.486"
"R-HSA-2023837"	"Signaling by FGFR2 amplification mutants"	"-1.142"	"0"	"1.36"	"1.191"
"R-HSA-8853333"	"Signaling by FGFR2 fusions"	"-1.142"	"0"	"1.36"	"1.191"
"R-HSA-9025046"	"NTF3 activates NTRK2 (TRKB) signaling"	"-1.151"	"0"	"1.3"	"1.129"
"R-HSA-4641258"	"Degradation of DVL"	"-1.152"	"270"	"294.38"	"21.165"
"R-HSA-9024909"	"BDNF activates NTRK2 (TRKB) signaling"	"-1.154"	"0"	"1.42"	"1.23"
"R-HSA-390696"	"Adrenoceptors"	"-1.156"	"29"	"36.04"	"6.091"
"R-HSA-193697"	"p75NTR regulates axonogenesis"	"-1.157"	"15"	"18.96"	"3.422"
"R-HSA-69481"	"G2/M Checkpoints"	"-1.164"	"737"	"775.36"	"32.947"
"R-HSA-6799990"	"Metal sequestration by antimicrobial proteins"	"-1.176"	"2"	"3.88"	"1.599"
"R-HSA-2855086"	"Ficolins bind to repetitive carbohydrate structures on the target cell surface"	"-1.178"	"0"	"1.58"	"1.341"
"R-HSA-168643"	"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways"	"-1.18"	"176"	"189.98"	"11.849"
"R-HSA-5250968"	"Toxicity of botulinum toxin type A (BoNT/A)"	"-1.183"	"1"	"3"	"1.69"
"R-HSA-5250992"	"Toxicity of botulinum toxin type E (BoNT/E)"	"-1.183"	"1"	"3"	"1.69"
"R-HSA-447115"	"Interleukin-12 family signaling"	"-1.188"	"38"	"46.32"	"7.006"
"R-HSA-163680"	"AMPK inhibits chREBP transcriptional activation activity"	"-1.211"	"14"	"19.3"	"4.376"
"R-HSA-75102"	"C6 deamination of adenosine"	"-1.219"	"0"	"1.86"	"1.525"
"R-HSA-77042"	"Formation of editosomes by ADAR proteins"	"-1.219"	"0"	"1.86"	"1.525"
"R-HSA-75064"	"mRNA Editing: A to I Conversion"	"-1.219"	"0"	"1.86"	"1.525"
"R-HSA-2393930"	"Phosphate bond hydrolysis by NUDT proteins"	"-1.22"	"0"	"1.44"	"1.181"
"R-HSA-162791"	"Attachment of GPI anchor to uPAR"	"-1.221"	"4"	"6.9"	"2.375"
"R-HSA-8935690"	"Digestion"	"-1.222"	"2"	"4.92"	"2.389"
"R-HSA-5658442"	"Regulation of RAS by GAPs"	"-1.234"	"276"	"302.86"	"21.771"
"R-HSA-349425"	"Autodegradation of the E3 ubiquitin ligase COP1"	"-1.236"	"245"	"266.8"	"17.632"
"R-HSA-163359"	"Glucagon signaling in metabolic regulation"	"-1.244"	"120"	"134.98"	"12.038"
"R-HSA-5661231"	"Metallothioneins bind metals"	"-1.247"	"0"	"1.32"	"1.058"
"R-HSA-2024101"	"CS/DS degradation"	"-1.248"	"0"	"1.8"	"1.443"
"R-HSA-4608870"	"Asymmetric localization of PCP proteins"	"-1.256"	"251"	"275.3"	"19.353"
"R-HSA-1234176"	"Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha"	"-1.26"	"281"	"306.22"	"20.02"
"R-HSA-5250982"	"Toxicity of tetanus toxin (TeNT)"	"-1.284"	"2"	"5.16"	"2.461"
"R-HSA-164939"	"Nef mediated downregulation of CD28 cell surface expression"	"-1.285"	"6"	"10.8"	"3.736"
"R-HSA-2142670"	"Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)"	"-1.287"	"6"	"9.52"	"2.735"
"R-HSA-430039"	"mRNA decay by 5, to 3, exoribonuclease"	"-1.288"	"64"	"74.54"	"8.185"
"R-HSA-8939211"	"ESR-mediated signaling"	"-1.29"	"1007"	"1057.96"	"39.517"
"R-HSA-8985947"	"Interleukin-9 signaling"	"-1.29"	"3"	"6.74"	"2.898"
"R-HSA-69017"	"CDK-mediated phosphorylation and removal of Cdc6"	"-1.292"	"299"	"324.16"	"19.475"
"R-HSA-975110"	"TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling"	"-1.293"	"30"	"38.02"	"6.202"
"R-HSA-8963743"	"Digestion and absorption"	"-1.3"	"2"	"5.14"	"2.416"
"R-HSA-425986"	"Sodium/Proton exchangers"	"-1.302"	"0"	"1.58"	"1.214"
"R-HSA-1482801"	"Acyl chain remodelling of PS"	"-1.304"	"2"	"4.62"	"2.009"
"R-HSA-5689896"	"Ovarian tumor domain proteases"	"-1.304"	"387"	"414.38"	"20.995"
"R-HSA-166662"	"Lectin pathway of complement activation"	"-1.314"	"0"	"2.48"	"1.887"
"R-HSA-197264"	"Nicotinamide salvaging"	"-1.317"	"1"	"3.5"	"1.898"
"R-HSA-2262749"	"Cellular response to hypoxia"	"-1.32"	"282"	"308.64"	"20.186"
"WP2727"	"Regulation of Hypoxia-inducible Factor (HIF) by oxygen"	"-1.32"	"282"	"308.64"	"20.186"
"R-HSA-198203"	"PI3K/AKT activation"	"-1.323"	"74"	"82.88"	"6.712"
"R-HSA-5693567"	"HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)"	"-1.335"	"863"	"914.34"	"38.455"
"R-HSA-975577"	"N-Glycan antennae elongation"	"-1.339"	"1"	"3.72"	"2.031"
"R-HSA-4641265"	"Repression of WNT target genes"	"-1.34"	"68"	"81.08"	"9.762"
"R-HSA-8863795"	"Downregulation of ERBB2 signaling"	"-1.341"	"330"	"362.54"	"24.274"
"R-HSA-5654732"	"Negative regulation of FGFR3 signaling"	"-1.344"	"364"	"392.56"	"21.257"
"R-HSA-192105"	"Synthesis of bile acids and bile salts"	"-1.348"	"31"	"38.66"	"5.684"
"R-HSA-1663150"	"The activation of arylsulfatases"	"-1.355"	"0"	"1.78"	"1.314"
"R-HSA-165160"	"PDE3B signalling"	"-1.368"	"1"	"3.28"	"1.666"
"R-HSA-109703"	"PKB-mediated events"	"-1.368"	"1"	"3.28"	"1.666"
"R-HSA-111932"	"CaMK IV-mediated phosphorylation of CREB"	"-1.375"	"22"	"28.72"	"4.887"
"R-HSA-2022857"	"Keratan sulfate degradation"	"-1.375"	"0"	"1.8"	"1.309"
"R-HSA-68949"	"Orc1 removal from chromatin"	"-1.376"	"361"	"391.14"	"21.912"
"R-HSA-6785631"	"ERBB2 Regulates Cell Motility"	"-1.377"	"48"	"57.78"	"7.101"
"R-HSA-5653890"	"Lactose synthesis"	"-1.378"	"0"	"1.68"	"1.22"
"R-HSA-8866427"	"VLDLR internalisation and degradation"	"-1.379"	"59"	"71.7"	"9.21"
"R-HSA-189085"	"Digestion of dietary carbohydrate"	"-1.381"	"1"	"3.4"	"1.738"
"R-HSA-166020"	"Transfer of LPS from LBP carrier to CD14"	"-1.382"	"0"	"2.06"	"1.49"
"R-HSA-199920"	"CREB phosphorylation"	"-1.387"	"10"	"15.1"	"3.677"
"R-HSA-174084"	"Autodegradation of Cdh1 by Cdh1:APC/C"	"-1.391"	"260"	"286.42"	"18.992"
"R-HSA-977441"	"GABA A receptor activation"	"-1.395"	"2"	"4.64"	"1.893"
"R-HSA-75072"	"mRNA Editing"	"-1.395"	"0"	"2.54"	"1.821"
"R-HSA-428890"	"Role of ABL in ROBO-SLIT signaling"	"-1.404"	"21"	"29.7"	"6.195"
"R-HSA-73943"	"Reversal of alkylation damage by DNA dioxygenases"	"-1.405"	"2"	"5.1"	"2.206"
"R-HSA-1296053"	"Classical Kir channels"	"-1.409"	"0"	"1.8"	"1.278"
"R-HSA-5663213"	"RHO GTPases Activate WASPs and WAVEs"	"-1.413"	"223"	"246.82"	"16.853"
"R-HSA-937039"	"IRAK1 recruits IKK complex"	"-1.417"	"41"	"52.68"	"8.242"
"R-HSA-975144"	"IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation"	"-1.417"	"41"	"52.68"	"8.242"
"R-HSA-112126"	"ALKBH3 mediated reversal of alkylation damage"	"-1.421"	"2"	"4.88"	"2.027"
"R-HSA-194068"	"Bile acid and bile salt metabolism"	"-1.425"	"36"	"45.84"	"6.906"
"R-HSA-2562578"	"TRIF-mediated programmed cell death"	"-1.43"	"12"	"18.66"	"4.658"
"R-HSA-73930"	"Abasic sugar-phosphate removal via the single-nucleotide replacement pathway"	"-1.435"	"1"	"4.08"	"2.146"
"R-HSA-5358565"	"Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)"	"-1.467"	"74"	"87.54"	"9.23"
"R-HSA-174154"	"APC/C:Cdc20 mediated degradation of Securin"	"-1.471"	"260"	"289.36"	"19.958"
"R-HSA-429914"	"Deadenylation-dependent mRNA decay"	"-1.472"	"218"	"240.06"	"14.982"
"R-HSA-418889"	"Ligand-independent caspase activation via DCC"	"-1.475"	"9"	"15.4"	"4.338"
"R-HSA-5654733"	"Negative regulation of FGFR4 signaling"	"-1.481"	"362"	"393.44"	"21.226"
"R-HSA-442717"	"CREB phosphorylation through the activation of CaMKK"	"-1.483"	"22"	"29.24"	"4.88"
"R-HSA-804914"	"Transport of fatty acids"	"-1.487"	"0"	"2.24"	"1.506"
"R-HSA-74749"	"Signal attenuation"	"-1.49"	"72"	"85.08"	"8.78"
"R-HSA-9017802"	"Noncanonical activation of NOTCH3"	"-1.493"	"11"	"17.36"	"4.261"
"R-HSA-191647"	"c-src mediated regulation of Cx43 function and closure of gap junctions"	"-1.494"	"14"	"19.98"	"4.002"
"R-HSA-191650"	"Regulation of gap junction activity"	"-1.494"	"14"	"19.98"	"4.002"
"R-HSA-5140745"	"WNT5A-dependent internalization of FZD2, FZD5 and ROR2"	"-1.495"	"2"	"5.5"	"2.341"
"R-HSA-917729"	"Endosomal Sorting Complex Required For Transport (ESCRT)"	"-1.52"	"263"	"292.84"	"19.638"
"R-HSA-8866652"	"Synthesis of active ubiquitin: roles of E1 and E2 enzymes"	"-1.526"	"297"	"328.1"	"20.378"
"R-HSA-442380"	"Zinc influx into cells by the SLC39 gene family"	"-1.526"	"1"	"4.36"	"2.202"
"R-HSA-8939242"	"RUNX1 regulates transcription of genes involved in differentiation of keratinocytes"	"-1.531"	"5"	"8.98"	"2.599"
"R-HSA-69656"	"Cyclin A:Cdk2-associated events at S phase entry"	"-1.537"	"354"	"388.2"	"22.258"
"R-HSA-110312"	"Translesion synthesis by REV1"	"-1.537"	"294"	"328.4"	"22.382"
"R-HSA-5578749"	"Transcriptional regulation by small RNAs"	"-1.551"	"660"	"703.68"	"28.16"
"R-HSA-389513"	"CTLA4 inhibitory signaling"	"-1.56"	"125"	"142.02"	"10.907"
"R-HSA-110381"	"Resolution of AP sites via the single-nucleotide replacement pathway"	"-1.564"	"5"	"9.72"	"3.017"
"R-HSA-170145"	"Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes"	"-1.565"	"13"	"20.4"	"4.729"
"R-HSA-5221030"	"TET1,2,3 and TDG demethylate DNA"	"-1.566"	"0"	"2.06"	"1.316"
"R-HSA-1187000"	"Fertilization"	"-1.575"	"0"	"3.9"	"2.476"
"R-HSA-5250989"	"Toxicity of botulinum toxin type G (BoNT/G)"	"-1.576"	"5"	"10.18"	"3.287"
"R-HSA-209968"	"Thyroxine biosynthesis"	"-1.577"	"0"	"3.74"	"2.372"
"R-HSA-6803157"	"Antimicrobial peptides"	"-1.587"	"21"	"30.16"	"5.772"
"R-HSA-169131"	"Inhibition of PKR"	"-1.591"	"0"	"2.24"	"1.408"
"R-HSA-2122948"	"Activated NOTCH1 Transmits Signal to the Nucleus"	"-1.593"	"269"	"299.38"	"19.077"
"R-HSA-5656121"	"Translesion synthesis by POLI"	"-1.593"	"294"	"329.4"	"22.222"
"R-HSA-5693538"	"Homology Directed Repair"	"-1.597"	"873"	"934.06"	"38.23"
"R-HSA-5655862"	"Translesion synthesis by POLK"	"-1.611"	"295"	"330.7"	"22.155"
"R-HSA-212165"	"Epigenetic regulation of gene expression"	"-1.614"	"818"	"872.26"	"33.616"
"R-HSA-110313"	"Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template"	"-1.619"	"374"	"412.82"	"23.979"
"R-HSA-8948751"	"Regulation of PTEN stability and activity"	"-1.631"	"311"	"349.22"	"23.427"
"R-HSA-9020265"	"Biosynthesis of aspirin-triggered D-series resolvins"	"-1.635"	"0"	"2.38"	"1.455"
"R-HSA-9018676"	"Biosynthesis of D-series resolvins"	"-1.635"	"0"	"2.38"	"1.455"
"R-HSA-389599"	"Alpha-oxidation of phytanate"	"-1.636"	"1"	"4.16"	"1.931"
"R-HSA-5358606"	"Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)"	"-1.641"	"71"	"86.08"	"9.187"
"R-HSA-435354"	"Zinc transporters"	"-1.641"	"2"	"6.16"	"2.534"
"R-HSA-5660526"	"Response to metal ions"	"-1.643"	"0"	"2.16"	"1.315"
"R-HSA-76061"	"RNA Polymerase III Transcription Initiation From Type 1 Promoter"	"-1.643"	"114"	"129.84"	"9.643"
"R-HSA-6802948"	"Signaling by high-kinase activity BRAF mutants"	"-1.654"	"161"	"180.1"	"11.546"
"R-HSA-9036866"	"Expression and Processing of Neurotrophins"	"-1.656"	"0"	"2.44"	"1.473"
"R-HSA-167060"	"NGF processing"	"-1.656"	"0"	"2.44"	"1.473"
"R-HSA-936440"	"Negative regulators of DDX58/IFIH1 signaling"	"-1.66"	"55"	"68.14"	"7.918"
"R-HSA-76066"	"RNA Polymerase III Transcription Initiation From Type 2 Promoter"	"-1.663"	"113"	"129.26"	"9.775"
"R-HSA-3899300"	"SUMOylation of transcription cofactors"	"-1.667"	"46"	"59.1"	"7.856"
"R-HSA-9023661"	"Biosynthesis of E-series 18(R)-resolvins"	"-1.676"	"0"	"2.42"	"1.444"
"R-HSA-9018896"	"Biosynthesis of E-series 18(S)-resolvins"	"-1.676"	"0"	"2.42"	"1.444"
"R-HSA-5654727"	"Negative regulation of FGFR2 signaling"	"-1.683"	"362"	"397.24"	"20.936"
"R-HSA-1839120"	"Signaling by FGFR1 amplification mutants"	"-1.692"	"0"	"2.86"	"1.69"
"R-HSA-209776"	"Amine-derived hormones"	"-1.695"	"0"	"4.34"	"2.56"
"R-HSA-5654726"	"Negative regulation of FGFR1 signaling"	"-1.7"	"362"	"397.36"	"20.8"
"R-HSA-549132"	"Organic cation/anion/zwitterion transport"	"-1.704"	"0"	"2.62"	"1.537"
"R-HSA-549127"	"Organic cation transport"	"-1.705"	"0"	"2.6"	"1.525"
"R-HSA-5626978"	"TNFR1-mediated ceramide production"	"-1.705"	"17"	"24.58"	"4.445"
"R-HSA-8875513"	"MET interacts with TNS proteins"	"-1.706"	"4"	"9.58"	"3.271"
"R-HSA-195721"	"Signaling by WNT"	"-1.707"	"1430"	"1518.02"	"51.566"
"R-HSA-8856688"	"Golgi-to-ER retrograde transport"	"-1.711"	"349"	"383.5"	"20.161"
"R-HSA-209563"	"Axonal growth stimulation"	"-1.715"	"10"	"15.34"	"3.114"
"R-HSA-1307965"	"betaKlotho-mediated ligand binding"	"-1.715"	"0"	"2.48"	"1.446"
"R-HSA-3769402"	"Deactivation of the beta-catenin transactivating complex"	"-1.721"	"320"	"356.28"	"21.081"
"R-HSA-211958"	"Miscellaneous substrates"	"-1.731"	"6"	"11.42"	"3.13"
"R-HSA-399710"	"Activation of AMPA receptors"	"-1.733"	"2"	"6.7"	"2.712"
"R-HSA-165158"	"Activation of AKT2"	"-1.739"	"2"	"6.76"	"2.737"
"R-HSA-8851708"	"Signaling by FGFR2 IIIa TM"	"-1.744"	"1"	"4.92"	"2.248"
"R-HSA-8964011"	"HDL clearance"	"-1.745"	"1"	"5.2"	"2.407"
"R-HSA-8951911"	"RUNX3 regulates RUNX1-mediated transcription"	"-1.746"	"1"	"3.88"	"1.649"
"R-HSA-6806664"	"Metabolism of vitamin K"	"-1.751"	"0"	"2.3"	"1.313"
"R-HSA-6806942"	"MET Receptor Activation"	"-1.752"	"1"	"5.78"	"2.728"
"R-HSA-8853336"	"Signaling by plasma membrane FGFR1 fusions"	"-1.756"	"3"	"8.34"	"3.041"
"R-HSA-1234158"	"Regulation of gene expression by Hypoxia-inducible Factor"	"-1.757"	"4"	"9.6"	"3.188"
"R-HSA-182218"	"Nef Mediated CD8 Down-regulation"	"-1.762"	"27"	"38.7"	"6.64"
"R-HSA-216083"	"Integrin cell surface interactions"	"-1.764"	"85"	"101.12"	"9.138"
"R-HSA-8849472"	"PTK6 Down-Regulation"	"-1.782"	"1"	"4.78"	"2.122"
"R-HSA-1296072"	"Voltage gated Potassium channels"	"-1.782"	"6"	"11.86"	"3.289"
"R-HSA-5601884"	"PIWI-interacting RNA (piRNA) biogenesis"	"-1.789"	"0"	"3.82"	"2.135"
"R-HSA-168638"	"NOD1/2 Signaling Pathway"	"-1.79"	"110"	"128.44"	"10.304"
"R-HSA-1295596"	"Spry regulation of FGF signaling"	"-1.792"	"306"	"341.78"	"19.969"
"R-HSA-69206"	"G1/S Transition"	"-1.812"	"651"	"712.6"	"34.002"
"R-HSA-76071"	"RNA Polymerase III Transcription Initiation From Type 3 Promoter"	"-1.825"	"115"	"133.18"	"9.963"
"R-HSA-5627083"	"RHO GTPases regulate CFTR trafficking"	"-1.826"	"6"	"13.5"	"4.107"
"R-HSA-203615"	"eNOS activation"	"-1.831"	"54"	"70.04"	"8.762"
"R-HSA-5696394"	"DNA Damage Recognition in GG-NER"	"-1.832"	"385"	"429.88"	"24.495"
"R-HSA-5660668"	"CLEC7A/inflammasome pathway"	"-1.841"	"2"	"7.14"	"2.792"
"R-HSA-69273"	"Cyclin A/B1/B2 associated events during G2/M transition"	"-1.844"	"178"	"204.44"	"14.34"
"R-HSA-111957"	"Cam-PDE 1 activation"	"-1.849"	"11"	"19.66"	"4.684"
"R-HSA-425410"	"Metal ion SLC transporters"	"-1.855"	"2"	"7.1"	"2.75"
"R-HSA-2173782"	"Binding and Uptake of Ligands by Scavenger Receptors"	"-1.859"	"92"	"112.18"	"10.857"
"R-HSA-381676"	"Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"	"-1.861"	"132"	"156"	"12.898"
"WP4086"	"Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors"	"-1.862"	"242"	"272.62"	"16.449"
"R-HSA-68867"	"Assembly of the pre-replicative complex"	"-1.874"	"272"	"310.86"	"20.735"
"R-HSA-425561"	"Sodium/Calcium exchangers"	"-1.883"	"11"	"20.34"	"4.959"
"R-HSA-205017"	"NFG and proNGF binds to p75NTR"	"-1.887"	"0"	"2.68"	"1.421"
"R-HSA-881907"	"Gastrin-CREB signalling pathway via PKC and MAPK"	"-1.891"	"114"	"134.8"	"11.001"
"R-HSA-193681"	"Ceramide signalling"	"-1.904"	"0"	"3.26"	"1.712"
"R-HSA-73887"	"Death Receptor Signalling"	"-1.913"	"587"	"631.74"	"23.382"
"R-HSA-5696397"	"Gap-filling DNA repair synthesis and ligation in GG-NER"	"-1.915"	"312"	"354.28"	"22.08"
"WP4129"	"Plasma lipoprotein assembly, remodeling, and clearance"	"-1.918"	"140"	"163.84"	"12.428"
"R-HSA-9018519"	"Estrogen-dependent gene expression"	"-1.925"	"876"	"948.7"	"37.77"
"R-HSA-5357905"	"Regulation of TNFR1 signaling"	"-1.931"	"82"	"99.06"	"8.833"
"R-HSA-8934593"	"Regulation of RUNX1 Expression and Activity"	"-1.944"	"64"	"83.84"	"10.205"
"R-HSA-844615"	"The AIM2 inflammasome"	"-1.954"	"1"	"4.88"	"1.986"
"R-HSA-211163"	"AKT-mediated inactivation of FOXO1A"	"-1.956"	"10"	"17.52"	"3.845"
"WP3513"	"Regulation of beta-cell development"	"-1.956"	"10"	"17.52"	"3.845"
"R-HSA-210745"	"Regulation of gene expression in beta cells"	"-1.956"	"10"	"17.52"	"3.845"
"R-HSA-8985586"	"SLIT2:ROBO1 increases RHOA activity"	"-1.957"	"6"	"11.82"	"2.974"
"WP3313"	"Hedgehog ,on, state"	"-1.975"	"310"	"351.5"	"21.014"
"R-HSA-75158"	"TRAIL  signaling"	"-1.979"	"5"	"12.26"	"3.669"
"R-HSA-5545619"	"XAV939 inhibits tankyrase, stabilizing AXIN"	"-1.982"	"0"	"2.74"	"1.382"
"R-HSA-9018679"	"Biosynthesis of EPA-derived SPMs"	"-1.994"	"0"	"3.04"	"1.525"
"R-HSA-434316"	"Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion"	"-1.995"	"16"	"26.16"	"5.092"
"R-HSA-400451"	"Free fatty acids regulate insulin secretion"	"-1.995"	"16"	"26.16"	"5.092"
"R-HSA-420029"	"Tight junction interactions"	"-2"	"8"	"13.64"	"2.819"
"R-HSA-8866906"	"TFAP2 (AP-2) family regulates transcription of other transcription factors"	"-2.001"	"2"	"6.08"	"2.039"
"R-HSA-419771"	"Opsins"	"-2.014"	"0"	"3.86"	"1.917"
"R-HSA-193993"	"Mineralocorticoid biosynthesis"	"-2.017"	"0"	"5.96"	"2.955"
"R-HSA-211000"	"Gene Silencing by RNA"	"-2.019"	"674"	"730.58"	"28.028"
"R-HSA-4791275"	"Signaling by WNT in cancer"	"-2.022"	"0"	"2.78"	"1.375"
"R-HSA-8951671"	"RUNX3 regulates YAP1-mediated transcription"	"-2.027"	"3"	"9.34"	"3.127"
"R-HSA-8939247"	"RUNX1 regulates transcription of genes involved in interleukin signaling"	"-2.039"	"0"	"4.14"	"2.03"
"R-HSA-450302"	"activated TAK1 mediates p38 MAPK activation"	"-2.04"	"66"	"82.46"	"8.069"
"R-HSA-5632681"	"Ligand-receptor interactions"	"-2.048"	"1"	"6.2"	"2.539"
"R-HSA-8866904"	"Negative regulation of activity of TFAP2 (AP-2) family transcription factors"	"-2.061"	"50"	"66.94"	"8.22"
"R-HSA-1234162"	"Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha"	"-2.066"	"3"	"8.96"	"2.885"
"R-HSA-159740"	"Gamma-carboxylation of protein precursors"	"-2.067"	"1"	"6.2"	"2.515"
"R-HSA-5674135"	"MAP2K and MAPK activation"	"-2.067"	"161"	"185.06"	"11.638"
"R-HSA-194306"	"Neurophilin interactions with VEGF and VEGFR"	"-2.075"	"0"	"4.74"	"2.284"
"R-HSA-179409"	"APC-Cdc20 mediated degradation of Nek2A"	"-2.078"	"269"	"310.2"	"19.827"
"Glycosphingolipid metabolism"	"Glycosphingolipid metabolism"	"-2.086"	"5"	"11.42"	"3.078"
"R-HSA-5656169"	"Termination of translesion DNA synthesis"	"-2.089"	"327"	"374.18"	"22.584"
"R-HSA-2995383"	"Initiation of Nuclear Envelope Reformation"	"-2.09"	"49"	"64.62"	"7.475"
"R-HSA-2995410"	"Nuclear Envelope Reassembly"	"-2.09"	"49"	"64.62"	"7.475"
"R-HSA-8939902"	"Regulation of RUNX2 expression and activity"	"-2.092"	"319"	"364.32"	"21.661"
"R-HSA-1236973"	"Cross-presentation of particulate exogenous antigens (phagosomes)"	"-2.094"	"2"	"6.94"	"2.36"
"R-HSA-198693"	"AKT phosphorylates targets in the nucleus"	"-2.102"	"23"	"33.16"	"4.833"
"R-HSA-174048"	"APC/C:Cdc20 mediated degradation of Cyclin B"	"-2.105"	"268"	"311.78"	"20.799"
"R-HSA-418890"	"Role of second messengers in netrin-1 signaling"	"-2.111"	"11"	"20.38"	"4.444"
"R-HSA-190374"	"FGFR1c and Klotho ligand binding and activation"	"-2.113"	"0"	"5.28"	"2.499"
"R-HSA-2214320"	"Anchoring fibril formation"	"-2.114"	"0"	"5"	"2.365"
"R-HSA-5576890"	"Phase 3 - rapid repolarisation"	"-2.114"	"1"	"5.42"	"2.091"
"R-HSA-5357786"	"TNFR1-induced proapoptotic signaling"	"-2.126"	"28"	"41.82"	"6.502"
"R-HSA-159782"	"Removal of aminoterminal propeptides from gamma-carboxylated proteins"	"-2.128"	"1"	"6.62"	"2.641"
"R-HSA-69200"	"Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes"	"-2.133"	"29"	"40.36"	"5.325"
"R-HSA-173736"	"Alternative complement activation"	"-2.134"	"0"	"5.44"	"2.549"
"R-HSA-2168880"	"Scavenging of heme from plasma"	"-2.134"	"7"	"15.38"	"3.927"
"R-HSA-2132295"	"MHC class II antigen presentation"	"-2.144"	"181"	"204.74"	"11.075"
"R-HSA-8849474"	"PTK6 Activates STAT3"	"-2.145"	"4"	"11.8"	"3.637"
"R-HSA-5210891"	"Uptake and function of anthrax toxins"	"-2.148"	"20"	"33.18"	"6.137"
"R-HSA-1169091"	"Activation of NF-kappaB in B cells"	"-2.16"	"102"	"123.28"	"9.85"
"R-HSA-428359"	"Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA"	"-2.166"	"0"	"4.94"	"2.28"
"R-HSA-159854"	"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins"	"-2.168"	"1"	"7.06"	"2.795"
"R-HSA-166665"	"Terminal pathway of complement"	"-2.185"	"2"	"8.66"	"3.048"
"R-HSA-376176"	"Signaling by ROBO receptors"	"-2.193"	"385"	"439.28"	"24.753"
"R-HSA-446199"	"Synthesis of Dolichyl-phosphate"	"-2.2"	"1"	"5.06"	"1.845"
"R-HSA-165181"	"Inhibition of TSC complex formation by PKB"	"-2.202"	"1"	"6.56"	"2.525"
"R-HSA-5173214"	"O-glycosylation of TSR domain-containing proteins"	"-2.204"	"0"	"5.66"	"2.568"
"R-HSA-75109"	"Triglyceride biosynthesis"	"-2.207"	"1"	"7"	"2.718"
"R-HSA-8941333"	"RUNX2 regulates genes involved in differentiation of myeloid cells"	"-2.213"	"1"	"5.52"	"2.043"
"R-HSA-397014"	"Muscle contraction"	"-2.222"	"281"	"321.88"	"18.401"
"R-HSA-174184"	"Cdc20:Phospho-APC/C mediated degradation of Cyclin A"	"-2.227"	"280"	"325.24"	"20.317"
"R-HSA-195399"	"VEGF binds to VEGFR leading to receptor dimerization"	"-2.23"	"0"	"5.22"	"2.341"
"R-HSA-194313"	"VEGF ligand-receptor interactions"	"-2.23"	"0"	"5.22"	"2.341"
"R-HSA-425366"	"Transport of bile salts and organic acids, metal ions and amine compounds"	"-2.234"	"8"	"18.48"	"4.691"
"R-HSA-110362"	"POLB-Dependent Long Patch Base Excision Repair"	"-2.244"	"11"	"20.76"	"4.35"
"R-HSA-432040"	"Vasopressin regulates renal water homeostasis via Aquaporins"	"-2.248"	"124"	"149.32"	"11.262"
"R-HSA-3304351"	"Signaling by TGF-beta Receptor Complex in Cancer"	"-2.249"	"27"	"41.76"	"6.564"
"R-HSA-190377"	"FGFR2b ligand binding and activation"	"-2.252"	"1"	"8.78"	"3.454"
"R-HSA-190371"	"FGFR3b ligand binding and activation"	"-2.255"	"3"	"8.84"	"2.59"
"R-HSA-2173789"	"TGF-beta receptor signaling activates SMADs"	"-2.261"	"406"	"461.1"	"24.371"
"R-HSA-445717"	"Aquaporin-mediated transport"	"-2.267"	"124"	"149.56"	"11.274"
"R-HSA-69231"	"Cyclin D associated events in G1"	"-2.267"	"433"	"493.44"	"26.659"
"R-HSA-69236"	"G1 Phase"	"-2.267"	"433"	"493.44"	"26.659"
"R-HSA-6804116"	"TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"	"-2.271"	"66"	"85.8"	"8.718"
"R-HSA-8985801"	"Regulation of cortical dendrite branching"	"-2.274"	"1"	"5.38"	"1.926"
"R-HSA-164952"	"The role of Nef in HIV-1 replication and disease pathogenesis"	"-2.275"	"96"	"120.4"	"10.725"
"R-HSA-425397"	"Transport of vitamins, nucleosides, and related molecules"	"-2.283"	"7"	"17.9"	"4.773"
"R-HSA-5666185"	"RHO GTPases Activate Rhotekin and Rhophilins"	"-2.287"	"12"	"23.5"	"5.027"
"R-HSA-3295583"	"TRP channels"	"-2.291"	"1"	"7.9"	"3.012"
"R-HSA-8875791"	"MET activates STAT3"	"-2.297"	"3"	"12"	"3.918"
"R-HSA-8849470"	"PTK6 Regulates Cell Cycle"	"-2.298"	"30"	"41.36"	"4.944"
"R-HSA-429958"	"mRNA decay by 3, to 5, exoribonuclease"	"-2.311"	"22"	"35.04"	"5.642"
"R-HSA-8854521"	"Interaction between PHLDA1 and AURKA"	"-2.326"	"3"	"9.7"	"2.88"
"R-HSA-3772470"	"Negative regulation of TCF-dependent signaling by WNT ligand antagonists"	"-2.326"	"2"	"9.94"	"3.413"
"R-HSA-201688"	"WNT mediated activation of DVL"	"-2.33"	"56"	"78.26"	"9.555"
"R-HSA-8866910"	"TFAP2 (AP-2) family regulates transcription of growth factors and their receptors"	"-2.334"	"50"	"67.24"	"7.386"
"R-HSA-76046"	"RNA Polymerase III Transcription Initiation"	"-2.335"	"124"	"146.36"	"9.576"
"R-HSA-209822"	"Glycoprotein hormones"	"-2.341"	"0"	"8.06"	"3.443"
"R-HSA-5635851"	"GLI proteins bind promoters of Hh responsive genes to promote transcription"	"-2.346"	"3"	"11.68"	"3.7"
"R-HSA-416700"	"Other semaphorin interactions"	"-2.349"	"4"	"11.88"	"3.354"
"R-HSA-1461973"	"Defensins"	"-2.35"	"5"	"14.76"	"4.153"
"R-HSA-5250971"	"Toxicity of botulinum toxin type C (BoNT/C)"	"-2.354"	"2"	"8.78"	"2.881"
"R-HSA-2453902"	"The canonical retinoid cycle in rods (twilight vision)"	"-2.358"	"0"	"5.52"	"2.341"
"R-HSA-9020702"	"Interleukin-1 signaling"	"-2.36"	"443"	"505.32"	"26.412"
"R-HSA-5357956"	"TNFR1-induced NFkappaB signaling pathway"	"-2.367"	"94"	"114.38"	"8.609"
"R-HSA-73772"	"RNA Polymerase I Promoter Escape"	"-2.368"	"142"	"175.3"	"14.063"
"R-HSA-539107"	"Activation of E2F1 target genes at G1/S"	"-2.371"	"60"	"78.78"	"7.921"
"R-HSA-69205"	"G1/S-Specific Transcription"	"-2.371"	"60"	"78.78"	"7.921"
"R-HSA-179419"	"APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint"	"-2.38"	"282"	"330.6"	"20.421"
"R-HSA-201451"	"Signaling by BMP"	"-2.385"	"38"	"57.7"	"8.262"
"R-HSA-5339562"	"Uptake and actions of bacterial toxins"	"-2.385"	"50"	"71.78"	"9.132"
"R-HSA-6783310"	"Fanconi Anemia Pathway"	"-2.39"	"278"	"330.6"	"22.007"
"R-HSA-9020558"	"Interleukin-2 signaling"	"-2.392"	"22"	"36.9"	"6.228"
"R-HSA-69052"	"Switching of origins to a post-replicative state"	"-2.403"	"389"	"445.14"	"23.36"
"R-HSA-1433617"	"Regulation of signaling by NODAL"	"-2.417"	"0"	"5.06"	"2.094"
"R-HSA-73863"	"RNA Polymerase I Transcription Termination"	"-2.419"	"142"	"176.48"	"14.252"
"R-HSA-5607764"	"CLEC7A (Dectin-1) signaling"	"-2.421"	"183"	"216.74"	"13.937"
"R-HSA-5250958"	"Toxicity of botulinum toxin type B (BoNT/B)"	"-2.421"	"3"	"11.32"	"3.437"
"R-HSA-1855204"	"Synthesis of IP3 and IP4 in the cytosol"	"-2.434"	"39"	"57.92"	"7.774"
"R-HSA-2142691"	"Synthesis of Leukotrienes (LT) and Eoxins (EX)"	"-2.434"	"3"	"11.52"	"3.501"
"R-HSA-5696395"	"Formation of Incision Complex in GG-NER"	"-2.447"	"502"	"576.12"	"30.288"
"R-HSA-8964046"	"VLDL clearance"	"-2.467"	"0"	"6.38"	"2.586"
"WP3579"	"Surfactant metabolism"	"-2.468"	"5"	"14.9"	"4.011"
"R-HSA-1592389"	"Activation of Matrix Metalloproteinases"	"-2.472"	"5"	"12.62"	"3.083"
"R-HSA-176408"	"Regulation of APC/C activators between G1/S and early anaphase"	"-2.473"	"365"	"421.66"	"22.91"
"R-HSA-174178"	"APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1"	"-2.481"	"270"	"323.44"	"21.543"
"R-HSA-4086398"	"Ca2+ pathway"	"-2.485"	"159"	"196.84"	"15.227"
"R-HSA-3000480"	"Scavenging by Class A Receptors"	"-2.488"	"16"	"28.1"	"4.862"
"R-HSA-975578"	"Reactions specific to the complex N-glycan synthesis pathway"	"-2.489"	"0"	"7.94"	"3.191"
"R-HSA-211979"	"Eicosanoids"	"-2.502"	"2"	"9.18"	"2.869"
"R-HSA-8964058"	"HDL remodeling"	"-2.528"	"5"	"13.86"	"3.505"
"R-HSA-8964038"	"LDL clearance"	"-2.537"	"61"	"81.76"	"8.183"
"R-HSA-211916"	"Vitamins"	"-2.545"	"0"	"6.64"	"2.609"
"R-HSA-9020956"	"Interleukin-27 signaling"	"-2.547"	"15"	"29.7"	"5.772"
"R-HSA-112308"	"Presynaptic depolarization and calcium channel opening"	"-2.563"	"2"	"9.56"	"2.95"
"R-HSA-176409"	"APC/C:Cdc20 mediated degradation of mitotic proteins"	"-2.568"	"288"	"341.76"	"20.938"
"R-HSA-156584"	"Cytosolic sulfonation of small molecules"	"-2.57"	"3"	"12.96"	"3.875"
"R-HSA-170660"	"Adenylate cyclase activating pathway"	"-2.572"	"2"	"12.68"	"4.152"
"R-HSA-4085001"	"Sialic acid metabolism"	"-2.575"	"0"	"6.26"	"2.431"
"R-HSA-75205"	"Dissolution of Fibrin Clot"	"-2.589"	"2"	"10.58"	"3.314"
"R-HSA-168315"	"Inhibition of Host mRNA Processing and RNA Silencing"	"-2.602"	"3"	"12.96"	"3.828"
"R-HSA-8964041"	"LDL remodeling"	"-2.604"	"0"	"4.64"	"1.782"
"R-HSA-73893"	"DNA Damage Bypass"	"-2.617"	"398"	"462.54"	"24.665"
"R-HSA-8875360"	"InlB-mediated entry of Listeria monocytogenes into host cell"	"-2.621"	"260"	"306.68"	"17.811"
"R-HSA-749476"	"RNA Polymerase III Abortive And Retractive Initiation"	"-2.621"	"125"	"150.96"	"9.904"
"R-HSA-74158"	"RNA Polymerase III Transcription"	"-2.621"	"125"	"150.96"	"9.904"
"R-HSA-9032845"	"Activated NTRK2 signals through CDK5"	"-2.624"	"8"	"19.98"	"4.565"
"R-HSA-447043"	"Neurofascin interactions"	"-2.634"	"1"	"9.32"	"3.159"
"hsa00590"	"Arachidonic acid metabolism"	"-2.67"	"20"	"34.82"	"5.55"
"R-HSA-430116"	"GP1b-IX-V activation signalling"	"-2.675"	"41"	"62.24"	"7.94"
"R-HSA-5635838"	"Activation of SMO"	"-2.676"	"20"	"34.52"	"5.426"
"R-HSA-264876"	"Insulin processing"	"-2.679"	"0"	"7.2"	"2.688"
"R-HSA-8931987"	"RUNX1 regulates estrogen receptor mediated transcription"	"-2.688"	"12"	"25.24"	"4.926"
"R-HSA-879518"	"Transport of organic anions"	"-2.688"	"3"	"12.84"	"3.661"
"R-HSA-8948216"	"Collagen chain trimerization"	"-2.69"	"6"	"18.86"	"4.781"
"R-HSA-3000497"	"Scavenging by Class H Receptors"	"-2.691"	"0"	"5.44"	"2.022"
"R-HSA-6802957"	"Oncogenic MAPK signaling"	"-2.699"	"192"	"225.96"	"12.581"
"R-HSA-451326"	"Activation of kainate receptors upon glutamate binding"	"-2.715"	"85"	"113.34"	"10.439"
"R-HSA-2142845"	"Hyaluronan metabolism"	"-2.72"	"0"	"7.5"	"2.757"
"R-HSA-1168372"	"Downstream signaling events of B Cell Receptor (BCR)"	"-2.721"	"142"	"177.64"	"13.099"
"R-HSA-446652"	"Interleukin-1 family signaling"	"-2.731"	"445"	"518.78"	"27.012"
"R-HSA-177539"	"Autointegration results in viral DNA circles"	"-2.741"	"1"	"7.6"	"2.407"
"R-HSA-175567"	"Integration of viral DNA into host genomic DNA"	"-2.741"	"1"	"7.6"	"2.407"
"R-HSA-450321"	"JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1"	"-2.745"	"52"	"74.44"	"8.175"
"R-HSA-3928662"	"EPHB-mediated forward signaling"	"-2.754"	"198"	"243.44"	"16.501"
"R-HSA-1461957"	"Beta defensins"	"-2.762"	"0"	"9.08"	"3.288"
"R-HSA-2160916"	"Hyaluronan uptake and degradation"	"-2.768"	"0"	"7.1"	"2.565"
"R-HSA-69895"	"Transcriptional  activation of  cell cycle inhibitor p21 "	"-2.768"	"20"	"33.48"	"4.871"
"R-HSA-69560"	"Transcriptional activation of p53 responsive genes  "	"-2.768"	"20"	"33.48"	"4.871"
"R-HSA-69109"	"Leading Strand Synthesis"	"-2.771"	"43"	"65.86"	"8.249"
"R-HSA-69091"	"Polymerase switching"	"-2.771"	"43"	"65.86"	"8.249"
"R-HSA-174411"	"Polymerase switching on the C-strand of the telomere"	"-2.771"	"43"	"65.86"	"8.249"
"R-HSA-399997"	"Acetylcholine regulates insulin secretion"	"-2.773"	"19"	"34"	"5.41"
"R-HSA-5621575"	"CD209 (DC-SIGN) signaling"	"-2.774"	"99"	"129"	"10.816"
"R-HSA-2243919"	"Crosslinking of collagen fibrils"	"-2.778"	"0"	"4.2"	"1.512"
"R-HSA-174143"	"APC/C-mediated degradation of cell cycle proteins"	"-2.782"	"384"	"452.26"	"24.54"
"R-HSA-453276"	"Regulation of mitotic cell cycle"	"-2.782"	"384"	"452.26"	"24.54"
"R-HSA-8849473"	"PTK6 Expression"	"-2.784"	"5"	"16.62"	"4.174"
"R-HSA-9012852"	"Signaling by NOTCH3"	"-2.789"	"328"	"395.62"	"24.244"
"R-HSA-2514853"	"Condensation of Prometaphase Chromosomes"	"-2.809"	"65"	"93.82"	"10.261"
"R-HSA-8941284"	"RUNX2 regulates chondrocyte maturation"	"-2.812"	"0"	"7.06"	"2.51"
"R-HSA-9008059"	"Interleukin-37 signaling"	"-2.813"	"2"	"11.48"	"3.37"
"R-HSA-176034"	"Interactions of Tat with host cellular proteins"	"-2.825"	"3"	"12.52"	"3.37"
"R-HSA-446107"	"Type I hemidesmosome assembly"	"-2.825"	"1"	"10.52"	"3.37"
"R-HSA-450604"	"KSRP (KHSRP) binds and destabilizes mRNA"	"-2.827"	"38"	"55.86"	"6.318"
"R-HSA-2993913"	"Clearance of Nuclear Envelope Membranes from Chromatin"	"-2.828"	"4"	"11.6"	"2.688"
"R-HSA-437239"	"Recycling pathway of L1"	"-2.829"	"109"	"139.1"	"10.639"
"R-HSA-2029482"	"Regulation of actin dynamics for phagocytic cup formation"	"-2.83"	"364"	"415.46"	"18.181"
"R-HSA-5218900"	"CASP8 activity is inhibited"	"-2.831"	"14"	"29.86"	"5.603"
"R-HSA-69416"	"Dimerization of procaspase-8"	"-2.831"	"14"	"29.86"	"5.603"
"R-HSA-3371378"	"Regulation by c-FLIP"	"-2.831"	"14"	"29.86"	"5.603"
"R-HSA-5675482"	"Regulation of necroptotic cell death"	"-2.831"	"14"	"29.86"	"5.603"
"R-HSA-110314"	"Recognition of DNA damage by PCNA-containing replication complex"	"-2.842"	"327"	"393.74"	"23.483"
"R-HSA-8963901"	"Chylomicron remodeling"	"-2.843"	"1"	"12.8"	"4.15"
"R-HSA-8964026"	"Chylomicron clearance"	"-2.856"	"4"	"12.56"	"2.998"
"R-HSA-416993"	"Trafficking of GluR2-containing AMPA receptors"	"-2.865"	"46"	"69.06"	"8.049"
"R-HSA-159418"	"Recycling of bile acids and salts"	"-2.871"	"6"	"19.68"	"4.766"
"R-HSA-190370"	"FGFR1b ligand binding and activation"	"-2.877"	"1"	"9.38"	"2.913"
"R-HSA-2129379"	"Molecules associated with elastic fibres"	"-2.88"	"12"	"28.76"	"5.819"
"WP4047"	"PTEN Regulation"	"-2.885"	"685"	"768.68"	"29.007"
"R-HSA-110056"	"MAPK3 (ERK1) activation"	"-2.89"	"33"	"52.54"	"6.762"
"R-HSA-3214842"	"HDMs demethylate histones"	"-2.891"	"66"	"92.96"	"9.324"
"R-HSA-6794361"	"Neurexins and neuroligins"	"-2.891"	"71"	"100.96"	"10.365"
"R-HSA-5696399"	"Global Genome Nucleotide Excision Repair (GG-NER)"	"-2.893"	"677"	"770.32"	"32.256"
"R-HSA-376172"	"DSCAM interactions"	"-2.907"	"19"	"37.28"	"6.289"
"R-HSA-176407"	"Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase"	"-2.917"	"40"	"62.94"	"7.865"
"R-HSA-3238698"	"WNT ligand biogenesis and trafficking"	"-2.919"	"4"	"15"	"3.769"
"R-HSA-211935"	"Fatty acids"	"-2.923"	"4"	"14.28"	"3.517"
"WP4105"	"Transcriptional regulation by RUNX1"	"-2.925"	"990"	"1121.12"	"44.833"
"R-HSA-8943724"	"Regulation of PTEN gene transcription"	"-2.934"	"310"	"362.76"	"17.984"
"R-HSA-204005"	"COPII-mediated vesicle transport"	"-2.943"	"181"	"223.88"	"14.571"
"R-HSA-445355"	"Smooth Muscle Contraction"	"-2.948"	"122"	"154"	"10.853"
"R-HSA-5668599"	"RHO GTPases Activate NADPH Oxidases"	"-2.952"	"10"	"24.9"	"5.048"
"R-HSA-75157"	"FasL/ CD95L signaling"	"-2.96"	"3"	"12.26"	"3.129"
"R-HSA-2022923"	"Dermatan sulfate biosynthesis"	"-2.966"	"0"	"7.26"	"2.448"
"R-HSA-1236975"	"Antigen processing-Cross presentation"	"-3.001"	"64"	"93.54"	"9.842"
"R-HSA-211227"	"Activation of DNA fragmentation factor"	"-3.003"	"34"	"52.64"	"6.207"
"R-HSA-140342"	"Apoptosis induced DNA fragmentation"	"-3.003"	"34"	"52.64"	"6.207"
"R-HSA-111446"	"Activation of BIM and translocation to mitochondria "	"-3.013"	"10"	"22.58"	"4.175"
"R-HSA-6804754"	"Regulation of TP53 Expression"	"-3.013"	"12"	"24.58"	"4.175"
"R-HSA-176814"	"Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins"	"-3.016"	"289"	"353.82"	"21.491"
"R-HSA-1810476"	"RIP-mediated NFkB activation via ZBP1"	"-3.028"	"90"	"130.86"	"13.494"
"R-HSA-140877"	"Formation of Fibrin Clot (Clotting Cascade)"	"-3.034"	"22"	"42.7"	"6.822"
"R-HSA-5683057"	"MAPK family signaling cascades"	"-3.043"	"964"	"1087.56"	"40.598"
"R-HSA-182971"	"EGFR downregulation"	"-3.052"	"297"	"359.08"	"20.34"
"R-HSA-428540"	"Activation of RAC1"	"-3.056"	"31"	"51.16"	"6.597"
"R-HSA-428543"	"Inactivation of CDC42 and RAC1"	"-3.06"	"13"	"27.8"	"4.836"
"R-HSA-1606322"	"ZBP1(DAI) mediated induction of type I IFNs"	"-3.061"	"95"	"138.14"	"14.094"
"R-HSA-72306"	"tRNA processing"	"-3.081"	"188"	"233.6"	"14.801"
"R-HSA-8935964"	"RUNX1 regulates expression of components of tight junctions"	"-3.09"	"0"	"6.22"	"2.013"
"R-HSA-74713"	"IRS activation"	"-3.093"	"0"	"10.94"	"3.536"
"R-HSA-6807004"	"Negative regulation of MET activity"	"-3.094"	"261"	"315.9"	"17.743"
"R-HSA-203765"	"eNOS activation and regulation"	"-3.102"	"61"	"88.76"	"8.95"
"R-HSA-202131"	"Metabolism of nitric oxide"	"-3.102"	"61"	"88.76"	"8.95"
"R-HSA-1251985"	"Nuclear signaling by ERBB4"	"-3.103"	"48"	"68.96"	"6.755"
"R-HSA-5658623"	"FGFRL1 modulation of FGFR1 signaling"	"-3.115"	"2"	"13.92"	"3.827"
"R-HSA-8866376"	"Reelin signalling pathway"	"-3.117"	"6"	"20.68"	"4.71"
"R-HSA-1650814"	"Collagen biosynthesis and modifying enzymes"	"-3.12"	"28"	"47.5"	"6.251"
"R-HSA-6809371"	"Formation of the cornified envelope"	"-3.12"	"8"	"25.86"	"5.725"
"R-HSA-113510"	"E2F mediated regulation of DNA replication"	"-3.128"	"100"	"135.58"	"11.375"
"R-HSA-8963899"	"Plasma lipoprotein remodeling"	"-3.13"	"8"	"24"	"5.111"
"R-HSA-2173788"	"Downregulation of TGF-beta receptor signaling"	"-3.141"	"338"	"409.42"	"22.739"
"R-HSA-975576"	"N-glycan antennae elongation in the medial/trans-Golgi"	"-3.15"	"1"	"11.66"	"3.384"
"R-HSA-933543"	"NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10"	"-3.151"	"19"	"40.34"	"6.772"
"R-HSA-112315"	"Transmission across Chemical Synapses"	"-3.159"	"453"	"525.34"	"22.897"
"R-HSA-5693532"	"DNA Double-Strand Break Repair"	"-3.167"	"936"	"1055.12"	"37.617"
"R-HSA-69002"	"DNA Replication Pre-Initiation"	"-3.172"	"331"	"406.86"	"23.917"
"R-HSA-68874"	"M/G1 Transition"	"-3.172"	"331"	"406.86"	"23.917"
"R-HSA-114516"	"Disinhibition of SNARE formation"	"-3.177"	"3"	"14.26"	"3.545"
"WP4063"	"Interleukin-10 signaling"	"-3.177"	"3"	"14.54"	"3.632"
"R-HSA-373760"	"L1CAM interactions"	"-3.188"	"346"	"407.76"	"19.376"
"R-HSA-2894862"	"Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants"	"-3.19"	"398"	"477.52"	"24.931"
"R-HSA-2644606"	"Constitutive Signaling by NOTCH1 PEST Domain Mutants"	"-3.19"	"398"	"477.52"	"24.931"
"R-HSA-2894858"	"Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer"	"-3.19"	"398"	"477.52"	"24.931"
"R-HSA-2644603"	"Signaling by NOTCH1 in Cancer"	"-3.19"	"398"	"477.52"	"24.931"
"R-HSA-2644602"	"Signaling by NOTCH1 PEST Domain Mutants in Cancer"	"-3.19"	"398"	"477.52"	"24.931"
"R-HSA-383280"	"Nuclear Receptor transcription pathway"	"-3.227"	"122"	"159.82"	"11.719"
"R-HSA-8964043"	"Plasma lipoprotein clearance"	"-3.232"	"66"	"96.28"	"9.368"
"R-HSA-180786"	"Extension of Telomeres"	"-3.243"	"142"	"179"	"11.409"
"R-HSA-139910"	"Activation of BMF and translocation to mitochondria"	"-3.249"	"2"	"11"	"2.77"
"R-HSA-449836"	"Other interleukin signaling"	"-3.258"	"18"	"39.52"	"6.606"
"R-HSA-68952"	"DNA replication initiation"	"-3.259"	"7"	"19.88"	"3.952"
"R-HSA-174430"	"Telomere C-strand synthesis initiation"	"-3.259"	"7"	"19.88"	"3.952"
"R-HSA-8953750"	"Transcriptional Regulation by E2F6"	"-3.261"	"173"	"218.3"	"13.894"
"R-HSA-5693548"	"Sensing of DNA Double Strand Breaks"	"-3.262"	"17"	"35.8"	"5.764"
"R-HSA-5685939"	"HDR through MMEJ (alt-NHEJ)"	"-3.263"	"16"	"32.56"	"5.076"
"R-HSA-2586552"	"Signaling by Leptin"	"-3.265"	"16"	"34.96"	"5.806"
"WP4107"	"Transcriptional regulation by RUNX3"	"-3.28"	"438"	"523.18"	"25.969"
"R-HSA-140534"	"Ligand-dependent caspase activation"	"-3.3"	"15"	"36.96"	"6.655"
"R-HSA-8852276"	"The role of GTSE1 in G2/M progression after G2 checkpoint"	"-3.309"	"122"	"163.74"	"12.615"
"R-HSA-157118"	"Signaling by NOTCH"	"-3.311"	"637"	"749.6"	"34.008"
"R-HSA-68616"	"Assembly of the ORC complex at the origin of replication"	"-3.317"	"2"	"13.64"	"3.51"
"R-HSA-352238"	"Breakdown of the nuclear lamina"	"-3.319"	"2"	"11.84"	"2.965"
"R-HSA-8876384"	"Listeria monocytogenes entry into host cells"	"-3.319"	"270"	"328.62"	"17.66"
"R-HSA-176974"	"Unwinding of DNA"	"-3.326"	"38"	"62.42"	"7.343"
"R-HSA-3000170"	"Syndecan interactions"	"-3.334"	"25"	"47.06"	"6.616"
"R-HSA-5576892"	"Phase 0 - rapid depolarisation"	"-3.339"	"20"	"44.9"	"7.457"
"R-HSA-388844"	"Receptor-type tyrosine-protein phosphatases"	"-3.339"	"0"	"7.14"	"2.138"
"R-HSA-5696400"	"Dual Incision in GG-NER"	"-3.34"	"372"	"452.52"	"24.106"
"R-HSA-75893"	"TNF signaling"	"-3.342"	"96"	"127.28"	"9.359"
"R-HSA-5686938"	"Regulation of TLR by endogenous ligand"	"-3.35"	"3"	"18.74"	"4.698"
"R-HSA-9026527"	"Activated NTRK2 signals through PLCG1"	"-3.352"	"0"	"8.84"	"2.637"
"R-HSA-2024096"	"HS-GAG degradation"	"-3.356"	"5"	"19.94"	"4.451"
"R-HSA-444209"	"Free fatty acid receptors"	"-3.357"	"0"	"8.58"	"2.556"
"R-HSA-1566948"	"Elastic fibre formation"	"-3.359"	"12"	"32.44"	"6.085"
"WP3370"	"RORA activates gene expression"	"-3.359"	"5"	"20.62"	"4.651"
"R-HSA-1474228"	"Degradation of the extracellular matrix"	"-3.364"	"46"	"67.94"	"6.523"
"R-HSA-2173795"	"Downregulation of SMAD2/3:SMAD4 transcriptional activity"	"-3.371"	"277"	"337.14"	"17.841"
"R-HSA-2022854"	"Keratan sulfate biosynthesis"	"-3.379"	"2"	"16.04"	"4.155"
"R-HSA-6803211"	"TP53 Regulates Transcription of Death Receptors and Ligands"	"-3.385"	"19"	"41.4"	"6.618"
"R-HSA-3134963"	"DEx/H-box helicases activate type I IFN and inflammatory cytokines production "	"-3.387"	"61"	"97.22"	"10.695"
"R-HSA-6811436"	"COPI-independent Golgi-to-ER retrograde traffic"	"-3.394"	"79"	"117.82"	"11.437"
"WP2738"	"YAP1- and WWTR1 (TAZ)-stimulated gene expression"	"-3.395"	"9"	"25.02"	"4.719"
"R-HSA-877312"	"Regulation of IFNG signaling"	"-3.399"	"47"	"75.18"	"8.29"
"R-HSA-2562597"	"Optineurin and Myosin Phosphatase Negatively Regulate PLK1"	"-3.418"	"5"	"20.1"	"4.418"
"R-HSA-203641"	"NOSTRIN mediated eNOS trafficking"	"-3.423"	"9"	"24.24"	"4.452"
"R-HSA-209952"	"Peptide hormone biosynthesis"	"-3.428"	"0"	"14.34"	"4.183"
"R-HSA-8941332"	"RUNX2 regulates genes involved in cell migration"	"-3.429"	"8"	"19.38"	"3.319"
"WP3382"	"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation"	"-3.433"	"29"	"47.12"	"5.279"
"R-HSA-380095"	"Tachykinin receptors bind tachykinins"	"-3.438"	"0"	"14.54"	"4.229"
"R-HSA-168799"	"Neurotoxicity of clostridium toxins"	"-3.442"	"7"	"21.72"	"4.276"
"R-HSA-8940973"	"RUNX2 regulates osteoblast differentiation"	"-3.444"	"77"	"108.32"	"9.095"
"R-HSA-6804756"	"Regulation of TP53 Activity through Phosphorylation"	"-3.445"	"664"	"777.36"	"32.901"
"R-HSA-8849468"	"PTK6 Regulates Proteins Involved in RNA Processing"	"-3.457"	"2"	"13.84"	"3.425"
"R-HSA-1236974"	"ER-Phagosome pathway"	"-3.46"	"36"	"61.44"	"7.352"
"R-HSA-68881"	"Mitotic Metaphase/Anaphase Transition"	"-3.467"	"1"	"13.06"	"3.478"
"R-HSA-174414"	"Processive synthesis on the C-strand of the telomere"	"-3.474"	"45"	"72.88"	"8.025"
"R-HSA-1963642"	"PI3K events in ERBB2 signaling"	"-3.488"	"55"	"87"	"9.174"
"R-HSA-5694530"	"Cargo concentration in the ER"	"-3.489"	"64"	"93.88"	"8.563"
"R-HSA-2980736"	"Peptide hormone metabolism"	"-3.517"	"31"	"65.16"	"9.713"
"R-HSA-5654741"	"Signaling by FGFR3"	"-3.521"	"373"	"452.16"	"22.479"
"R-HSA-2122947"	"NOTCH1 Intracellular Domain Regulates Transcription"	"-3.525"	"429"	"521.06"	"26.114"
"R-HSA-6811440"	"Retrograde transport at the Trans-Golgi-Network"	"-3.528"	"61"	"92.54"	"8.94"
"R-HSA-5357769"	"Caspase activation via extrinsic apoptotic signalling pathway"	"-3.534"	"24"	"52.36"	"8.025"
"R-HSA-8952158"	"RUNX3 regulates BCL2L11 (BIM) transcription"	"-3.537"	"7"	"23.74"	"4.733"
"R-HSA-3214858"	"RMTs methylate histone arginines"	"-3.54"	"282"	"344.24"	"17.581"
"R-HSA-6802952"	"Signaling by BRAF and RAF fusions"	"-3.542"	"174"	"218.08"	"12.444"
"R-HSA-6807878"	"COPI-mediated anterograde transport"	"-3.543"	"303"	"360.68"	"16.281"
"R-HSA-416550"	"Sema4D mediated inhibition of cell attachment and migration"	"-3.556"	"9"	"29.84"	"5.86"
"R-HSA-977068"	"Termination of O-glycan biosynthesis"	"-3.559"	"2"	"18.02"	"4.502"
"R-HSA-68689"	"CDC6 association with the ORC:origin complex"	"-3.564"	"4"	"17.64"	"3.827"
"R-HSA-194002"	"Glucocorticoid biosynthesis"	"-3.568"	"1"	"11.04"	"2.814"
"R-HSA-1638074"	"Keratan sulfate/keratin metabolism"	"-3.574"	"2"	"17.84"	"4.433"
"R-HSA-112316"	"Neuronal System"	"-3.598"	"515"	"606.36"	"25.391"
"R-HSA-9028731"	"Activated NTRK2 signals through FRS2 and FRS3"	"-3.601"	"0"	"10.88"	"3.021"
"R-HSA-933541"	"TRAF6 mediated IRF7 activation"	"-3.606"	"55"	"83.28"	"7.843"
"R-HSA-164843"	"2-LTR circle formation"	"-3.608"	"12"	"27.88"	"4.401"
"R-HSA-174437"	"Removal of the Flap Intermediate from the C-strand"	"-3.631"	"41"	"70.56"	"8.142"
"R-HSA-5654743"	"Signaling by FGFR4"	"-3.653"	"371"	"452.84"	"22.404"
"R-HSA-1368108"	"BMAL1:CLOCK,NPAS2 activates circadian gene expression"	"-3.661"	"2"	"15.9"	"3.797"
"R-HSA-4086400"	"PCP/CE pathway"	"-3.662"	"324"	"411.84"	"23.988"
"R-HSA-210500"	"Glutamate Neurotransmitter Release Cycle"	"-3.665"	"15"	"31.62"	"4.535"
"R-HSA-194315"	"Signaling by Rho GTPases"	"-3.669"	"1614"	"1783.8"	"46.278"
"R-HSA-445989"	"TAK1 activates NFkB by phosphorylation and activation of IKKs complex"	"-3.674"	"122"	"172.24"	"13.673"
"R-HSA-174577"	"Activation of C3 and C5"	"-3.68"	"0"	"13.76"	"3.739"
"R-HSA-264870"	"Caspase-mediated cleavage of cytoskeletal proteins"	"-3.683"	"15"	"34.9"	"5.403"
"R-HSA-6803207"	"TP53 Regulates Transcription of Caspase Activators and Caspases"	"-3.685"	"22"	"42.58"	"5.585"
"R-HSA-5651801"	"PCNA-Dependent Long Patch Base Excision Repair"	"-3.687"	"78"	"117.46"	"10.702"
"R-HSA-982772"	"Growth hormone receptor signaling"	"-3.7"	"27"	"55.14"	"7.605"
"R-HSA-453279"	"Mitotic G1-G1/S phases"	"-3.707"	"705"	"841.36"	"36.78"
"R-HSA-3000157"	"Laminin interactions"	"-3.71"	"5"	"27.1"	"5.956"
"R-HSA-167044"	"Signalling to RAS"	"-3.71"	"104"	"138.46"	"9.287"
"R-HSA-5218920"	"VEGFR2 mediated vascular permeability"	"-3.715"	"109"	"159.34"	"13.552"
"R-HSA-3214841"	"PKMTs methylate histone lysines"	"-3.727"	"158"	"217.58"	"15.985"
"WP4079"	"RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)"	"-3.727"	"1"	"18.9"	"4.803"
"R-HSA-1502540"	"Signaling by Activin"	"-3.738"	"13"	"34.66"	"5.794"
"R-HSA-198933"	"Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"	"-3.758"	"86"	"125.56"	"10.527"
"R-HSA-933542"	"TRAF6 mediated NF-kB activation"	"-3.76"	"111"	"160.32"	"13.119"
"R-HSA-69478"	"G2/M DNA replication checkpoint"	"-3.766"	"12"	"32.32"	"5.396"
"R-HSA-2173796"	"SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription"	"-3.772"	"277"	"356.36"	"21.039"
"R-HSA-417973"	"Adenosine P1 receptors"	"-3.792"	"0"	"12.5"	"3.297"
"R-HSA-8874081"	"MET activates PTK2 signaling"	"-3.82"	"9"	"37.94"	"7.577"
"WP2781"	"Signaling by ERBB4"	"-3.854"	"346"	"430.3"	"21.874"
"R-HSA-69239"	"Synthesis of DNA"	"-3.873"	"470"	"579.6"	"28.297"
"R-HSA-2871837"	"FCERI mediated NF-kB activation"	"-3.877"	"68"	"109.4"	"10.677"
"R-HSA-8939256"	"RUNX1 regulates transcription of genes involved in WNT signaling"	"-3.88"	"12"	"36.92"	"6.423"
"R-HSA-187037"	"Signaling by NTRK1 (TRKA)"	"-3.891"	"373"	"441.2"	"17.525"
"R-HSA-5673001"	"RAF/MAP kinase cascade"	"-3.897"	"724"	"857.38"	"34.226"
"R-HSA-392023"	"Adrenaline signalling through Alpha-2 adrenergic receptor"	"-3.919"	"0"	"12.88"	"3.287"
"R-HSA-2022870"	"Chondroitin sulfate biosynthesis"	"-3.919"	"0"	"14.38"	"3.669"
"R-HSA-5654736"	"Signaling by FGFR1"	"-3.919"	"374"	"459.88"	"21.913"
"R-HSA-3296197"	"Hydroxycarboxylic acid-binding receptors"	"-3.928"	"0"	"12.9"	"3.284"
"R-HSA-1296071"	"Potassium Channels"	"-3.933"	"54"	"91.4"	"9.51"
"R-HSA-975634"	"Retinoid metabolism and transport"	"-3.948"	"28"	"55.48"	"6.961"
"R-HSA-918233"	"TRAF3-dependent IRF activation pathway"	"-3.949"	"32"	"57.98"	"6.579"
"R-HSA-8983432"	"Interleukin-15 signaling"	"-3.955"	"18"	"41.82"	"6.023"
"R-HSA-351906"	"Apoptotic cleavage of cell adhesion  proteins"	"-3.959"	"14"	"33.22"	"4.854"
"R-HSA-5576893"	"Phase 2 - plateau phase"	"-3.965"	"0"	"15.86"	"4"
"R-HSA-1169092"	"Activation of RAS in B cells"	"-3.97"	"2"	"18.14"	"4.066"
"R-HSA-909733"	"Interferon alpha/beta signaling"	"-3.971"	"58"	"95.02"	"9.323"
"R-HSA-1362277"	"Transcription of E2F targets under negative control by DREAM complex"	"-3.985"	"47"	"84.92"	"9.517"
"WP2673"	"Interleukin-7 signaling"	"-3.992"	"46"	"79.92"	"8.497"
"R-HSA-418990"	"Adherens junctions interactions"	"-3.997"	"13"	"34.02"	"5.259"
"R-HSA-2565942"	"Regulation of PLK1 Activity at G2/M Transition"	"-4.011"	"790"	"930.52"	"35.03"
"WP466"	"DNA Replication"	"-4.021"	"472"	"587.1"	"28.624"
"R-HSA-141430"	"Inactivation of APC/C via direct inhibition of the APC/C complex"	"-4.033"	"35"	"69.04"	"8.439"
"R-HSA-141405"	"Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components"	"-4.033"	"35"	"69.04"	"8.439"
"R-HSA-190239"	"FGFR3 ligand binding and activation"	"-4.036"	"3"	"15.9"	"3.196"
"R-HSA-190372"	"FGFR3c ligand binding and activation"	"-4.036"	"3"	"15.9"	"3.196"
"R-HSA-111448"	"Activation of NOXA and translocation to mitochondria"	"-4.041"	"21"	"45.08"	"5.958"
"R-HSA-6788467"	"IL-6-type cytokine receptor ligand interactions"	"-4.043"	"0"	"12.98"	"3.21"
"R-HSA-179812"	"GRB2 events in EGFR signaling"	"-4.045"	"44"	"75.22"	"7.718"
"R-HSA-6803205"	"TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain"	"-4.051"	"21"	"47.1"	"6.444"
"R-HSA-140875"	"Common Pathway of Fibrin Clot Formation"	"-4.052"	"3"	"20.34"	"4.279"
"R-HSA-1250196"	"SHC1 events in ERBB2 signaling"	"-4.063"	"80"	"120.64"	"10.002"
"WP3798"	"Regulation of TP53 Activity through Association with Co-factors"	"-4.078"	"25"	"54.18"	"7.156"
"R-HSA-6794362"	"Protein-protein interactions at synapses"	"-4.085"	"77"	"124.12"	"11.535"
"R-HSA-2033514"	"FGFR3 mutant receptor activation"	"-4.107"	"3"	"15.7"	"3.092"
"R-HSA-1839130"	"Signaling by activated point mutants of FGFR3"	"-4.107"	"3"	"15.7"	"3.092"
"R-HSA-9006927"	"Signaling by Non-Receptor Tyrosine Kinases"	"-4.107"	"359"	"464.42"	"25.671"
"WP3826"	"Signaling by PTK6"	"-4.107"	"359"	"464.42"	"25.671"
"R-HSA-419812"	"Calcitonin-like ligand receptors"	"-4.108"	"0"	"19.12"	"4.654"
"R-HSA-181430"	"Norepinephrine Neurotransmitter Release Cycle"	"-4.109"	"10"	"28.68"	"4.547"
"R-HSA-2029480"	"Fcgamma receptor (FCGR) dependent phagocytosis"	"-4.11"	"390"	"467.76"	"18.919"
"WP3558"	"Beta-catenin independent WNT signaling"	"-4.116"	"478"	"593.22"	"27.992"
"R-HSA-110373"	"Resolution of AP sites via the multiple-nucleotide patch replacement pathway"	"-4.132"	"82"	"128.98"	"11.37"
"R-HSA-6806667"	"Metabolism of fat-soluble vitamins"	"-4.133"	"28"	"57.82"	"7.216"
"R-HSA-1834949"	"Cytosolic sensors of pathogen-associated DNA "	"-4.136"	"351"	"471.04"	"29.026"
"R-HSA-500657"	"Presynaptic function of Kainate receptors"	"-4.139"	"37"	"70.12"	"8.002"
"R-HSA-418217"	"G beta:gamma signalling through PLC beta"	"-4.143"	"37"	"69.96"	"7.956"
"R-HSA-421270"	"Cell-cell junction organization"	"-4.146"	"22"	"48.52"	"6.396"
"R-HSA-3304349"	"Loss of Function of SMAD2/3 in Cancer"	"-4.146"	"10"	"35.48"	"6.145"
"WP3394"	"NR1D1 (REV-ERBA) represses gene expression"	"-4.146"	"1"	"14.34"	"3.217"
"R-HSA-3315487"	"SMAD2/3 MH2 Domain Mutants in Cancer"	"-4.146"	"10"	"35.48"	"6.145"
"R-HSA-3304356"	"SMAD2/3 Phosphorylation Motif Mutants in Cancer"	"-4.146"	"10"	"35.48"	"6.145"
"R-HSA-8957275"	"Post-translational protein phosphorylation"	"-4.151"	"117"	"184.24"	"16.197"
"R-HSA-2179392"	"EGFR Transactivation by Gastrin"	"-4.184"	"47"	"81.24"	"8.183"
"R-HSA-73884"	"Base Excision Repair"	"-4.187"	"95"	"144.26"	"11.764"
"R-HSA-73933"	"Resolution of Abasic Sites (AP sites)"	"-4.187"	"95"	"144.26"	"11.764"
"R-HSA-6811555"	"PI5P Regulates TP53 Acetylation"	"-4.19"	"23"	"52.84"	"7.121"
"R-HSA-1250342"	"PI3K events in ERBB4 signaling"	"-4.197"	"3"	"22"	"4.527"
"R-HSA-390651"	"Dopamine receptors"	"-4.219"	"0"	"18.7"	"4.432"
"R-HSA-399956"	"CRMPs in Sema3A signaling"	"-4.23"	"10"	"39.08"	"6.875"
"R-HSA-170670"	"Adenylate cyclase inhibitory pathway"	"-4.24"	"15"	"43.54"	"6.732"
"R-HSA-997269"	"Inhibition of adenylate cyclase pathway"	"-4.24"	"15"	"43.54"	"6.732"
"R-HSA-381771"	"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)"	"-4.243"	"0"	"20.08"	"4.733"
"R-HSA-1181150"	"Signaling by NODAL"	"-4.255"	"13"	"38.6"	"6.017"
"R-HSA-264642"	"Acetylcholine Neurotransmitter Release Cycle"	"-4.26"	"11"	"31.62"	"4.84"
"R-HSA-1971475"	"A tetrasaccharide linker sequence is required for GAG synthesis"	"-4.261"	"5"	"27.22"	"5.215"
"WP3436"	"Synthesis, secretion, and deacylation of Ghrelin"	"-4.267"	"0"	"17.2"	"4.03"
"R-HSA-5099900"	"WNT5A-dependent internalization of FZD4"	"-4.271"	"62"	"105.76"	"10.245"
"R-HSA-1442490"	"Collagen degradation"	"-4.285"	"2"	"14.7"	"2.964"
"R-HSA-913531"	"Interferon Signaling"	"-4.289"	"294"	"382.46"	"20.624"
"R-HSA-5684996"	"MAPK1/MAPK3 signaling"	"-4.291"	"728"	"882.16"	"35.926"
"WP3333"	"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"	"-4.292"	"31"	"55.66"	"5.745"
"R-HSA-4615885"	"SUMOylation of DNA replication proteins"	"-4.327"	"232"	"302.32"	"16.25"
"R-HSA-75892"	"Platelet Adhesion to exposed collagen"	"-4.342"	"6"	"29.54"	"5.422"
"WP2720"	"Signaling by NOTCH1"	"-4.345"	"460"	"576.4"	"26.791"
"R-HSA-9032500"	"Activated NTRK2 signals through FYN"	"-4.349"	"4"	"25.72"	"4.994"
"R-HSA-199977"	"ER to Golgi Anterograde Transport"	"-4.381"	"412"	"501.9"	"20.519"
"R-HSA-8854691"	"Interleukin-20 family signaling"	"-4.388"	"3"	"22.74"	"4.499"
"R-HSA-8939246"	"RUNX1 regulates transcription of genes involved in differentiation of myeloid cells"	"-4.389"	"2"	"22.72"	"4.721"
"R-HSA-391906"	"Leukotriene receptors"	"-4.398"	"0"	"18.82"	"4.279"
"R-HSA-1963640"	"GRB2 events in ERBB2 signaling"	"-4.405"	"52"	"89.64"	"8.545"
"R-HSA-380259"	"Loss of Nlp from mitotic centrosomes"	"-4.411"	"480"	"583.92"	"23.56"
"R-HSA-380284"	"Loss of proteins required for interphase microtubule organization from the centrosome"	"-4.411"	"480"	"583.92"	"23.56"
"WP4066"	"Interleukin-4 and 13 signaling"	"-4.417"	"9"	"30.46"	"4.858"
"R-HSA-390650"	"Histamine receptors"	"-4.43"	"0"	"13.1"	"2.957"
"R-HSA-113507"	"E2F-enabled inhibition of pre-replication complex formation"	"-4.434"	"11"	"38.1"	"6.112"
"R-HSA-164944"	"Nef and signal transduction"	"-4.453"	"14"	"42.26"	"6.346"
"R-HSA-449147"	"Signaling by Interleukins"	"-4.478"	"896"	"1075.62"	"40.114"
"R-HSA-187687"	"Signalling to ERKs"	"-4.483"	"142"	"186.14"	"9.846"
"R-HSA-400511"	"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)"	"-4.505"	"0"	"16.84"	"3.738"
"R-HSA-1912408"	"Pre-NOTCH Transcription and Translation"	"-4.516"	"124"	"186.44"	"13.827"
"R-HSA-390648"	"Muscarinic acetylcholine receptors"	"-4.526"	"0"	"18.82"	"4.159"
"R-HSA-181429"	"Serotonin Neurotransmitter Release Cycle"	"-4.528"	"10"	"30.48"	"4.523"
"R-HSA-2871796"	"FCERI mediated MAPK activation"	"-4.531"	"173"	"244.2"	"15.713"
"R-HSA-2022090"	"Assembly of collagen fibrils and other multimeric structures"	"-4.537"	"5"	"31.46"	"5.832"
"R-HSA-180336"	"SHC1 events in EGFR signaling"	"-4.543"	"48"	"84.58"	"8.051"
"R-HSA-375170"	"CDO in myogenesis"	"-4.546"	"49"	"97.16"	"10.593"
"R-HSA-525793"	"Myogenesis"	"-4.546"	"49"	"97.16"	"10.593"
"R-HSA-399955"	"SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion"	"-4.557"	"4"	"38.94"	"7.668"
"WP2786"	"Pre-NOTCH Expression and Processing"	"-4.564"	"130"	"195.52"	"14.356"
"R-HSA-3000471"	"Scavenging by Class B Receptors"	"-4.572"	"0"	"14.9"	"3.259"
"R-HSA-9006925"	"Intracellular signaling by second messengers"	"-4.576"	"1140"	"1301.66"	"35.329"
"R-HSA-8941855"	"RUNX3 regulates CDKN1A transcription"	"-4.576"	"23"	"52.38"	"6.42"
"R-HSA-3000178"	"ECM proteoglycans"	"-4.579"	"11"	"45.68"	"7.574"
"R-HSA-6811558"	"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"	"-4.597"	"289"	"371.96"	"18.048"
"R-HSA-373755"	"Semaphorin interactions"	"-4.611"	"180"	"261.38"	"17.65"
"R-HSA-5620924"	"Intraflagellar transport"	"-4.612"	"38"	"75.7"	"8.175"
"R-HSA-168274"	"Export of Viral Ribonucleoproteins from Nucleus"	"-4.617"	"154"	"224.34"	"15.234"
"R-HSA-6811442"	"Intra-Golgi and retrograde Golgi-to-ER traffic"	"-4.619"	"388"	"489.38"	"21.949"
"R-HSA-112314"	"Neurotransmitter receptors and postsynaptic signal transmission"	"-4.626"	"316"	"398.78"	"17.893"
"WP2728"	"Incretin synthesis, secretion, and inactivation"	"-4.629"	"0"	"22.02"	"4.757"
"R-HSA-171007"	"p38MAPK events"	"-4.66"	"22"	"53.08"	"6.67"
"R-HSA-381426"	"Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"	"-4.668"	"120"	"195.22"	"16.115"
"R-HSA-372708"	"p130Cas linkage to MAPK signaling for integrins"	"-4.673"	"36"	"68.28"	"6.908"
"R-HSA-5368598"	"Negative regulation of TCF-dependent signaling by DVL-interacting proteins"	"-4.685"	"0"	"17.46"	"3.726"
"R-HSA-8865999"	"MET activates PTPN11"	"-4.702"	"11"	"38"	"5.743"
"R-HSA-375281"	"Hormone ligand-binding receptors"	"-4.719"	"0"	"25.94"	"5.497"
"R-HSA-373753"	"Nephrin family interactions"	"-4.72"	"57"	"106.54"	"10.496"
"R-HSA-165054"	"Rev-mediated nuclear export of HIV RNA"	"-4.727"	"141"	"214"	"15.442"
"R-HSA-419037"	"NCAM1 interactions"	"-4.735"	"4"	"22.62"	"3.933"
"R-HSA-3247509"	"Chromatin modifying enzymes"	"-4.737"	"899"	"1054.22"	"32.766"
"R-HSA-4839726"	"Chromatin organization"	"-4.737"	"899"	"1054.22"	"32.766"
"R-HSA-69186"	"Lagging Strand Synthesis"	"-4.741"	"71"	"116.9"	"9.681"
"R-HSA-174417"	"Telomere C-strand (Lagging Strand) Synthesis"	"-4.743"	"78"	"126.9"	"10.31"
"R-HSA-8851907"	"MET activates PI3K/AKT signaling"	"-4.747"	"12"	"46.24"	"7.213"
"R-HSA-1538133"	"G0 and Early G1"	"-4.761"	"94"	"154.54"	"12.715"
"R-HSA-1474290"	"Collagen formation"	"-4.771"	"33"	"68.52"	"7.446"
"R-HSA-190241"	"FGFR2 ligand binding and activation"	"-4.775"	"1"	"20.54"	"4.092"
"R-HSA-176417"	"Phosphorylation of Emi1"	"-4.794"	"15"	"47.1"	"6.695"
"R-HSA-69183"	"Processive synthesis on the lagging strand"	"-4.795"	"45"	"82.76"	"7.875"
"R-HSA-139915"	"Activation of PUMA and translocation to mitochondria"	"-4.798"	"24"	"55.82"	"6.632"
"R-HSA-453274"	"Mitotic G2-G2/M phases"	"-4.805"	"1053"	"1249.46"	"40.891"
"R-HSA-913709"	"O-linked glycosylation of mucins"	"-4.805"	"3"	"34.56"	"6.569"
"R-HSA-2022928"	"HS-GAG biosynthesis"	"-4.806"	"6"	"36.46"	"6.338"
"R-HSA-8878166"	"Transcriptional regulation by RUNX2"	"-4.811"	"434"	"563.5"	"26.918"
"R-HSA-5625900"	"RHO GTPases activate CIT"	"-4.829"	"69"	"121.74"	"10.922"
"R-HSA-2033519"	"Activated point mutants of FGFR2"	"-4.846"	"1"	"20.38"	"3.999"
"R-HSA-1839126"	"FGFR2 mutant receptor activation"	"-4.846"	"1"	"20.38"	"3.999"
"R-HSA-5617833"	"Cilium Assembly"	"-4.862"	"799"	"933.24"	"27.608"
"R-HSA-948021"	"Transport to the Golgi and subsequent modification"	"-4.864"	"413"	"514.06"	"20.777"
"R-HSA-446728"	"Cell junction organization"	"-4.882"	"63"	"102.22"	"8.034"
"R-HSA-190322"	"FGFR4 ligand binding and activation"	"-4.906"	"1"	"16.58"	"3.176"
"R-HSA-212676"	"Dopamine Neurotransmitter Release Cycle"	"-4.909"	"14"	"39.26"	"5.146"
"R-HSA-111465"	"Apoptotic cleavage of cellular proteins"	"-4.917"	"73"	"114.76"	"8.494"
"R-HSA-418886"	"Netrin mediated repulsion signals"	"-4.933"	"16"	"49.8"	"6.851"
"R-HSA-8854518"	"AURKA Activation by TPX2"	"-4.937"	"484"	"599.24"	"23.344"
"WP3354"	"C-type lectin receptors (CLRs)"	"-4.937"	"261"	"357.58"	"19.562"
"R-HSA-380320"	"Recruitment of NuMA to mitotic centrosomes"	"-4.938"	"491"	"610.78"	"24.258"
"R-HSA-8875555"	"MET activates RAP1 and RAC1"	"-4.939"	"21"	"54.5"	"6.783"
"R-HSA-190373"	"FGFR1c ligand binding and activation"	"-4.946"	"1"	"16.42"	"3.117"
"R-HSA-193670"	"p75NTR negatively regulates cell cycle via SC1"	"-4.95"	"7"	"40.5"	"6.768"
"R-HSA-1839122"	"Signaling by activated point mutants of FGFR1"	"-4.951"	"1"	"16.4"	"3.11"
"R-HSA-380287"	"Centrosome maturation"	"-4.955"	"491"	"610.06"	"24.03"
"R-HSA-380270"	"Recruitment of mitotic centrosome proteins and complexes"	"-4.955"	"491"	"610.06"	"24.03"
"R-HSA-69166"	"Removal of the Flap Intermediate"	"-4.96"	"41"	"80.44"	"7.952"
"R-HSA-180292"	"GAB1 signalosome"	"-4.964"	"47"	"99.32"	"10.539"
"R-HSA-912694"	"Regulation of IFNA signaling"	"-4.994"	"6"	"38.8"	"6.568"
"R-HSA-1227986"	"Signaling by ERBB2"	"-5.015"	"380"	"506.48"	"25.222"
"R-HSA-69190"	"DNA strand elongation"	"-5.039"	"109"	"179.32"	"13.954"
"R-HSA-190242"	"FGFR1 ligand binding and activation"	"-5.078"	"1"	"20.5"	"3.84"
"R-HSA-69275"	"G2/M Transition"	"-5.081"	"1030"	"1232.26"	"39.811"
"R-HSA-166520"	"Signaling by NTRKs"	"-5.09"	"382"	"481.16"	"19.48"
"R-HSA-3134973"	"LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production"	"-5.095"	"13"	"45.78"	"6.434"
"R-HSA-354194"	"GRB2:SOS provides linkage to MAPK signaling for Integrins "	"-5.148"	"47"	"86.74"	"7.719"
"R-HSA-190375"	"FGFR2c ligand binding and activation"	"-5.158"	"1"	"16.68"	"3.04"
"R-HSA-8866907"	"Activation of the TFAP2 (AP-2) family of transcription factors"	"-5.189"	"13"	"45.26"	"6.217"
"R-HSA-1839117"	"Signaling by cytosolic FGFR1 fusion mutants"	"-5.193"	"44"	"90.88"	"9.027"
"R-HSA-199418"	"Negative regulation of the PI3K/AKT network"	"-5.201"	"296"	"385.8"	"17.265"
"R-HSA-2980767"	"Activation of NIMA Kinases NEK9, NEK6, NEK7"	"-5.247"	"16"	"49.42"	"6.37"
"R-HSA-5637810"	"Constitutive Signaling by EGFRvIII"	"-5.283"	"87"	"149.52"	"11.834"
"R-HSA-5637812"	"Signaling by EGFRvIII in Cancer"	"-5.283"	"87"	"149.52"	"11.834"
"R-HSA-388479"	"Vasopressin-like receptors"	"-5.289"	"0"	"23.44"	"4.432"
"R-HSA-5654227"	"Phospholipase C-mediated cascade; FGFR3"	"-5.312"	"3"	"23.06"	"3.776"
"R-HSA-2514856"	"The phototransduction cascade"	"-5.326"	"24"	"75.34"	"9.64"
"R-HSA-2514859"	"Inactivation, recovery and regulation of the phototransduction cascade"	"-5.33"	"24"	"75.3"	"9.624"
"WP3802"	"TP53 Regulates Transcription of Cell Death Genes"	"-5.331"	"44"	"90.48"	"8.718"
"R-HSA-5685942"	"HDR through Homologous Recombination (HRR)"	"-5.348"	"344"	"477.74"	"25.007"
"R-HSA-8951936"	"RUNX3 regulates p14-ARF"	"-5.352"	"10"	"42.38"	"6.05"
"R-HSA-2485179"	"Activation of the phototransduction cascade"	"-5.389"	"4"	"35.34"	"5.816"
"R-HSA-5620912"	"Anchoring of the basal body to the plasma membrane"	"-5.392"	"579"	"726.9"	"27.431"
"R-HSA-3000171"	"Non-integrin membrane-ECM interactions"	"-5.413"	"27"	"71.14"	"8.154"
"R-HSA-1362300"	"Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1"	"-5.417"	"37"	"85.36"	"8.928"
"R-HSA-5633007"	"Regulation of TP53 Activity"	"-5.42"	"832"	"1043.74"	"39.064"
"R-HSA-73762"	"RNA Polymerase I Transcription Initiation"	"-5.444"	"174"	"277.32"	"18.98"
"R-HSA-176187"	"Activation of ATR in response to replication stress"	"-5.472"	"116"	"198.22"	"15.026"
"R-HSA-8941326"	"RUNX2 regulates bone development"	"-5.476"	"82"	"135.8"	"9.825"
"R-HSA-5690714"	"CD22 mediated BCR regulation"	"-5.485"	"1"	"37.1"	"6.582"
"R-HSA-1793185"	"Chondroitin sulfate/dermatan sulfate metabolism"	"-5.488"	"5"	"38.54"	"6.112"
"WP383"	"Striated Muscle Contraction"	"-5.488"	"35"	"85.3"	"9.166"
"R-HSA-3928665"	"EPH-ephrin mediated repulsion of cells"	"-5.495"	"15"	"57.62"	"7.756"
"R-HSA-1280215"	"Cytokine Signaling in Immune system"	"-5.509"	"1222"	"1472.58"	"45.484"
"R-HSA-157052"	"NICD traffics to nucleus"	"-5.527"	"32"	"73.9"	"7.582"
"R-HSA-350054"	"Notch-HLH transcription pathway"	"-5.527"	"32"	"73.9"	"7.582"
"R-HSA-2454202"	"Fc epsilon receptor (FCERI) signaling"	"-5.529"	"294"	"413.14"	"21.546"
"R-HSA-389357"	"CD28 dependent PI3K/Akt signaling"	"-5.561"	"34"	"80.18"	"8.305"
"R-HSA-8853659"	"RET signaling"	"-5.564"	"73"	"141.18"	"12.254"
"R-HSA-6781823"	"Formation of TC-NER Pre-Incision Complex"	"-5.568"	"462"	"612.1"	"26.958"
"WP2821"	"Transcriptional regulation of pluripotent stem cells"	"-5.569"	"48"	"92.5"	"7.99"
"R-HSA-202424"	"Downstream TCR signaling"	"-5.588"	"97"	"175.96"	"14.131"
"R-HSA-2029481"	"FCGR activation"	"-5.605"	"6"	"42.88"	"6.58"
"WP2653"	"PIP3 activates AKT signaling"	"-5.605"	"996"	"1175.86"	"32.087"
"R-HSA-389397"	"Orexin and neuropeptides FF and QRFP bind to their respective receptors"	"-5.608"	"0"	"24.92"	"4.444"
"R-HSA-170834"	"Signaling by TGF-beta Receptor Complex"	"-5.616"	"468"	"620.84"	"27.213"
"R-HSA-202430"	"Translocation of ZAP-70 to Immunological synapse"	"-5.632"	"14"	"53.18"	"6.957"
"R-HSA-75153"	"Apoptotic execution phase"	"-5.636"	"122"	"174.5"	"9.316"
"R-HSA-173623"	"Classical antibody-mediated complement activation"	"-5.638"	"1"	"27.86"	"4.764"
"R-HSA-211976"	"Endogenous sterols"	"-5.666"	"9"	"41.3"	"5.701"
"R-HSA-983189"	"Kinesins"	"-5.67"	"26"	"82.72"	"10.004"
"R-HSA-168928"	"DDX58/IFIH1-mediated induction of interferon-alpha/beta"	"-5.698"	"179"	"266.26"	"15.315"
"R-HSA-1834941"	"STING mediated induction of host immune responses"	"-5.708"	"18"	"54.56"	"6.405"
"R-HSA-5654228"	"Phospholipase C-mediated cascade; FGFR4"	"-5.71"	"1"	"23.94"	"4.017"
"R-HSA-177243"	"Interactions of Rev with host cellular proteins"	"-5.73"	"159"	"251.66"	"16.172"
"R-HSA-416572"	"Sema4D induced cell migration and growth-cone collapse"	"-5.73"	"33"	"87.3"	"9.477"
"R-HSA-1638091"	"Heparan sulfate/heparin (HS-GAG) metabolism"	"-5.737"	"6"	"47.82"	"7.289"
"R-HSA-112412"	"SOS-mediated signalling"	"-5.741"	"15"	"54.32"	"6.85"
"R-HSA-5627117"	"RHO GTPases Activate ROCKs"	"-5.749"	"61"	"109.94"	"8.513"
"R-HSA-9013508"	"NOTCH3 Intracellular Domain Regulates Transcription"	"-5.781"	"36"	"95.3"	"10.258"
"R-HSA-456926"	"Thrombin signalling through proteinase activated receptors (PARs)"	"-5.793"	"83"	"161.02"	"13.467"
"R-HSA-168254"	"Influenza Infection"	"-5.807"	"425"	"554.1"	"22.233"
"R-HSA-877300"	"Interferon gamma signaling"	"-5.818"	"113"	"195.96"	"14.26"
"R-HSA-2173793"	"Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer"	"-5.822"	"312"	"426.58"	"19.68"
"R-HSA-9006936"	"Signaling by TGF-beta family members"	"-5.824"	"487"	"653.22"	"28.542"
"R-HSA-5696398"	"Nucleotide Excision Repair"	"-5.831"	"802"	"1005.82"	"34.955"
"R-HSA-5654221"	"Phospholipase C-mediated cascade; FGFR2"	"-5.839"	"1"	"27.74"	"4.58"
"WP1775"	"Cell Cycle Checkpoints"	"-5.845"	"1305"	"1602.44"	"50.884"
"R-HSA-195258"	"RHO GTPase Effectors"	"-5.845"	"1337"	"1613.86"	"47.367"
"R-HSA-3270619"	"IRF3-mediated induction of type I IFN"	"-5.864"	"17"	"48.84"	"5.43"
"R-HSA-6804114"	"TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest"	"-5.867"	"75"	"143.56"	"11.685"
"R-HSA-159227"	"Transport of the SLBP independent Mature mRNA"	"-5.87"	"115"	"205.84"	"15.477"
"R-HSA-211897"	"Cytochrome P450 - arranged by substrate type"	"-5.877"	"33"	"83.1"	"8.524"
"R-HSA-159230"	"Transport of the SLBP Dependant Mature mRNA"	"-5.889"	"115"	"206.2"	"15.487"
"R-HSA-450520"	"HuR (ELAVL1) binds and stabilizes mRNA"	"-5.898"	"45"	"100.84"	"9.468"
"R-HSA-5173105"	"O-linked glycosylation"	"-5.899"	"3"	"44.12"	"6.971"
"R-HSA-1236382"	"Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants"	"-5.904"	"88"	"163.14"	"12.726"
"R-HSA-1643713"	"Signaling by EGFR in Cancer"	"-5.904"	"88"	"163.14"	"12.726"
"R-HSA-5637815"	"Signaling by Ligand-Responsive EGFR Variants in Cancer"	"-5.904"	"88"	"163.14"	"12.726"
"R-HSA-6804115"	"TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain"	"-5.919"	"37"	"93.54"	"9.552"
"R-HSA-389948"	"PD-1 signaling"	"-5.921"	"15"	"67.34"	"8.84"
"R-HSA-5654219"	"Phospholipase C-mediated cascade: FGFR1"	"-5.927"	"1"	"27.84"	"4.528"
"R-HSA-5218921"	"VEGFR2 mediated cell proliferation"	"-5.93"	"25"	"88.9"	"10.776"
"R-HSA-444821"	"Relaxin receptors"	"-5.933"	"0"	"26.96"	"4.544"
"WP1797"	"Circadian Clock"	"-5.934"	"106"	"163.72"	"9.727"
"R-HSA-9006934"	"Signaling by Receptor Tyrosine Kinases"	"-5.947"	"1560"	"1780.56"	"37.086"
"R-HSA-6805567"	"Keratinization"	"-5.951"	"23"	"79.82"	"9.548"
"R-HSA-418885"	"DCC mediated attractive signaling"	"-5.952"	"29"	"87.48"	"9.825"
"R-HSA-5625970"	"RHO GTPases activate KTN1"	"-5.952"	"14"	"56.5"	"7.141"
"R-HSA-8856828"	"Clathrin-mediated endocytosis"	"-5.963"	"716"	"901.14"	"31.05"
"R-HSA-5621480"	"Dectin-2 family"	"-5.994"	"8"	"45.18"	"6.203"
"R-HSA-170822"	"Regulation of Glucokinase by Glucokinase Regulatory Protein"	"-5.995"	"83"	"150.94"	"11.332"
"R-HSA-392170"	"ADP signalling through P2Y purinoceptor 12"	"-6.012"	"35"	"98.24"	"10.518"
"R-HSA-1059683"	"Interleukin-6 signaling"	"-6.018"	"8"	"44.12"	"6.002"
"R-HSA-444473"	"Formyl peptide receptors bind formyl peptides and many other ligands"	"-6.04"	"35"	"96.44"	"10.172"
"R-HSA-1250347"	"SHC1 events in ERBB4 signaling"	"-6.043"	"21"	"64.94"	"7.271"
"R-HSA-166786"	"Creation of C4 and C2 activators"	"-6.058"	"1"	"30.34"	"4.843"
"R-HSA-9026519"	"Activated NTRK2 signals through RAS"	"-6.069"	"19"	"59.72"	"6.71"
"R-HSA-8875878"	"MET promotes cell motility"	"-6.069"	"30"	"89.44"	"9.794"
"R-HSA-8853334"	"Signaling by FGFR3 fusions in cancer"	"-6.069"	"18"	"69.54"	"8.493"
"R-HSA-202427"	"Phosphorylation of CD3 and TCR zeta chains"	"-6.07"	"15"	"59.26"	"7.292"
"R-HSA-392851"	"Prostacyclin signalling through prostacyclin receptor"	"-6.085"	"21"	"68.44"	"7.796"
"R-HSA-391908"	"Prostanoid ligand receptors"	"-6.092"	"1"	"28.06"	"4.442"
"R-HSA-2559586"	"DNA Damage/Telomere Stress Induced Senescence"	"-6.108"	"86"	"156.78"	"11.589"
"R-HSA-389359"	"CD28 dependent Vav1 pathway"	"-6.152"	"39"	"85.94"	"7.63"
"R-HSA-180746"	"Nuclear import of Rev protein"	"-6.159"	"118"	"201.8"	"13.607"
"R-HSA-4570464"	"SUMOylation of RNA binding proteins"	"-6.161"	"195"	"317.14"	"19.824"
"R-HSA-176412"	"Phosphorylation of the APC/C"	"-6.177"	"35"	"82.02"	"7.612"
"R-HSA-2470946"	"Cohesin Loading onto Chromatin"	"-6.188"	"8"	"45.78"	"6.106"
"R-HSA-68962"	"Activation of the pre-replicative complex"	"-6.205"	"99"	"171.06"	"11.614"
"WP2772"	"S Phase"	"-6.223"	"519"	"713.52"	"31.256"
"R-HSA-177929"	"Signaling by EGFR"	"-6.228"	"312"	"450"	"22.158"
"R-HSA-445095"	"Interaction between L1 and Ankyrins"	"-6.229"	"5"	"41.5"	"5.86"
"R-HSA-391160"	"Signal regulatory protein family interactions"	"-6.235"	"15"	"58.2"	"6.928"
"R-HSA-5654710"	"PI-3K cascade:FGFR3"	"-6.262"	"15"	"66.7"	"8.257"
"R-HSA-1296065"	"Inwardly rectifying K+ channels"	"-6.268"	"15"	"69.22"	"8.65"
"R-HSA-606279"	"Deposition of new CENPA-containing nucleosomes at the centromere"	"-6.276"	"73"	"128.5"	"8.844"
"R-HSA-774815"	"Nucleosome assembly"	"-6.276"	"73"	"128.5"	"8.844"
"R-HSA-2428933"	"SHC-related events triggered by IGF1R"	"-6.297"	"20"	"61.4"	"6.575"
"R-HSA-6781827"	"Transcription-Coupled Nucleotide Excision Repair (TC-NER)"	"-6.312"	"558"	"741.68"	"29.099"
"R-HSA-6783589"	"Interleukin-6 family signaling"	"-6.319"	"8"	"46.08"	"6.027"
"R-HSA-72312"	"rRNA processing"	"-6.323"	"224"	"320.22"	"15.219"
"R-HSA-8941856"	"RUNX3 regulates NOTCH signaling"	"-6.334"	"25"	"82.56"	"9.087"
"R-HSA-166663"	"Initial triggering of complement"	"-6.346"	"1"	"39.42"	"6.054"
"R-HSA-381753"	"Olfactory Signaling Pathway"	"-6.384"	"7"	"52.12"	"7.067"
"R-HSA-1296041"	"Activation of G protein gated Potassium channels"	"-6.385"	"13"	"68.76"	"8.733"
"R-HSA-1296059"	"G protein gated Potassium channels"	"-6.385"	"13"	"68.76"	"8.733"
"R-HSA-997272"	"Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"	"-6.385"	"13"	"68.76"	"8.733"
"R-HSA-162906"	"HIV Infection"	"-6.4"	"1045"	"1285.82"	"37.626"
"R-HSA-73894"	"DNA Repair"	"-6.401"	"1432"	"1720.16"	"45.015"
"R-HSA-6782135"	"Dual incision in TC-NER"	"-6.401"	"508"	"688.96"	"28.273"
"R-HSA-416482"	"G alpha (12/13) signalling events"	"-6.402"	"132"	"215.42"	"13.031"
"R-HSA-8849471"	"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases"	"-6.405"	"13"	"66.08"	"8.288"
"R-HSA-202433"	"Generation of second messenger molecules"	"-6.409"	"36"	"102.04"	"10.303"
"R-HSA-2871809"	"FCERI mediated Ca+2 mobilization"	"-6.427"	"75"	"152.2"	"12.012"
"R-HSA-2559584"	"Formation of Senescence-Associated Heterochromatin Foci (SAHF)"	"-6.446"	"34"	"88.66"	"8.48"
"R-HSA-6790901"	"rRNA modification in the nucleus and cytosol"	"-6.457"	"217"	"315.56"	"15.265"
"R-HSA-8868773"	"rRNA processing in the nucleus and cytosol"	"-6.457"	"217"	"315.56"	"15.265"
"R-HSA-6803204"	"TP53 Regulates Transcription of Genes Involved in Cytochrome C Release"	"-6.496"	"26"	"66.6"	"6.25"
"R-HSA-375165"	"NCAM signaling for neurite out-growth"	"-6.502"	"91"	"172.78"	"12.577"
"R-HSA-4419969"	"Depolymerisation of the Nuclear Lamina"	"-6.52"	"13"	"48.84"	"5.497"
"R-HSA-6782210"	"Gap-filling DNA repair synthesis and ligation in TC-NER"	"-6.529"	"498"	"682.98"	"28.331"
"R-HSA-2187338"	"Visual phototransduction"	"-6.537"	"52"	"133.58"	"12.48"
"R-HSA-5626467"	"RHO GTPases activate IQGAPs"	"-6.541"	"27"	"78.68"	"7.901"
"R-HSA-1474244"	"Extracellular matrix organization"	"-6.549"	"178"	"270.54"	"14.131"
"R-HSA-400685"	"Sema4D in semaphorin signaling"	"-6.566"	"38"	"105.7"	"10.31"
"R-HSA-4551638"	"SUMOylation of chromatin organization proteins"	"-6.569"	"278"	"408.22"	"19.823"
"R-HSA-983231"	"Factors involved in megakaryocyte development and platelet production"	"-6.575"	"284"	"407.9"	"18.843"
"R-HSA-3928664"	"Ephrin signaling"	"-6.589"	"35"	"87.86"	"8.023"
"R-HSA-168333"	"NEP/NS2 Interacts with the Cellular Export Machinery"	"-6.598"	"92"	"184.6"	"14.035"
"R-HSA-5654695"	"PI-3K cascade:FGFR2"	"-6.631"	"13"	"71.38"	"8.804"
"R-HSA-451927"	"Interleukin-2 family signaling"	"-6.633"	"47"	"119.96"	"10.999"
"R-HSA-400042"	"Adrenaline,noradrenaline inhibits insulin secretion"	"-6.636"	"30"	"89.26"	"8.93"
"R-HSA-156711"	"Polo-like kinase mediated events"	"-6.647"	"15"	"67.88"	"7.956"
"R-HSA-1839124"	"FGFR1 mutant receptor activation"	"-6.648"	"48"	"112.76"	"9.741"
"R-HSA-111367"	"SLBP independent Processing of Histone Pre-mRNAs"	"-6.653"	"12"	"65.76"	"8.08"
"R-HSA-202403"	"TCR signaling"	"-6.663"	"122"	"236.38"	"17.168"
"R-HSA-77588"	"SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs"	"-6.669"	"12"	"66.12"	"8.116"
"R-HSA-5654720"	"PI-3K cascade:FGFR4"	"-6.681"	"13"	"67.58"	"8.169"
"R-HSA-8856825"	"Cargo recognition for clathrin-mediated endocytosis"	"-6.69"	"498"	"688.76"	"28.516"
"R-HSA-388841"	"Costimulation by the CD28 family"	"-6.709"	"206"	"319.1"	"16.857"
"R-HSA-168255"	"Influenza Life Cycle"	"-6.714"	"350"	"500.08"	"22.353"
"R-HSA-390666"	"Serotonin receptors"	"-6.752"	"2"	"43.54"	"6.152"
"R-HSA-74751"	"Insulin receptor signalling cascade"	"-6.756"	"93"	"179.92"	"12.866"
"R-HSA-68886"	"M Phase"	"-6.761"	"1703"	"2085"	"56.497"
"R-HSA-354192"	"Integrin alphaIIb beta3 signaling"	"-6.766"	"68"	"135.3"	"9.947"
"R-HSA-9006921"	"Integrin signaling"	"-6.766"	"68"	"135.3"	"9.947"
"R-HSA-168271"	"Transport of Ribonucleoproteins into the Host Nucleus"	"-6.815"	"81"	"162.7"	"11.989"
"R-HSA-418592"	"ADP signalling through P2Y purinoceptor 1"	"-6.834"	"29"	"92.8"	"9.335"
"R-HSA-5654689"	"PI-3K cascade:FGFR1"	"-6.837"	"13"	"71.48"	"8.553"
"R-HSA-2468052"	"Establishment of Sister Chromatid Cohesion"	"-6.845"	"9"	"49.72"	"5.949"
"R-HSA-72649"	"Translation initiation complex formation"	"-6.943"	"316"	"486.58"	"24.568"
"R-HSA-5663205"	"Infectious disease"	"-6.944"	"1324"	"1611.34"	"41.38"
"R-HSA-68884"	"Mitotic Telophase/Cytokinesis"	"-6.948"	"12"	"67.5"	"7.988"
"hsa04360"	"Axon guidance"	"-6.954"	"1085"	"1393.24"	"44.327"
"R-HSA-199991"	"Membrane Trafficking"	"-6.97"	"1718"	"2065.98"	"49.924"
"R-HSA-5653656"	"Vesicle-mediated transport"	"-6.996"	"1810"	"2171.1"	"51.618"
"R-HSA-202040"	"G-protein activation"	"-7.013"	"37"	"115.16"	"11.145"
"R-HSA-5693568"	"Resolution of D-loop Structures through Holliday Junction Intermediates"	"-7.02"	"39"	"108.26"	"9.866"
"R-HSA-8851805"	"MET activates RAS signaling"	"-7.021"	"20"	"66.14"	"6.571"
"R-HSA-5627123"	"RHO GTPases activate PAKs"	"-7.043"	"71"	"146.96"	"10.785"
"R-HSA-6806834"	"Signaling by MET"	"-7.054"	"294"	"447.26"	"21.725"
"R-HSA-418597"	"G alpha (z) signalling events"	"-7.07"	"52"	"142.26"	"12.766"
"R-HSA-2682334"	"EPH-Ephrin signaling"	"-7.103"	"239"	"358.7"	"16.851"
"R-HSA-5655291"	"Signaling by FGFR4 in disease"	"-7.126"	"16"	"76.54"	"8.495"
"R-HSA-5693554"	"Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"	"-7.161"	"30"	"94.98"	"9.074"
"R-HSA-72662"	"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S"	"-7.182"	"319"	"490.62"	"23.896"
"R-HSA-180910"	"Vpr-mediated nuclear import of PICs"	"-7.188"	"73"	"156.44"	"11.608"
"R-HSA-417957"	"P2Y receptors"	"-7.199"	"1"	"49.34"	"6.715"
"R-HSA-5693537"	"Resolution of D-Loop Structures"	"-7.256"	"39"	"109.66"	"9.739"
"R-HSA-977606"	"Regulation of Complement cascade"	"-7.26"	"5"	"73.76"	"9.471"
"R-HSA-166658"	"Complement cascade"	"-7.276"	"6"	"76.74"	"9.722"
"R-HSA-5654704"	"SHC-mediated cascade:FGFR3"	"-7.276"	"22"	"73.94"	"7.138"
"R-HSA-2029485"	"Role of phospholipids in phagocytosis"	"-7.297"	"32"	"95.18"	"8.658"
"WP2797"	"Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)"	"-7.404"	"20"	"81.18"	"8.263"
"R-HSA-8939243"	"RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known"	"-7.413"	"82"	"183"	"13.625"
"R-HSA-210990"	"PECAM1 interactions"	"-7.419"	"7"	"66.08"	"7.964"
"R-HSA-109704"	"PI3K Cascade"	"-7.431"	"30"	"107.34"	"10.407"
"R-HSA-5654706"	"FRS-mediated FGFR3 signaling"	"-7.482"	"18"	"73.98"	"7.482"
"R-HSA-912526"	"Interleukin receptor SHC signaling"	"-7.488"	"28"	"98.02"	"9.351"
"R-HSA-210993"	"Tie2 Signaling"	"-7.511"	"26"	"93.28"	"8.958"
"R-HSA-418038"	"Nucleotide-like (purinergic) receptors"	"-7.518"	"1"	"61.84"	"8.092"
"R-HSA-428930"	"Thromboxane signalling through TP receptor"	"-7.611"	"21"	"83.24"	"8.178"
"R-HSA-186763"	"Downstream signal transduction"	"-7.614"	"48"	"158.12"	"14.463"
"R-HSA-76009"	"Platelet Aggregation (Plug Formation)"	"-7.614"	"68"	"153.58"	"11.24"
"R-HSA-5654699"	"SHC-mediated cascade:FGFR2"	"-7.647"	"20"	"78.62"	"7.666"
"R-HSA-420092"	"Glucagon-type ligand receptors"	"-7.681"	"22"	"103.92"	"10.665"
"R-HSA-391903"	"Eicosanoid ligand-binding receptors"	"-7.688"	"1"	"51.18"	"6.527"
"R-HSA-72702"	"Ribosomal scanning and start codon recognition"	"-7.71"	"289"	"468.76"	"23.316"
"R-HSA-5685938"	"HDR through Single Strand Annealing (SSA)"	"-7.736"	"83"	"184.12"	"13.071"
"R-HSA-9006115"	"Signaling by NTRK2 (TRKB)"	"-7.748"	"31"	"119.5"	"11.422"
"R-HSA-5693579"	"Homologous DNA Pairing and Strand Exchange"	"-7.798"	"75"	"184.8"	"14.08"
"R-HSA-1433559"	"Regulation of KIT signaling"	"-7.858"	"23"	"101.08"	"9.936"
"R-HSA-159231"	"Transport of Mature mRNA Derived from an Intronless Transcript"	"-7.88"	"125"	"244.62"	"15.18"
"R-HSA-991365"	"Activation of GABAB receptors"	"-7.912"	"28"	"112.3"	"10.655"
"R-HSA-5654693"	"FRS-mediated FGFR1 signaling"	"-7.912"	"16"	"78.76"	"7.932"
"R-HSA-977444"	"GABA B receptor activation"	"-7.912"	"28"	"112.3"	"10.655"
"R-HSA-5663202"	"Diseases of signal transduction"	"-7.918"	"931"	"1226.54"	"37.323"
"R-HSA-5693616"	"Presynaptic phase of homologous DNA pairing and strand exchange"	"-7.918"	"69"	"178.14"	"13.784"
"R-HSA-159234"	"Transport of Mature mRNAs Derived from Intronless Transcripts"	"-7.931"	"125"	"244.98"	"15.129"
"R-HSA-6784531"	"tRNA processing in the nucleus"	"-7.977"	"83"	"191.1"	"13.551"
"R-HSA-5655332"	"Signaling by FGFR3 in disease"	"-7.98"	"19"	"90.98"	"9.02"
"R-HSA-8853338"	"Signaling by FGFR3 point mutants in cancer"	"-7.98"	"19"	"90.98"	"9.02"
"R-HSA-5654700"	"FRS-mediated FGFR2 signaling"	"-8.012"	"16"	"78.66"	"7.821"
"R-HSA-373752"	"Netrin-1 signaling"	"-8.027"	"40"	"137.02"	"12.087"
"R-HSA-5654688"	"SHC-mediated cascade:FGFR1"	"-8.03"	"20"	"78.72"	"7.312"
"R-HSA-5654719"	"SHC-mediated cascade:FGFR4"	"-8.034"	"20"	"74.82"	"6.823"
"R-HSA-977443"	"GABA receptor activation"	"-8.075"	"30"	"117.12"	"10.789"
"R-HSA-392518"	"Signal amplification"	"-8.083"	"43"	"133.94"	"11.251"
"R-HSA-375280"	"Amine ligand-binding receptors"	"-8.084"	"31"	"132.08"	"12.504"
"R-HSA-983169"	"Class I MHC mediated antigen processing & presentation"	"-8.123"	"846"	"1116.92"	"33.353"
"R-HSA-186797"	"Signaling by PDGF"	"-8.123"	"53"	"173.84"	"14.875"
"R-HSA-3301854"	"Nuclear Pore Complex (NPC) Disassembly"	"-8.151"	"68"	"173.88"	"12.989"
"WP3804"	"TP53 Regulates Transcription of Cell Cycle Genes"	"-8.153"	"156"	"273.78"	"14.447"
"R-HSA-389356"	"CD28 co-stimulation"	"-8.168"	"77"	"176.3"	"12.158"
"R-HSA-2730905"	"Role of LAT2/NTAL/LAB on calcium mobilization"	"-8.296"	"30"	"115.32"	"10.285"
"R-HSA-397795"	"G-protein beta:gamma signalling"	"-8.345"	"75"	"181.4"	"12.75"
"R-HSA-5655253"	"Signaling by FGFR2 in disease"	"-8.347"	"17"	"95.66"	"9.423"
"R-HSA-5654708"	"Downstream signaling of activated FGFR3"	"-8.356"	"23"	"108.4"	"10.22"
"R-HSA-77595"	"Processing of Intronless Pre-mRNAs"	"-8.401"	"30"	"118.82"	"10.573"
"R-HSA-3108214"	"SUMOylation of DNA damage response and repair proteins"	"-8.461"	"276"	"450.1"	"20.578"
"R-HSA-419408"	"Lysosphingolipid and LPA receptors"	"-8.565"	"1"	"50.32"	"5.759"
"R-HSA-1226099"	"Signaling by FGFR in disease"	"-8.58"	"54"	"157.56"	"12.07"
"R-HSA-5654712"	"FRS-mediated FGFR4 signaling"	"-8.591"	"16"	"74.86"	"6.851"
"R-HSA-76002"	"Platelet activation, signaling and aggregation"	"-8.595"	"622"	"843.36"	"25.754"
"R-HSA-69278"	"Cell Cycle, Mitotic"	"-8.608"	"2247"	"2845.92"	"69.58"
"R-HSA-5654696"	"Downstream signaling of activated FGFR2"	"-8.643"	"21"	"113.08"	"10.654"
"R-HSA-5655302"	"Signaling by FGFR1 in disease"	"-8.649"	"52"	"147.84"	"11.081"
"R-HSA-2219528"	"PI3K/AKT Signaling in Cancer"	"-8.665"	"195"	"323.92"	"14.879"
"R-HSA-5654687"	"Downstream signaling of activated FGFR1"	"-8.722"	"22"	"113.88"	"10.534"
"R-HSA-5654738"	"Signaling by FGFR2"	"-8.786"	"470"	"706.22"	"26.885"
"R-HSA-5654716"	"Downstream signaling of activated FGFR4"	"-8.803"	"21"	"109.28"	"10.029"
"R-HSA-983705"	"Signaling by the B Cell Receptor (BCR)"	"-8.811"	"182"	"327.42"	"16.505"
"R-HSA-112399"	"IRS-mediated signalling"	"-8.825"	"34"	"131.32"	"11.028"
"R-HSA-1630316"	"Glycosaminoglycan metabolism"	"-8.888"	"9"	"82.88"	"8.312"
"R-HSA-190236"	"Signaling by FGFR"	"-8.918"	"475"	"716.68"	"27.101"
"R-HSA-162599"	"Late Phase of HIV Life Cycle"	"-8.919"	"716"	"985.96"	"30.269"
"WP179"	"Cell Cycle"	"-8.942"	"2601"	"3246.62"	"72.199"
"R-HSA-72695"	"Formation of the ternary complex, and subsequently, the 43S complex"	"-8.96"	"210"	"411.28"	"22.464"
"R-HSA-167161"	"HIV Transcription Initiation"	"-8.96"	"241"	"374.2"	"14.867"
"R-HSA-167162"	"RNA Polymerase II HIV Promoter Escape"	"-8.96"	"241"	"374.2"	"14.867"
"R-HSA-75953"	"RNA Polymerase II Transcription Initiation"	"-8.96"	"241"	"374.2"	"14.867"
"R-HSA-76042"	"RNA Polymerase II Transcription Initiation And Promoter Clearance"	"-8.96"	"241"	"374.2"	"14.867"
"R-HSA-73779"	"RNA Polymerase II Transcription Pre-Initiation And Promoter Opening"	"-8.96"	"241"	"374.2"	"14.867"
"R-HSA-983168"	"Antigen processing: Ubiquitination & Proteasome degradation"	"-8.974"	"678"	"934.16"	"28.544"
"R-HSA-162587"	"HIV Life Cycle"	"-9.049"	"758"	"1046.84"	"31.92"
"R-HSA-2428928"	"IRS-related events triggered by IGF1R"	"-9.085"	"35"	"136.94"	"11.22"
"R-HSA-73776"	"RNA Polymerase II Promoter Escape"	"-9.11"	"237"	"366.92"	"14.261"
"R-HSA-512988"	"Interleukin-3, 5 and GM-CSF signaling"	"-9.157"	"101"	"211.72"	"12.092"
"R-HSA-392451"	"G beta:gamma signalling through PI3Kgamma"	"-9.182"	"59"	"173.7"	"12.492"
"R-HSA-77075"	"RNA Pol II CTD phosphorylation and interaction with CE"	"-9.199"	"111"	"235.2"	"13.501"
"R-HSA-167160"	"RNA Pol II CTD phosphorylation and interaction with CE during HIV infection"	"-9.199"	"111"	"235.2"	"13.501"
"R-HSA-3928663"	"EPHA-mediated growth cone collapse"	"-9.21"	"24"	"99.22"	"8.167"
"R-HSA-6804758"	"Regulation of TP53 Activity through Acetylation"	"-9.388"	"47"	"144.74"	"10.412"
"R-HSA-167238"	"Pausing and recovery of Tat-mediated HIV elongation"	"-9.432"	"97"	"225.94"	"13.67"
"R-HSA-167243"	"Tat-mediated HIV elongation arrest and recovery"	"-9.432"	"97"	"225.94"	"13.67"
"R-HSA-1643685"	"Disease"	"-9.524"	"2120"	"2622.82"	"52.793"
"R-HSA-114604"	"GPVI-mediated activation cascade"	"-9.647"	"34"	"141.8"	"11.174"
"R-HSA-167287"	"HIV elongation arrest and recovery"	"-9.653"	"99"	"232.5"	"13.83"
"R-HSA-167290"	"Pausing and recovery of HIV elongation"	"-9.653"	"99"	"232.5"	"13.83"
"R-HSA-373080"	"Class B/2 (Secretin family receptors)"	"-9.655"	"32"	"165.92"	"13.871"
"R-HSA-2219530"	"Constitutive Signaling by Aberrant PI3K in Cancer"	"-9.678"	"90"	"220.06"	"13.438"
"R-HSA-2428924"	"IGF1R signaling cascade"	"-9.69"	"39"	"146.3"	"11.074"
"R-HSA-2404192"	"Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"	"-9.69"	"39"	"146.3"	"11.074"
"R-HSA-4420097"	"VEGFA-VEGFR2 Pathway"	"-9.695"	"206"	"405.18"	"20.545"
"R-HSA-983695"	"Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"	"-9.721"	"50"	"161.18"	"11.437"
"R-HSA-167242"	"Abortive elongation of HIV-1 transcript in the absence of Tat"	"-9.78"	"92"	"213.38"	"12.411"
"WP3808"	"TP53 Regulates Transcription of DNA Repair Genes"	"-9.839"	"269"	"426.92"	"16.051"
"R-HSA-194138"	"Signaling by VEGF"	"-9.912"	"206"	"408.64"	"20.444"
"WP2751"	"Transcriptional regulation of white adipocyte differentiation"	"-9.93"	"58"	"171.3"	"11.409"
"R-HSA-912631"	"Regulation of signaling by CBL"	"-9.934"	"29"	"114.6"	"8.617"
"R-HSA-2172127"	"DAP12 interactions"	"-10.129"	"60"	"166.04"	"10.469"
"R-HSA-1500931"	"Cell-Cell communication"	"-10.13"	"122"	"260.14"	"13.637"
"R-HSA-113418"	"Formation of the Early Elongation Complex"	"-10.176"	"131"	"268.92"	"13.554"
"R-HSA-167158"	"Formation of the HIV-1 Early Elongation Complex"	"-10.176"	"131"	"268.92"	"13.554"
"R-HSA-1433557"	"Signaling by SCF-KIT"	"-10.176"	"56"	"204.62"	"14.605"
"R-HSA-3108232"	"SUMO E3 ligases SUMOylate target proteins"	"-10.354"	"420"	"661.3"	"23.306"
"R-HSA-2408522"	"Selenoamino acid metabolism"	"-10.373"	"479"	"802.24"	"31.162"
"R-HSA-109582"	"Hemostasis"	"-10.395"	"1160"	"1499.52"	"32.662"
"R-HSA-194441"	"Metabolism of non-coding RNA"	"-10.477"	"89"	"244.06"	"14.8"
"R-HSA-191859"	"snRNP Assembly"	"-10.477"	"89"	"244.06"	"14.8"
"R-HSA-75067"	"Processing of Capped Intronless Pre-mRNA"	"-10.489"	"36"	"162.04"	"12.017"
"R-HSA-167172"	"Transcription of the HIV genome"	"-10.527"	"280"	"463.26"	"17.408"
"R-HSA-2990846"	"SUMOylation"	"-10.548"	"420"	"666.26"	"23.347"
"R-HSA-2980766"	"Nuclear Envelope Breakdown"	"-10.552"	"77"	"222.7"	"13.808"
"R-HSA-674695"	"RNA Polymerase II Pre-transcription Events"	"-10.558"	"294"	"489.54"	"18.52"
"R-HSA-72086"	"mRNA Capping"	"-10.615"	"117"	"258.1"	"13.293"
"R-HSA-2467813"	"Separation of Sister Chromatids"	"-10.642"	"511"	"832.44"	"30.204"
"R-HSA-6803529"	"FGFR2 alternative splicing"	"-10.784"	"99"	"250.78"	"14.075"
"R-HSA-167200"	"Formation of HIV-1 elongation complex containing HIV-1 Tat"	"-10.819"	"142"	"304.38"	"15.009"
"R-HSA-167169"	"HIV Transcription Elongation"	"-10.819"	"142"	"304.38"	"15.009"
"R-HSA-167246"	"Tat-mediated elongation of the HIV-1 transcript"	"-10.819"	"142"	"304.38"	"15.009"
"R-HSA-202733"	"Cell surface interactions at the vascular wall"	"-10.838"	"129"	"285.42"	"14.432"
"R-HSA-2424491"	"DAP12 signaling"	"-10.855"	"41"	"153.54"	"10.367"
"R-HSA-68882"	"Mitotic Anaphase"	"-10.866"	"520"	"864.24"	"31.681"
"R-HSA-2555396"	"Mitotic Metaphase and Anaphase"	"-10.879"	"520"	"865.24"	"31.735"
"R-HSA-112382"	"Formation of RNA Pol II elongation complex "	"-10.997"	"160"	"339.66"	"16.337"
"R-HSA-75955"	"RNA Polymerase II Transcription Elongation"	"-10.997"	"160"	"339.66"	"16.337"
"R-HSA-167152"	"Formation of HIV elongation complex in the absence of HIV Tat"	"-11.292"	"144"	"310.94"	"14.783"
"R-HSA-168273"	"Influenza Viral RNA Transcription and Replication"	"-11.421"	"166"	"348.34"	"15.965"
"R-HSA-156842"	"Eukaryotic Translation Elongation"	"-11.71"	"438"	"799.84"	"30.901"
"R-HSA-1280218"	"Adaptive Immune System"	"-11.796"	"1485"	"1966.1"	"40.784"
"R-HSA-420499"	"Class C/3 (Metabotropic glutamate/pheromone receptors)"	"-11.801"	"0"	"160.88"	"13.633"
"R-HSA-72737"	"Cap-dependent Translation Initiation"	"-12.184"	"546"	"927.1"	"31.279"
"R-HSA-72613"	"Eukaryotic Translation Initiation"	"-12.184"	"546"	"927.1"	"31.279"
"R-HSA-141444"	"Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal"	"-12.185"	"243"	"497.3"	"20.869"
"R-HSA-141424"	"Amplification of signal from the kinetochores"	"-12.185"	"243"	"497.3"	"20.869"
"R-HSA-68877"	"Mitotic Prometaphase"	"-12.274"	"760"	"1144.32"	"31.312"
"WP3827"	"RNA polymerase II transcribes snRNA genes"	"-12.322"	"164"	"365.56"	"16.357"
"R-HSA-168325"	"Viral Messenger RNA Synthesis"	"-12.366"	"121"	"305.3"	"14.904"
"R-HSA-156827"	"L13a-mediated translational silencing of Ceruloplasmin expression"	"-12.492"	"491"	"886.14"	"31.632"
"R-HSA-69618"	"Mitotic Spindle Checkpoint"	"-12.494"	"268"	"543.58"	"22.057"
"R-HSA-156902"	"Peptide chain elongation"	"-12.704"	"356"	"750.22"	"31.031"
"WP3379"	"RHO GTPases Activate Formins"	"-12.757"	"355"	"649.66"	"23.097"
"R-HSA-380108"	"Chemokine receptors bind chemokines"	"-12.806"	"4"	"180.08"	"13.75"
"R-HSA-72706"	"GTP hydrolysis and joining of the 60S ribosomal subunit"	"-13.065"	"470"	"876.76"	"31.134"
"R-HSA-1266738"	"Developmental Biology"	"-13.466"	"1276"	"1858.94"	"43.29"
"R-HSA-2408557"	"Selenocysteine synthesis"	"-13.828"	"314"	"714.84"	"28.987"
"R-HSA-72689"	"Formation of a pool of free 40S subunits"	"-14.297"	"355"	"787.74"	"30.269"
"R-HSA-2500257"	"Resolution of Sister Chromatid Cohesion"	"-14.4"	"264"	"576.92"	"21.731"
"R-HSA-1799339"	"SRP-dependent cotranslational protein targeting to membrane"	"-14.597"	"373"	"804.68"	"29.573"
"R-HSA-72764"	"Eukaryotic Translation Termination"	"-14.615"	"293"	"725.5"	"29.593"
"R-HSA-975956"	"Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"	"-14.784"	"335"	"781.9"	"30.228"
"R-HSA-72187"	"mRNA 3,-end processing"	"-14.835"	"99"	"328.1"	"15.443"
"R-HSA-159236"	"Transport of Mature mRNA derived from an Intron-Containing Transcript"	"-15.006"	"161"	"397.34"	"15.75"
"R-HSA-72165"	"mRNA Splicing - Minor Pathway"	"-15.097"	"155"	"409.5"	"16.857"
"R-HSA-212436"	"Generic Transcription Pathway"	"-15.708"	"3295"	"4329.5"	"65.86"
"R-HSA-418555"	"G alpha (s) signalling events"	"-15.854"	"78"	"355.82"	"17.524"
"R-HSA-72202"	"Transport of Mature Transcript to Cytoplasm"	"-15.984"	"193"	"449.46"	"16.045"
"R-HSA-975957"	"Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"	"-15.995"	"353"	"858.54"	"31.607"
"R-HSA-927802"	"Nonsense-Mediated Decay (NMD)"	"-15.995"	"353"	"858.54"	"31.607"
"R-HSA-109688"	"Cleavage of Growing Transcript in the Termination Region "	"-16.442"	"105"	"371.32"	"16.197"
"R-HSA-73856"	"RNA Polymerase II Transcription Termination"	"-16.442"	"105"	"371.32"	"16.197"
"R-HSA-73857"	"RNA Polymerase II Transcription"	"-19.48"	"3466"	"4822.44"	"69.631"
"R-HSA-416476"	"G alpha (q) signalling events"	"-20.129"	"218"	"790.96"	"28.465"
"R-HSA-74160"	"Gene expression (Transcription)"	"-20.644"	"3771"	"5220.72"	"70.226"
"R-HSA-72163"	"mRNA Splicing - Major Pathway"	"-22.127"	"509"	"1323.22"	"36.797"
"R-HSA-72172"	"mRNA Splicing"	"-22.335"	"517"	"1334.32"	"36.593"
"R-HSA-72203"	"Processing of Capped Intron-Containing Pre-mRNA"	"-24.569"	"664"	"1568.32"	"36.808"
"R-HSA-8953854"	"Metabolism of RNA"	"-25.69"	"1712"	"3102.6"	"54.131"
"R-HSA-162582"	"Signal Transduction"	"-26.056"	"5185"	"7304.92"	"81.359"
"R-HSA-418594"	"G alpha (i) signalling events"	"-26.295"	"434"	"1337.28"	"34.352"
"R-HSA-375276"	"Peptide ligand-binding receptors"	"-27.356"	"43"	"739.08"	"25.445"
"R-HSA-372790"	"Signaling by GPCR"	"-33.885"	"711"	"2205.66"	"44.11"
"R-HSA-388396"	"GPCR downstream signalling"	"-34.995"	"701"	"2177.1"	"42.18"
"R-HSA-373076"	"Class A/1 (Rhodopsin-like receptors)"	"-35.476"	"84"	"1138.86"	"29.734"
"R-HSA-500792"	"GPCR ligand binding"	"-37.497"	"116"	"1465.66"	"35.994"
